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ABSTRACT.  
 
This thesis evaluates and explores the effectiveness of post discharge physiotherapy exercise 
following total knee arthroplasty (TKA) for osteoarthritis in three ways.  
 
1. A systematic review evaluated the effectiveness of post discharge physiotherapy exercise 
on function, walking, range of motion, quality of life and muscle strength, for patients 
following elective primary TKA. Functional physiotherapy exercise interventions following 
discharge resulted in short term, but not long term, benefit. Effect sizes were small to 
moderate for function (0.33). Weighted mean differences were small to moderate for motion 
(2.9) and small for quality of life (1.66).   
 
2. A randomised clinical trial compared the effectiveness of a post discharge physiotherapy 
intervention in improving patient function versus usual physiotherapy for patients undergoing 
primary TKA. No significant statistical differences were observed between the two groups for 
all outcomes. This early trial was underpowered and impacted upon by some important 
factors which could potentially have masked any treatment trends occurring in the home visit 
group. 
 
3. Since blinding procedures are often assumed to indicate trial quality, the feasibility of 
achieving blind outcome assessment in a pragmatic physiotherapy rehabilitation trial 
involving older people was explored. Reasons for unblinding were explored and successful 
blinding rates of 81-91% were achieved. 
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1 CHAPTER ONE. INTRODUCTION. 
 
1.1 INTRODUCTION TO THESIS. 
Physiotherapy has traditionally been part of the routine aftercare provided to patients 
following elective, primary total knee arthroplasty for osteoarthritis. Total knee arthroplasty 
itself is an increasingly common procedure and the numbers of patients undergoing the 
procedure is expected to continue to rise. Several issues have recently arisen relating to the 
rehabilitation of patients following knee joint arthroplasty. The length of hospital stay 
following surgery has reduced, thus compressing the time available for in-patient 
rehabilitation. Furthermore, research now indicates that outcome following total knee 
arthroplasty is less satisfactory than previously assumed, with patients experiencing 
considerable functional impairment post operatively when compared with their peers.  
The effectiveness of physiotherapy following discharge from hospital lacks evaluation. 
The uncertainty regarding effectiveness subsequently makes it difficult for commissioning 
organisations, health care practitioners and patients to make decisions regarding rehabilitation 
and service provision in the UK varies widely. The purpose of this thesis was threefold. 
Firstly, to evaluate existing evidence regarding post discharge physiotherapy exercise. 
Secondly, to contribute to the evidence base for this under-researched, but increasingly 
common, area of physiotherapy practice by developing and evaluating a new physiotherapy 
intervention. Thirdly to assess the feasibility of achieving blind outcome assessment in a 
pragmatic rehabilitation trial. 
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1.2 DEVELOPMENTS ALTERING THE THESIS. 
Originally this thesis intended to include both knee and hip arthroplasty patients. The clinical 
site at which this research was carried out was, at that time, a new Diagnostic and Treatment 
Centre for hip and knee arthroplasty and the research initially planned to assist the evaluation 
of this new care approach. Systematic reviews were therefore simultaneously undertaken to 
evaluate the effectiveness of physiotherapy practice for both knee and hip arthroplasty 
patients. During this time two developments altered this initial plan. Firstly, the political and 
health care climate changed and evaluating Diagnostic and Treatment Centres was no longer a 
priority. Secondly, it became apparent that, whilst there was little research available for the 
knee, research regarding the effectiveness of physiotherapy following hip arthroplasty was 
shockingly absent. It was possible to perform a systematic review with meta-analyses for knee 
joint patients but not for hip patients, where only a narrative review could be performed. This 
meant that whilst it was possible to use evidence to design a potentially feasible clinical 
physiotherapy intervention for use in a prospective trial for knee patients, the same could not 
be said for hip patients for whom research needs to begin at an earlier level. The decision was 
made therefore to tighten the focus of this Ph.D. thesis to knee arthroplasty patients only.  
This decision was also made to improve the flow of the thesis which thus concentrated on 
knee joint arthroplasty rehabilitation. The hip systematic review was completed (see list of 
publications) but is not included in this thesis.   
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1.3 AIMS AND HYPOTHESES OF THIS THESIS. 
1.3.1 PART ONE. THE SYSTEMATIC REVIEW. 
 
1.3.2 Background.  
Initial literature reviews indicated that much of the published literature surrounding 
physiotherapy following joint arthroplasty consisted of descriptions of hospital care pathways 
and non evidence based opinions regarding rehabilitation. However, a change could be seen in 
recent years with the publication of clinical trials exploring physiotherapy interventions after 
discharge from hospital. No systematic review of these trials had yet been performed and it 
seemed appropriate for the first part of this thesis to consist of an evaluation of these trials.  
 
1.3.2.1 Aim of the Systematic Review.  
A systematic review of the literature evaluating the effectiveness of post operative 
physiotherapy exercise following elective joint arthroplasty was undertaken to determine the 
extent of previous research, to check the value of the future research in to the topic area, and 
to inform the development of a future trial intervention and the choice of appropriate 
outcomes for such a trial. 
 
1.3.2.2 Objective for the Systematic Review. 
The objective for the systematic review is as follows: to what extent is post discharge 
physiotherapy exercise effective, in terms of improving functional activities of daily living, 
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walking, range of joint motion, muscle strength and quality of life, for osteoarthritic patients 
following primary unilateral elective total knee arthroplasty?  
 
1.3.3 PART TWO. THE RANDOMISED CLINICAL TRIAL. 
 
1.3.3.1 Background. 
The systematic review identified that functional interventions seem more promising than 
traditional programmes in improving short term function, range of joint motion and quality of 
life. The review highlighted the need for further trials evaluating physiotherapy following 
knee replacement, a need identified in both a nationwide survey of physiotherapy 
rehabilitation following knee replacement in Australia (Naylor  et al.,   2006) and a 
subsequent review (Dauty  et al.,  2007). It was decided therefore to undertake a phase II 
randomised clinical trial to evaluate whether such a functional exercise intervention provided 
to patients following discharge after primary unilateral total knee arthroplasty was of benefit 
in terms of improving terms of improving both self report and objective functional outcomes. 
 
1.3.3.2 Aim of Trial.  
The aim of the trial was to compare the effectiveness of a post discharge physiotherapy 
intervention in improving patient self report and objective functional outcomes versus usual 
care for osteoarthritis patients undergoing primary total knee arthroplasty. 
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1.3.3.3 Hypotheses for the Trial.  
The hypotheses for the trial are now presented.  
 
Alternate Hypothesis for the Primary Outcome: Participants receiving two additional 
physiotherapy home visits after discharge from hospital following knee joint arthroplasty will 
show greater improvement in Oxford Knee Scores than participants receiving usual 
physiotherapy care. 
 
Null Hypothesis for the Primary Outcome: There will be no statistically significant difference 
in Oxford Knee Outcome Scores at 3,6, and 12 months post operation time points between 
participants receiving two physiotherapy home visits and participants receiving usual 
physiotherapy care. 
 
Alternate Hypotheses for the Secondary Outcomes:  For each of the secondary outcomes, 
namely, the Knee injury and Osteoarthritis Outcome Score (KOOS), the Leg Extensor Press, 
the Timed Walk test and the Timed Sit to Stand test the follow alternate hypothesis will be 
tested. 
 
Participants receiving two additional physiotherapy home visits after discharge from hospital 
following knee joint arthroplasty will show greater improvement in the secondary outcome 
scores than participants receiving usual physiotherapy care. 
 
Null Hypotheses for the Secondary Outcomes: For each of the secondary outcomes, namely, 
the KOOS, the Leg Extensor Press, the Timed Walk test and the Timed Sit to Stand test the 
follow null hypothesis will be tested. 
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There will be no statistically significant difference in the secondary outcome scores at 3,6, 
and 12 months post operation time points between participants receiving two physiotherapy 
home visits and participants receiving usual physiotherapy care. 
 
1.3.4 PART THREE. THE EVALUATION OF BLIND OUTCOME ASSESSMENT. 
1.3.4.1 Background. 
During the systematic review it became apparent that many systems / scores used to assess the 
quality of trial reports immediately denigrate and downgrade a trial’s quality if it is not a 
double blinded trial. This occurs even when double blinding is inappropriate or impossible to 
achieve within a trial, as in the trials included in the systematic trial in Chapter 3,  and even 
though the vast majority of reports provide no information whatsoever regarding the success 
or otherwise of their blinding procedures.  It cannot be assumed that the use of procedures to 
promote blinding in trials lead automatically to a successfully blinded trial, even what is 
meant by a successfully blinded trial appears unknown, and yet the presence of blinding 
procedures are still being used as a key indicator of trial quality.  
 For pragmatic trials, where double blinding is often inappropriate, the emphasis has 
been upon ensuring blind outcome assessment. The systematic review shows blind outcome 
assessment procedures were used in the component trials although, again, no details about the 
feasibility and success of blind outcome assessment were included in any of the trial reports. 
Since no research could be found regarding the feasibility of achieving successful blind 
outcome assessment in non pharmacological trials, or what constitutes success, it was 
considered appropriate to explore this topic further during this PhD by measuring to what 
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extent blind outcome assessment occurred in the trial mentioned above and by exploring the 
circumstances surrounding incidents of unblinding. 
 
1.3.4.2 Aim of Study. 
The aim of this study was to explore the feasibility of achieving blind outcome assessment in 
a pragmatic physiotherapy rehabilitation trial involving older people and to contribute to the 
limited available knowledge in this area.  
 
1.3.4.3 Objectives of the Study. 
The objectives of the study were as follows: 
1. To record and present the number of instances of unblinding occurring during the trial. 
2.   To fully document details surrounding each instance of unblinding and to present a 
content analysis of the results. 
 
1.4 OVERVIEW OF CHAPTERS. 
Chapter two provides a summary of the background literature regarding osteoarthritis of the 
knee, the treatment and management of osteoarthritis of the knee, the prevalence of total knee 
arthroplasty and rehabilitation and outcome following arthroplasty.  
 
Chapter three presents the systematic review used to evaluate the effectiveness of post 
discharge physiotherapy exercise on function, walking, range of motion, quality of life and 
muscle strength, for osteoarthritic patients following elective primary total knee arthroplasty. 
It includes a background literature review and a justification for the choice of methodology, 
 19
the review protocol, the results of the review and the discussion sections. The discussion 
section includes a discussion of the implications for clinical practice and identifies areas of 
future research. 
 
Chapter four presents the randomised clinical trial to compare the effectiveness of an 
innovative post discharge physiotherapy intervention in improving patient function versus 
usual physiotherapy for osteoarthritis patients undergoing primary total knee arthroplasty. The 
chapter includes a background literature review, a justification for the choice of methodology, 
a section describing the development and rationale of the trial intervention, plus the trial 
protocol and results sections. Following this the discussion section is presented, this  
includes implications for clinical practice and identifies areas of future research. 
 
Chapter five presents a study to explore the feasibility of achieving blind outcome assessment 
in a pragmatic physiotherapy rehabilitation trial involving older people. It includes a 
background literature review and a justification for the choice of methodology,  
plus the study protocol and results. The discussion section follows next and again this 
includes a discussion of the implications for clinical practice and identifies areas of future 
research. 
 
Chapter six summarises the main findings and implications, the future research suggestions  
and the conclusions of this thesis.   
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 2 CHAPTER TWO. BACKGROUND LITERATURE REVIEW. 
2.1 CHAPTER OVERVIEW. 
This chapter commences with definitions of osteoarthritis and will then provide current 
opinions regarding its aetiology. The prevalence of osteoarthritis of the knee and the signs and 
symptoms and current concepts of treatment of this condition will then be presented. This is 
followed by a section on knee joint arthroplasty; including factors known to effect outcome 
and the role of physiotherapy within post operative rehabilitation.   
 
2.2 DEFINITIONS OF OSTEOARTHRITIS. 
There are multiple definitions of osteoarthritis: a reflection of both the lack of consensus and 
the development of understanding regarding the condition. The condition is one of great 
antiquity, with examples of the condition being found in fossils dating back 100 million years, 
with the term itself dating from 1890 (Dequeker and Luyten, 2008).  The term osteoarthritis 
remains problematic; some believe it to be a misnomer since it implies an inherently 
inflammatory condition and suggest preferred alternative terms such as osteoarthrosis and 
degenerative joint disease (Dequeker and Luyten, 2008). 
Definitions have ranged from the rather vague: 
Clinical and pathological outcome of a range of disorders that results in structural and 
functional failure of synovial joints 
      Hunter and Felson, 2006 
which has the benefit of including function, to the more precise: 
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a non-inflammatory disorder of movable joints characterised by deterioration and abrasion of 
articular cartilage, and also by formation of new bone at the articular surface and subchondral 
bone involvement. 
      Dequeker and Luyten, 2008 
One of the most recent inclusive definitions was developed at a workshop of experts 
(Kuettner and Goldberg, 1995 cited in Brandt  et al.,  2008) and is as follows: 
Osteoarthritis is a group of overlapping distinct diseases which may have different etiologies, 
but with similar biologic, morphologic, and clinical outcomes. The disease processes not only 
affect the articular cartilage, but involve the entire joint, including the subchondral bone, 
ligaments, capsule, synovial membrane, and periarticular muscles. Ultimately, the articular 
cartilage degenerates with fibrillation, fissures, ulceration, and full thickness loss of the joint 
surface. OA diseases are a result of mechanical and biologic events that destabilise the normal 
coupling of degradation and synthesis of articular cartilage of chondrocytes and extracellular 
matrix, and subchondral bone. Although they may be initiated by multiple factors, including 
genetic, developmental, metabolic, and traumatic, OA tissues involve all of the tissues of the 
diarthrodial joint. Ultimately, OA diseases are manifested by morphologic, biochemical, 
molecular, and biomechanical changes of both cells and matrix which lead to a softening, 
fibrillation, ulceration, loss of articular cartilage, sclerosis and eburnation of subchondral 
bone, osteophytes, and subchondral cysts. When clinically evident, OA diseases are 
characterised by joint pain, tenderness, limitation of movement, crepitus, occasional effusion, 
and variable degrees of inflammation without systemic effects. 
Even such comprehensive definitions are incomplete; not mentioning important factors such 
as joint biomechanics or emphasizing that osteoarthritis reflects the failed repair of damage 
caused by excessive mechanical stress on joint tissues (Brandt  et al.,  2008). Although the 
term osteoarthritis also encompasses patients with very rare systemic diseases (Brandt  et al.,  
2008) such subjects are not the subject of this thesis and will not be further discussed. 
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 For the purposes of this thesis symptomatic osteoarthritis is defined as a painful 
disease whereby processes of aberrant repair, as discussed above, involve the entire joint and 
affect the whole person. Sufferers experience pain, impairments, limitations in functional 
abilities and activities plus restricted participation in activities and behaviours of their choice. 
The disease not only affects physical health but can, and often does, impact upon emotional 
health and prevent sufferers from living the type of lives they wish to lead within their 
society. 
 
2.3 SIGNS AND SYMPTOMS OF OSTEOARTHRITIS OF THE KNEE.  
Osteoarthritis of the knee may cause pain and functional disability (Jordan  et al.,  2003). 
There is a unexplained lack of correlation between disease severity and the level of reported 
disability in pain and the source and causes of pain are complex and not well understood 
(Hunter  et al.,  2008). Whilst pain is not generated by the aneural cartilage there are many 
other structures that may contribute to pain, for example subchondral bone, ligaments, the 
periosteum, synovium and joint capsule are all richly innervated (Dieppe and Lohmander, 
2005).  There is also no simple definitive test for osteoarthritis; severe osteoarthritis may be 
detected by radiography but radiographic findings relate poorly to self reported pain, function, 
muscle power and disability (Rogers  et al.,  2004; Barker  et al.,  2004; Creamer  et al.,  
2000; Hannan et al., 2000).  
Hunter  et al.,  (2008) reviewed the main symptoms of osteoarthritis as follows: 
1.   Activity related or mechanical pain usually of insidious onset (which may occur at rest 
in severe disease); often non localised deep aching pain and associated with increased age. 
Biologic, psychologic and social factors all seem involved in pain creation and perception. 
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There is also some evidence that women report greater pain levels than men (Affleck  et 
al.,  1999).  
2. Limited function. 
3. Stiffness; usually shortlived after inactivity. 
4. Joint instability. 
Hunter  et al., list additional possible symptoms as reduced range of joint motion, joint 
deformity, swelling not associated any systemic causes, pain related psychological distress, 
altered gait and muscle atrophy or weakness.  
 Gooberman-Hill  et al., (2007) explored pain experiences with people (n=28) suffering 
from clinical knee and hip osteoarthritis. They found that pain was generally experienced as 
intermittent (or in bouts) and was variable by activity, time of day, day by day and month by 
month. One participant, however, described constant pain. Pain was also often present 
elsewhere in the body and was inextricably linked with function, leading to avoidance or 
adaptation of activities.  
 Symptomatic osteoarthritis of the knee can lead to significant disability. Creamer  et 
al.,  (2000) developed a model of determinants of disability in symptomatic knee 
osteoarthritis. They used demographic data and self report function and pain scores and found 
that pain severity, obesity and helplessness accounted for 59.9% of variance in the Western 
Ontario and McMaster Universities OA Index disability scores. Further evidence for 
significant disability from osteoarthritis is provided by Fautrel  et al.,  (2005). Their French 
nationwide survey of over 10,000 patients with osteoarthritis found that limitations in 
performing activities of daily living, such as mobility outside the home, house chores and 
work duties, affect over 80% of patients .  For the 3,247 patients with knee osteoarthritis, 
72.8% of patients reported mobility problems when outside and, of the minority still working, 
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65.7% reported their osteoarthritis created occupational limitations. The substantial functional 
impact of osteoarthritis therefore seems evident.  
 
2.4 AETIOLOGY OF OSTEOARTHRITIS OF THE KNEE.       
Osteoarthritis is a multifactorial process caused by “aberrant local mechanical factors acting 
within the context of systemic susceptibility” (Hunter and Felson, 2006). It is a complex 
disease, since its aetiology bridges both biochemistry and biomechanics, and it is remains 
unclear whether osteoarthritis is a single disease or many diseases which subequently 
demonstrate a similar final pathway (Felson  et al., 2000a). Whilst traditionally osteoarthritis 
was considered a disease of articular cartilage with hyaline articular cartilage loss (Felson & 
Neogi, 2004), the contemporary view is that osteoarthritis involves the entire joint organ of 
subchondral bone, synovium, menisci, ligaments, periarticular muscle and capsule and that 
the disorder is characterised by tissue response in addition to tissue destruction (Hunter & 
Felson, 2006; Brandt et al., 2006; Dequeker and Luyten, 2008). Abnormal joint mechanics 
“provoke biological effects that are mediated biochemically – for example through cytokines, 
matrix-degrading enzymes and toxic oxygen radicals” (Brandt et al., 2006) causing a complex 
aetiology. In the knee the disease is primarily characterised by focal loss of articular cartilage 
plus marginal and central new bone formation (Jordan  et al.,  2003).  The loss of cartilage is 
clearly shown in the illustration below. The subsequent X ray pictures of knee osteoarthritis 
also illustrate these disease processes. 
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 Illustration 1.  Drawing of an osteoarthritic knee (eorthopod.com/images). 
Showing joint space narrowing, eroding meniscii and cartilage, and areas of exposed bone. 
 
 
 
 
Illustration 2. Radiograph showing an anterior-posterior view of an osteoarthritic knee joint with medial 
joint space narrowing and subchondral bone thickening. 
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Illustration 3. Radiograph showing a lateral view of an osteoarthritic knee joint.  
 
 
While severe joint injury may be sufficient to cause osteoarthritis,  Dequeker and 
Luyten (2008) comment that many of the radiographic and clinical features of the disorder are  
due to attempted repair processes occurring within the joint, the disease is often produced 
after an interplay of both local and systematic factors (Felson  et al.,  2000). Brandt  et al.,  
(2008) concur that osteoarthritis reflects processes occurring in joints attempting to contain 
damage.  
In a comprehensive editorial reviewing recent evidence regarding the aetiology of 
osteoarthritis Brandt  et al.,  (2006) usefully summarise possible effects of osteoarthritis on 
the entire joint organ as follows: 
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a) Excessive loading and abnormal mechanical stresses can damage hyaline articular 
cartilage. Alterations in gene expression can be caused leading to the degradation of cartilage. 
In addition when other joint tissue damage also occurs, such as joint capsule/synovium 
damage, higher levels of cartilage degrading chemicals may be produced than with cartilage 
damage alone. 
b) Ligament damage resulting in ligamentous laxity may lead to joint instability and 
osteoarthritis. 
c) Periarticular muscle weakness and non optimal loading on joint cartilage, for example 
through impulsive or unexpected loads, may also lead to osteoarthritis. 
d) Reduced proprioceptive ability may predispose or be linked to the development of 
osteoarthritis. 
e) Subchondral bone is thickened. This is thought to be due to altered biomechanics either 
leading to increased bone turnover and the reactivation of the secondary centre of ossification 
or to an increase in the stiffness of subchondral bone which makes the bone less capable of 
attenuating and distributing the load throughout the joint. This reduced capability increases 
stresses in the overlying articular hyaline cartilage which subsequently deteriorates.   
f) Meniscus subluxation may account for a large amount of the reduction of knee joint space 
rather than hyaline cartilage thinning. 
In addition, Felson and Neogi (2004) describe the formation of osteophytes as a 
further characteristic of osteoarthritis. These are outgrowths of cartilage at the joint margins, 
which secondarily ossify. Sclerosis then probably occurs because the localised mechanical 
stress placed on the bone leads to bony proliferation. Brandt  et al.,  (2008) disagree, using a 
slide of a Heberden’s node to show that osteophytes are not necessarily pathognomonic for 
osteoarthritis. 
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Mansell  et al.,  (2007) discuss the hypothesis that it is the increasingly thickened and 
stiffened subchondral bone that leads to articular cartilage damage during repetitive loading, 
believing that, whilst questions remain regarding the stimulation of such changes in bone 
tissue, osteoarthritis involves a metabolic dysfunction of bone rather than “wear and tear” of 
cartilage. An osteological study by Rogers  et al.,  (2004) supports the theory that 
osteoarthritis is part of a systemic disorder of bone. This study of 563 skeletons found that 
evidence of osteoarthritis in classic sites, such as the knee and hip, is associated with 
widespread skeletal osteoarthritis type changes. This challenges the division of osteoarthritis 
patients into monoarticular and generalised osteoarthritis groups, indicating that osteoarthritic 
joint changes are more likely to be widespread with some joints remaining asymptomatic. 
Similarly this also challenges the previous distinction between primary or secondary 
osteoarthritis, or the presence of absence of any obvious cause for the condition which the 
multifactorial nature of the disease makes complex (Dieppe and Lohmander, 2005).  
Systemic factors which appear to increase the vulnerability of joints to symptomatic 
osteoarthritis include increasing age, female gender, possible nutritional deficiencies and a 
major (as yet unidentified) genetic component whilst local factors include misalignment, 
muscle weakness and damage/alterations to the structural integrity of the joint organ (Hunter 
and Felson, 2006). Occupational factors, such as repetitious kneeling, squatting and heavy 
lifting are also associated with increased susceptibility to knee osteoarthritis (Felson  et al., 
2000a).  Furthermore injury and/or obesity can effect joint loading and adversely influence 
the development and progression of the condition (Hunter and Felson, 2006; Messier, 2008). 
A summary of risk factors is shown in the figure below. Since certain factors, such as obesity, 
are more clearly associated with knee osteoarthritis than hip osteoarthritis, some feel this adds 
support to the argument that osteoarthritis is likely to be several distinct disease entities 
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(Felson  et al.,  2000a). Given Rogers et al., (2004) study this might perhaps be linked to 
how/why joints become symptomatic rather than non generalised osteoarthritis per se.  
 
 
 
Systemic factors      Local biomechanical factors 
Age        Obesity 
Sex        Joint injury 
Ethnic characteristics      Joint deformity 
        Sports participation 
    Susceptibility to  Muscle weakness 
Bone density   Osteoarthritis 
Oestrogen replacement 
   therapy (in post-menopausal 
   women) 
Nutritional factors (?) 
Genetics       Site and severity 
         of osteoarthritis 
Other systemic factors 
 
Figure 1. Pathogenesis of osteoarthritis with putative risk factors 
 
This figure is Figure 2 from Felson  et al.,  2000a [a modified version of the original figure by Dieppe, P. The 
classification and diagnosis of osteoarthritis. In: Kuttner, K., Goldberg, V. eds. Osteoarthritis Disorders. 
Rosemount, IL: American Academy of Orthopaedic Surgeons 1997]. Permission to reproduce this figure has 
been obtained from the Annals of Internal Medicine (see Appendix 1). 
 
 
 
2.5 THE PREVALENCE OF OSTEOARTHRITIS OF THE KNEE AND 
THE RATE OF PRIMARY TOTAL KNEE JOINT REPLACEMENT 
IN THE UK.  
It is difficult to measure the prevalence of knee osteoarthritis since disparities exist between 
patient reported symptoms, objective clinical diagnosis and different systems of radiographic 
evidence (D’Ambrosia, 2005). A recent estimate is that osteoarthritis of the knee results in 
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disabling knee symptoms in an estimated ten per cent of people aged over fifty five, a quarter 
of whom are severely disabled (Peat  et al.,  2001). In an older hallmark study, the 
Framingham Osteoarthritis study, 1,424 knee radiographs were graded for osteoarthritis 
changes, which provided prevalence estimates ranging from 11.5% in participants aged under 
70 years to 19.4% in those aged over 80 (Felson  et al.,  1987). The different prevalences 
obtained via radiography may be partially due to some people having radiographic changes 
whilst remaining asymptomatic (Hannan  et al., 2000). Since osteoarthritis increases with age 
it is recognised that the incidence will increase in the future in line with the aging population 
(Felson  et al.,  2000a). 
The number of primary total knee joint replacement procedures is increasing, which may 
be both in response to the aging population and to the previous underprovision of  knee 
arthroplasty (Jüni  et al., 2003). The rate of primary total knee joint replacement procedures in 
England rose by up to 63% between 1991 and 2000 (Dixon  et al.,  2004) and has tripled in 
Scotland in the last 15 years (Scottish Arthroplasty Project Annual Report 2008). In 2007, 
55,091 primary total knee replacements were undertaken in England and Wales for 
osteoarthritis; 97% of all primary knee replacement procedures (National Joint Registry 5th 
Annual Report). Knee replacements were more common for women (58%) and for older 
people (average age 70.5). Knee replacement surgery is also more common for people not in 
the most deprived fifth of the population as measured via the Townsend index of population 
(Dixon  et al.,  2004). In Scotland in 2006/7 the number of total knee replacements overtook 
the number of hip replacements for the first time with 5799 total knee procedures being 
undertaken for osteoarthritis (Scottish Arthroplasty Project Annual Report 2008). Latest 
figures for Northern Ireland from the of Department of Health, Social Services and Public 
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Safety, obtained using the OPCS codes W40-42 for knee replacement, provisionally suggest 
that 1429 knee replacements were carried out in 2007/8 (Stewart, 2009).   
 
2.6 CURRENT CONCEPTS FOR TREATMENT OF 
OSTEOARTHRITIS OF THE KNEE.  
A recent fundamental shift has been from viewing osteoarthritis as a passive and 
degenerative disorder, for which little can be done, to viewing it as an active disease process 
susceptible to modification by mechanical and biochemical treatments (Dequeker and 
Luytens, 2008). The importance of restoring abnormal joint mechanics to a physiologic range 
to enable healing to occur has been emphasised by Brandt  et al., (2008).  
Even recent commentaries upon osteoarthritis however present very different treatments 
aims. Some authors advocate the use of therapeutic strategies primarily aimed at reducing 
pain and improving function (Hunter and Felson, 2006) while others advocate the mechanical 
or biochemical manipulation of the disease processes itself (Dequekker and Luyten, 2008). 
The emphasis upon treating cartilage alone by developing / seeking chondroprotective drugs 
has been recently criticised with a plea to direct attention to the entire joint organ and joint 
biomechanics (Brandt et al.,  2006 and 2008). Similarly, the EULAR evidence based 
recommendations cover both non pharmacological treatments, such as exercise and lifestyle 
changes, pharmacological treatments, such as paracetamol and NSAIDS, and invasive 
interventions such as surgery (Jordan  et al.,  2003). These guidelines state that, although the 
evidence available to support treatment efficacy remains variable, the optimal management of 
osteoarthritis of the knee includes both non pharmacological and pharmacological treatments. 
The aims of disease management listed are patient education, pain alleviation, the reduction of 
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disability and improvement of function and the prevention/retardation of the disease and 
management should be tailored according to a patient’s risk factors. Further evidence that 
exercise therapy is considered effective for patients with knee osteoarthritis has been provided 
by a review of three systematic reviews (Smidt  et al.,  2005). The muscles around the knee 
produce movement, absorb limb loading forces and provide dynamic joint stability around the 
knee: muscle weakness is both a risk factor for, and a potential result of, osteoarthritis of the 
knee (Bennell  et al.,  2008). This review of the role of muscle in the genesis and management 
of knee osteoarthritis usefully highlights the strong evidence that muscle strength can be 
improved by muscle strengthening programmes in people with knee osteoarthritis.  Such 
evidence has lead to the call for individualised holistic treatment plans with the 
recommendation that exercise should be a core treatment for people with osteoarthritis 
(National Institute for Health and Clinical Excellence, 2008). 
 
2.7 JOINT ARTHROPLASTY.   
Joint arthroplasty is an intervention for those patients who have severe disease, i.e. daily 
severe pain plus radiographic evidence, who have not responded satisfactorily to other 
treatment modalities (Jordan  et al.,  2003). Occasionally progressive deformity or instability 
may be the prime indicator (British Orthopaedic Association and the British Association for 
Surgery of the Knee, 1999). Patient motivation, age, health seeking behaviours, general 
practitioner referral pattern, the presence of co-morbidities, reluctance/willingness to undergo 
surgery, functional impairment and socio-economic status are other factors influencing 
whether or not people undergo arthroplasty surgery (Dieppe  et al.,  1999; Mancuso  et al.,  
1996; Jüni  et al.,  2003). 
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 The procedure involves an anterior incision to expose the distal end of the femur, the 
proximal end of the tibia and the posterior articular surface of the patella; followed by the 
insertion of the prostheses (with/without cement), any necessary balancing of the medial and 
lateral soft tissue structures and correction of deformities, then ensuring satisfactory patella 
tracking and the integrity of the extensor mechanism of the knee prior to wound closure 
(British Orthopaedic Association and the British Association for Surgery of the Knee, 1999). 
The following radiographs show a knee arthroplasty in situ. 
 
 
 
 
 
Illustration 4. Radiograph showing an anterior posterior view of a total knee joint arthroplasty. 
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Illustration 5. Radiograph showing lateral view of a total knee arthroplasty. 
 
 
 
As a guide to how well knee replacements perform over time, one of the largest and 
most recent survivorship analyses of 11,606 primary total knee arthroplasties showed 92% of 
knees surviving to 10 years, falling to 78% at twenty years (Rand  et al.,  2003). Patients 
under 55, considered more active than older patients, fared worse at 10 years (83%) than those 
aged over 70 (94%). Men fared worse (88%) at 10 years than women (93%). Type of 
prosthesis, use of cement, and diagnosis also influenced survivorship. Although long term 
figures are not yet available from the National Joint Registry the short term trends have been 
for a higher revision rate in those aged under 65, with a non statistically significant higher rate 
of revision amongst women than men (National Joint Registry 4th Annual Report p. 89-93).  
It has been pointed out that, whilst an established treatment, there are few trials of 
knee joint arthroplasty (Dieppe  et al.,  1999) and no trials yet comparing joint arthroplasty 
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with non-surgical interventions (Jordan  et al.,  2003). There has also been wide variation in 
the types of prosthesis used (Dieppe  et al.,  1999). It has also been noted that for the younger 
population, for whom prosthesis durability is an issue, alternative and less invasive treatments 
to total arthroplasty (such as osteotomy or unicompartmental procedures) appear to have a 
role requiring further research (Richmond, 2008).  
 
2.8 OUTCOME AFTER JOINT ARTHROPLASTY. 
Total joint arthroplasties have long been considered effective interventions to improve pain 
and function in patients, with few serious adverse outcomes and low mortality rates (Jones  et 
al.,  2007). Specific knee arthroplasty postoperative complications known to hinder recovery, 
and their rates, will be presented in Chapter four.  A relatively early systematic review 
reported good or excellent outcome for pain and mobility in 89.3% of patients (Callahan  et 
al.,  1994). However, the choice of outcome measure influences the results obtained; only 
revision and prosthesis failure rates were previously reported but, as survivorship rates 
became so successful, patient–centred outcomes began to be used more frequently (Woolhead  
et al.,  2005; Wylde  et al.,  2007).  The latter reveals that outcome is multifaceted. Jones et 
al., (2007) state that 15-30% of patients report little/no improvement, or dissatisfaction, post 
surgery. Problems include persistent pain, impairment and functional limitations (Westby, 
2008): the determinants of poor pain and functional outcomes are still largely unknown and it 
has been suggested that psychological factors may be influencing outcome in addition to 
physical, socio-demographic, medical, surgical and prosthetic-related factors   (Jones  et al.,  
2007; Wylde  et al.,  2007).    
 Recent qualitative research by Woolhead  et al.,  (2005) has helpfully further 
contributed to knowledge regarding outcome by exploring patients’ perspectives of outcome 
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following knee arthroplasty.  Most patients in the study provided contradictory accounts: 
whilst reporting a good outcome from surgery they went on to recount continuing pain and 
mobility problems. Patients struggled to make sense of these continuing difficulties and tried 
to take personal responsibility for them. This keenness to take responsibility for outcome was 
also noticed in an earlier qualitative study with patients undergoing orthopaedic surgery 
(Edwards, 2002). A further qualitative study after joint arthroplasty found that incongruence 
between patient expectations and reality regarding recovery was a source of distress 
(Showalter  et al.,  2000). It should be recognised that the outcomes used in many studies will 
not capture or reflect these complex issues and that patients have different opinions regarding 
outcome after arthroplasty than health care professionals, particularly when the patient is 
dissatisfied with their outcome (Wright  et al., 1994; Lieberman  et al.,  1996).  
 It should also be recognised that patients who have undergone knee arthroplasty 
experience substantial functional impairment when compared with their age and gender 
matched peers (Noble  et al.  2005; Walsh  et al., 1998). Noble  et al., found that the gap 
between post arthroplasty and control groups widened as activities became more demanding 
and that patients shifted their attention to less demanding pursuits upon discovering the 
limitations their joint arthroplasty imposes upon them. The authors conclude that patients 
should be warned that their knee pain is likely to be improved after arthroplasty, as the 
literature indicates (Wylde  et al.,  2007), but that their knee will still probably not function as 
well as it did prior to the onset their arthritis. 
Small scale research shows that persistent quadriceps weakness post knee arthroplasty 
is associated with poorer functional outcome (Silva  et al.,  2003). Another recent small study 
(n=56)  demonstrated that focused physiotherapy can improve outcome (as measured by the 
Knee Society score) and patient satisfaction at 24 months post operation amongst patients 
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reporting functional problems at least two months post knee joint arthroplasty (Ulrich  et al.,  
2007). Quadriceps muscle weakness and flexion contractures were the most common 
problems observed and treated. Knee muscle strength has previously been shown to be up to 
30-40% weaker for knee arthroplasty patients at 1 year post operation when compared to 
controls with no knee disease (Walsh  et al., 1998).  
Preoperative mobility appears to affect the recovery of mobility following knee 
arthroplasty: in a group of 76 patients recovery of walking speed and stair climbing was 
predicted by preoperative total power and, to a lesser extent, by body mass index (Lamb and 
Frost, 2003). Interestingly, the patients in the lowest tertile of preoperative leg power 
experienced the greatest recovery rates but did not achieve the levels of mobility reached by 
those starting with higher power within the 6 months follow up period. Again, walking speed 
and stair climbing speeds are known to remain far slower for knee arthroplasty patients at 1 
year post operation when compared to controls with no knee disease (Walsh  et al., 1998). 
The existence of other joint disease is also known to significantly and adversely affect post 
operative recovery mobility and function (Naylor et al., 2008). Mobility is impaired and 
recovery times are slowed. 
 Overall therefore, outcome following knee joint arthroplasty appears generally 
effective in terms of achieving pain relief but less effective in terms of regaining pre-arthritis  
levels of function. 
 
 
2.9. REHABILITATION.  
This section will outline physiotherapy rehabilitation procedures for knee joint arthroplasty. It 
will not include an exploration of the effectiveness of physiotherapy exercise programmes 
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following discharge since this subject is the focus of a systematic review in chapter three. 
Whilst comprehensive narrative reviews exist for rehabilitation following total hip 
replacement (for example, Brander and Mullarkey, 2002) the picture for total knee  
arthroplasty is less clear. There are no evidence based clinical guidelines post knee 
arthroplasty (Westby  et al.,  2008). As Naylor et al., (2006) phrase it “the evidence base 
regarding total knee replacement rehabilitation is somewhat fragmented” with considerable 
evidence for the use of acute postoperative cryotherapy and continuous passive movement but 
little for the treatments of choice such as exercise or hydrotherapy or for the progression of 
functional activities.     
 Pre-operative home physiotherapy remains rare in the UK with one trial demonstrating 
its lack of effect upon patient perceived health outcomes (Mitchell  et al.,  2005). Similarly, a 
review has found physical training before knee arthroplasty to be of no value (Dauty  et al.,  
2007).  
           Post-operatively, the main aims of physiotherapy rehabilitation following knee 
arthroplasty have been summarised as follows: to reduce pain, to maintain/increase joint range 
of motion, to maintain/improve muscle strength (particularly the quadriceps and gluteal 
muscles), to maximise functional ability (including improving/maintaining proprioception), to 
support/advise and educate patients as necessary and to encourage self-care and self 
management (Coutts,2005 p 251-262). The prevention of postoperative complications has 
been added to this list by Jones  et al.,  (2005). 
  In-patient rehabilitation concentrates on achieving sufficient functional independence 
for discharge and on improving knee range of motion and muscle strength (Oldmeadow  et 
al.,  2002).  The need to prepare patients for hospital discharge as soon as possible has been 
emphasized (Lenssen  et al., 2006) and there is pressure on clinicians to decrease and 
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minimise length of stay (Oldmeadow  et al.,  2002).  Indeed the goal of many in-patient 
pathways is to reduce costs and length of stay in hospital without compromising upon patient 
outcome and many pathways are considered successful in achieving this goal (Kim  et al., 
2003; Husted and Holm, 2006; Iyengar  et al.,  2007). The average UK length of hospital stay 
for total joint arthroplasties other than hips in 2005-6 was 8.2 days (Hospital Episode 
Statistics Online).  
Existing rehabilitation pathways and protocols show wide variation (Jones  et al.,  
2005). Generally, early mobilisation has been promoted as the gold standard approach for the 
achievement of functional mobility (Roos, 2003). Patients usually receive inpatient 
physiotherapy daily and are also advised regarding additional exercise and mobility activities 
to continue between sessions; the use of multiple sessions per day may occur but a trial 
comparing once or twice daily sessions has questioned the benefit of multiple daily sessions 
(Lenssen  et al., 2006).  Further adjuncts to exercise and mobility may be used if length of 
stay, staff time and resources permit. An example would be the use of continuous passive 
motion machines which, if tolerated by patients and available, can benefit range of joint 
motion and analgesia (Milne  et al.,  2003). 
The dosage and management of physiotherapy following the acute postoperative phase 
after surgery does vary widely (Roos, 2003; Jones et al., 2005), with financial reimbursement 
schemes seeming to influence practice (Lingard  et al., 2000; Roos, 2003). The amount of 
rehabilitation in some countries far exceeds the UK. A recent Netherlands, non assessment 
blinded trial, compared 3 weeks intensive rehabilitation in a resort (up to 4 hours with a 
physiotherapist per day) compared with ‘usual care’ of local physiotherapy or admission into 
a nursing home for rehabilitation (Bulthuis  et al.,  2007). The usual care therefore also 
appears intensive which may explain why, although the resort group improved more quickly, 
 40
there was no significant difference at a year. The trial (n=114) may also have been 
underpowered.  
 In the absence of evidence, Naylor et al., (2006) undertook a nationwide survey of 
current physiotherapy practice following knee arthroplasty in Australia. Consistently they 
found that physiotherapists provided gait retraining and exercise prescription, with 57% of 
programmes including functional activities and 83% including exercises, and with most 
programmes operating on a one-to-one basis. Unlike an earlier USA concensus study (Enloe  
et al.,  1996), this Australian survey therefore does now include functional exercises. The 
mean duration of post discharge programmes offered was 5.6 weeks and programmes were 
offered by the majority of providers (88%). The authors conclude that the survey suggests that 
the exercise programmes lack may adequate intensity to lead to optimal recovery, a concern 
also raised by Westby et al., (2008). 
In the UK the nature of post operative rehabilitation practices sounds similar to the 
Australian survey except that less UK patients are less likely to be referred for post discharge 
physiotherapy due to its disputed value (Rajan et al., 2005). Anecdotally we know of many 
other Trusts who do not routinely arrange post operative physiotherapy.  
In addition to the above, evidence demonstrates that progressive quadriceps muscle 
strengthening improves functional outcome following knee arthroplasty (Mizner  et al., 2005;  
Ulrich  et al.,  2007; Petterson  et al.,  2009). This is not surprising given that muscles around 
the knee produce movement, absorb limb loading and provide dynamic joint stability (Bennell  
et al.,  2008). Trials have shown quadriceps strength to be a stronger predictor of timed up 
and go, stair climbing and six minute walk test performance than pain and range of joint 
motion (Mizner  et al., 2005; Petterson  et al.,  2009). Participants receiving the muscle 
strengthening programme were significantly stronger and more able during the functional 
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tests than those receiving standard care (range of motion and non weightbearing exercises) 
(Petterson  et al.,  2009).  It is worth mentioning that the mean number of physiotherapy 
outpatient visits in this programme was 17 during the six week intervention, a high number 
compared to UK practice.  A helpful indication of the time course of functional recovery post 
knee arthroplasty was also provided (Mizner  et al., (2005). Whilst subjects experienced 
worsening quadriceps muscle strength, functional test performance and range of knee joint 
motion at the one month post-operative time point, the average time taken to return to pre-
operative levels was only two months post operation. Improvements were maintained at 12 
months post-operation and, for stair climbing, were even equivalent to previously published 
data for healthy controls (Petterson  et al.,  2009).  Overall therefore, post operative 
quadriceps muscle strengthening appears an important component of rehabilitation following 
arthroplasty.  
 In terms of late stage rehabilitation and return to sport, current practice again appears 
opinion rather than evidence lead; depending upon consensus recommendations based upon 
prosthesis wear, previous experience of activities, and joint loading (Kuster, 2002). Activities 
such as swimming, walking and golf are recommended/allowed whilst football and jogging 
are not recommended and no conclusion has been reached regarding downhill skiing (Kuster, 
2002).  A survey of 866 total knee arthroplasty patients found that, of the 253 who had been 
active in sport (generally low impact sport) preoperatively, 68 were unable to return to sport 
postoperatively because of their arthroplasty; pain and limitations in movement being the 
main reasons (Wylde  et al., 2008).  
With regard to multidisciplinary rehabilitation, a recent Cochrane review of such 
programmes after hip and knee joint arthroplasty found no trials addressing outpatient 
programmes (Khan  et al.,  2008); the review included one poor quality study comparing a 6 
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visit multidisciplinary care programme with a programme of up to 45 visits with no 
significant differences in self reported outcome.   
 
 
2.9 CHAPTER SUMMARY. 
Chapter two summarised the background literature regarding osteoarthritis of the knee, the 
treatment and management of osteoarthritis of the knee, the prevalence of total knee 
arthroplasty and rehabilitation and outcome following arthroplasty. It can be seen that, despite 
being a long known and common condition, many questions remain concerning the symptoms 
of the condition and how to effectively rehabilitate patients following joint replacement.  
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3 CHAPTER THREE. EFFECTIVENESS OF 
PHYSIOTHERAPY EXERCISE FOLLOWING KNEE 
ARTHROPLASTY FOR OSTEOARTHRITIS:  A 
SYSTEMATIC REVIEW OF RANDOMISED 
CONTROLLED TRIALS. 
3.1 CHAPTER OVERVIEW. 
This chapter will present the systematic review used to evaluate the effectiveness of post 
discharge physiotherapy exercise on function, walking, range of motion, quality of life and 
muscle strength, for osteoarthritic patients following elective primary total knee arthroplasty. 
The chapter begins with a background literature review, plus justification for the choice of 
methodology, before presenting the review protocol. The results will then be presented which 
will be followed by a discussion of the main findings, the strengths and weaknesses of the 
review procedures and the clinical implications from the systematic review. Finally a 
summary of the chapter is presented.  
 
3.2 SYSTEMATIC REVIEW: INTRODUCTION AND BACKGROUND. 
3.2.1 SECTION OVERVIEW. 
This section will define and describe systematic reviews. It will outline the advantages for the 
project of performing a systematic review, explain the limitations of this approach and justify 
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the inclusion of a systematic review in this thesis.  The section will particularly focus upon 
systematic reviews in relation to physiotherapy and the rehabilitation setting.  
3.2.2 DEFINITION. 
Egger et al., (2001a) combined several definitions to create the following:  
A review that has been prepared using a systematic approach to minimising biases and 
random errors which is documented in a materials and methods section. A systematic review 
may, or may not, include a meta-analysis: a statistical analysis of the results from 
independent studies, which generally aims to produce a single estimate of a treatment effect. 
    Egger, Davey Smith and O’Rourke (2001) p. 5. 
A systematic review should contain a clearly focused question (Main, 2003) and be conducted 
to an explicit and reproducible methodology (Greenhalgh, 1997) which strives to avoid the 
subjectivity and selection bias of traditional, or narrative, reviews (Main, 2003). The use of 
meta-analyses allows a single answer to a specific question to be produced from the multiple 
component studies (Main, 2003). Systematic reviews therefore are used to reduce or resolve 
uncertainty about evidence (Pettigrew, 2003). 
3.2.3 BACKGROUND. 
The increasing body of published evidence makes it difficult for clinicians and researchers to 
remain up to date (Main, 2003) and for effective policies and guidelines to be developed by 
health service providers and decision makers (Mulrow, 1994).  Previous research by the 
author of this thesis has found that physiotherapists in particular encounter problems locating 
and accessing literature (Beeston, et al.,  2001) with trials published  in “almost every journal 
you can think of”  many of which are not included in common databases such as Medline or 
Embase (Knipschild, 1994). Literature reviews are used to improve accessibility to research 
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findings. Traditionally narrative or journalistic reviews of the evidence have occurred, lacking 
a standardised and objective approach to the location and analysis of evidence and open to the 
personal biases of authors to present evidence supporting their own beliefs/theories 
(Greenhalgh, 1997). The consequences of this include confusion regarding choice of 
treatment, or poor/harmful practice being wrongfully continued (Chambers, 2001 p. xiv). The 
need for an objective, meaningful appraisal of the literature prior to undertaking research 
seems apparent.  Systematic reviews can save resources and prevent unnecessary research 
occurring in areas where conclusive evidence exists (Mulrow, 1994). Reviews have been 
increasingly popular in medicine from the 1980s; especially after 1992 and the introduction of 
the Cochrane Collaboration (Montori  et al.,  2003), an international organisation dedicated to 
the preparation and maintaining of systematic reviews regarding the effectiveness of health 
care interventions  (Chalmers, 1993). The result has been that within a relatively short period 
of time systematic reviews have become “one of the cornerstones of evidence-based 
medicine” (Moher, 2008).  As already mentioned, systematic may or may not include meta-
analyses. Where meta-analyses are appropriate and possible for a review these are considered 
beneficial since they improve power1 and precision2, answer questions not addressed by 
individual studies and address controversies arising from conflicting studies Deeks  et al.,  
(2006). However, sometimes the wide scope of a review, or the diversity within component 
trials, mean that it becomes meaningless and potentially misleading to compare component 
studies (Egger, Davey Smith and O’Rourke, 2001a p.4-5; Main, 2003). In physiotherapy, it is 
often impossible to acquire data in a format permitting meta-analyses (Main, 2003) or 
sufficient high quality studies to achieve clinically relevant systematic reviews.  
                                                          
1 Power is “ the chance of detecting a real difference as statistically significant if it exists” (Deeks  et al.,  2006). 
Combining multiple studies may mean there is a greater chance of detecting an effect. 
2 Precision refers to the degree of variability of an observed sample statistic (Sim and Reid, 1999).  
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The use of systematic reviews, and meta-analyses in particular, remain controversial 
with some statisticians and clinicians not accepting either the mathematics or the findings:  
confusion caused by conflicting reviews upon the same topic and of reviews of small trials 
being subsequently contradicted by larger definitive trials has contributed to this dissent 
(Egger  et al., 2001c p. 43). These discrepancies may be due in part to poor methodologic 
quality in smaller trials (Kjaergard  et al., 2001) plus the results of a review may be unable to 
predict the results of large trials for up to a third of the time (Main, 2003). 
It has been suggested that, for public health and social interventions, the “stainless 
steel” law of evaluation exists (Pettigrew, 2003), namely, “the more rigorous the review, the 
less evidence there will be that the intervention is effective” (Pettigrew, 2003).  Furthermore, 
systematic reviews are able to answer single questions regarding specific interventions; they 
are less likely to provide clear answers to questions regarding complex interventions 
(Pettigrew, 2003) and it might be argued that this could be true for many areas of 
physiotherapy which incorporate complex interventions.  
Despite being more explicit and objective than narrative reviews, systematic reviews 
may still be susceptible to bias (Main, 2003). An overview of sources of bias during the 
location and selection of trials has been provided by Egger and Davey Smith (1998) and 
summarised in the figure below. Such bias frequently results in an overestimation of a 
treatment.  A further source of potential bias is reporting bias; there may rapid or delayed 
publication, or selective reporting, of a trial depending on the nature and direction of results 
(Eggar et al.,  2001c p. 51-62).  
Overall, despite the limitations of the approach, systematic reviews are advocated as 
the best available approach which currently exists to summarise and synthesise data (Main, 
2003) and are considered a major advance in the objective review of evidence (Crombie and 
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McQuay, 1998).  Please see the table on the next page for a summary of the advantages and 
limitations of this approach. 
Inclusion Bias 
The criteria for including studies may be influenced 
by knowing the results of potential studies; therefore the review 
might selectively include/exclude studies i.e. Selection Bias 
 
Citation Bias                          Database Bias 
Can occur from using reference lists                      In less developed countries studies  
from trials because significant results are               with significant results are more likely 
cited more frequently (regardless of size                   to be published in a journal indexed 
and quality)                                           in a literature database 
 
 
 
English Language Bias                 Bias in Provision of Data 
Meta-analyses published in English              When information additional to the trial  
language journals are often based on             report is required this may be difficult to 
trials published in English (which are                   obtain since the investigators may be  
more likely to be significant)                   unwilling to make their data available 
 
 
Possible Sources of 
BIAS 
Affecting a Systematic Review 
  
 
 
Multiple Publication Bias         Publication Bias 
Multiple publications from single studies are             studies with significant results are more 
more likely to be studies with significant results.          likely to get published therefore there is a  
The inclusion of duplicate data can overestimate              risk of meta-analysis showing spurious 
treatment effects                                   beneficial treatment effects 
 
 
 
 
Need to Examine for 
Absence / Presence of Bias by 
 
 
 
 Sensitivity Analyses    Funnel Plots 
 
Figure 2. Summary of the Sources of Bias when locating and selecting studies for inclusion into a 
Systematic Review (Summarised using Eggar and Davey Smith, 1998). 
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 Advantages of Systematic 
Reviews  
Limitations of Systematic 
Reviews 
 
Vast amounts of literature can be summarised and 
presented to health care professionals and service 
decision makers 
 
Promotes the use of focused questions 
 
Review methodology is reproducible and explicit 
 
Explicit methodologies may limit bias in locating 
and selecting studies 
 
Increased reliability and accuracy of findings (i.e. 
effect sizes and risks) 
 
Meta-analysis can increase the precision of results 
 
Increased statistical power, useful for areas with 
low event rates or smaller effect sizes 
 
The time taken to implement research findings 
into practice may be reduced 
 
Can establish the generalisability and 
heterogeneity of results 
 
Can generate new hypotheses for future research 
from main findings or sub group findings 
 
May identify areas of inadequate research 
 
Can prevent obsolete research being undertaken in 
an already adequately explored area 
 
Efficient use of existing data 
 
Physiotherapy studies with large numbers, and 
multi-centre trials, are still rare. Large trial results 
are often not yet available thus systematic reviews 
may be able to inform practice more quickly. 
 
 
Poor/ differences in methodological decision 
making can still lead to erroneous and/or 
conflicting results. 
 
There is a lack of agreement regarding the 
assessment of study quality; many measures are 
inappropriate for physiotherapy studies. 
 
Quality affects results. Inadequate randomization, 
allocation concealment and double blinding effect 
treatment estimates. 
 
There is a lack of consensus regarding the 
appropriateness of analysis strategies used 
 
There are often insufficient physiotherapy studies 
to enable successful systematic reviews to occur 
 
Physiotherapy papers often do not report the 
information required for successful meta-analysis 
 
Physiotherapy  studies may be too diverse to 
allow meaningful meta-analysis to occur 
 
Combining data may disguise / oversimplify 
distinctions between studies  
 
Bias, such as selection bias, publication bias and 
language bias, can still be introduced 
 
The results of a systematic review may not predict 
trial results for up to a third of the time 
 
Systematic reviews are often criticised as being 
unable to give specific guidance; often because 
the studies provide few outcome evaluations 
 
There may be a “stainless steel” law in operation, 
that is, the more rigorous the review, the less 
evidence there is that the intervention is effective. 
 
Reviews may overlook important clinical details 
in the component papers, thereby reducing their 
validity 
 
Table 1. Summary of the advantages and limitations of systematic reviews for Physiotherapy (Summarised 
using Mulrow, 1994; Greenhalgh, 1997; Hopayian, 2001; Main, 2003; Pettigrew,  2003). 
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  A systematic review of the literature evaluating the effectiveness of post operative 
physiotherapy exercise following elective joint replacement appears worthwhile prior to 
undertaking the proposed trial for the following reasons: 
1. To systematically determine the extent of previous research; checking the value of the 
question and whether it has already been adequately addressed (Mulrow, 1994; 
Knipschild, 1994). 
2. To inform the development of the proposed trial intervention using previous studies 
(Knipschild, 1994), assisting the establishment of its theoretical basis (MRC, 2000) and 
lessening the chance of mistakes (Knipschild, 1994). 
3. To inform the choice of appropriate outcomes for the trial. 
4. To assist other clinicians seeking easily accessible knowledge (Greenhalgh, 1997; Main, 
2003) in this common area of practice.  
5. To provide, if possible, information regarding treatment effect size and its consistency 
(Mulrow, 1994).  
6. If the level of heterogeneity permits, to increase the power to detect treatment effects 
(Pettigrew, 2003).  
7. To determine the level of generalisability of the findings; since the diversity of multiple 
studies provides an interpretive context wider than in any single study (Mulrow, 1994). 
8. To identify and seek to explain inconsistencies and conflicts in the research/data (Mulrow, 
1994). 
Issues needing consideration to produce a high quality review are summarised in Table 1 and 
highlighted, where relevant, in the protocol. 
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3.2.4 SECTION SUMMARY. 
Although the science of systematic reviews is not accepted by all, the methodology remains 
the most systematic and rigorous means currently available by which existing evidence may 
be synthesized. As such, systematic reviews are considered appropriate prior to developing 
the proposed trial to assess its potential value and to synthesize the available evidence.   
 
3.3 PROTOCOL . 
3.3.1 SECTION OVERVIEW. 
This section  will present the eight stage protocol to evaluate the effectiveness of post 
operative physiotherapy exercise following discharge from hospital (in terms of improving 
function, walking, range of joint movement, muscle strength and quality of life) for 
osteoarthritic patients undergoing primary elective total knee joint arthroplasty.  The protocol 
incorporates both a scoping review of available evidence, plus meta-analyses and meta-
analytic summaries where appropriate, and follows the model outlined by Eggar and Davey 
Smith (2001 b, p. 24-28.) which is summarised the figure below. The Cochrane Handbook for 
Systematic Reviews of Intervention 4.2.5 (Higgins and Green, 2005a) was also used to assist 
protocol development.  The Quality of Reporting of Meta-Analyses, currently known as the 
QUOROM statement although shortly due to be updated to the PRISMA checklist (Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses), was also used throughout 
(Moher et al., 1999; Moher, 2008). 
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3.3.2 Step 1. Formulate Question for Review. 
Question formation is an iterative process where the focus of the topic area is broadened and 
narrowed until a feasible and relevant question is defined (Montori et al.,  2003). This 
occurred during an initial literature search and during discussions at the ‘Systematic Reviews’ 
Module at the Department of Continuing Education at Oxford University in May 2005.   
 
 
Step 1. Formulate Question for Review 
⇓ 
Step 2. Definition of Inclusion and Exclusion Criteria 
⇓ 
Step 3. Location of Studies 
⇓ 
Step 4. Selection of Studies 
⇓ 
Step 5. The Assessment of Study Quality 
⇓ 
Step 6. Data Extraction 
⇓ 
Step 7. Analysis and Presentation of Results 
⇓ 
Step 8. Interpretation of Results 
 
 
 
Figure 3. The Eight Steps for the conduction of a systematic review (Adapted from Egger and Davey 
Smith, 2001b, p. 25). 
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Although several narrative reviews were located (Brander and Mullarky, 2002; Kuster, 2002; 
Trudelle-Jackson, 2002) no systematic review of previous research was then available. The 
refined question then became the objective of this review as stated in chapter 1.  
 
3.3.3 Step 2. Definition of Inclusion and Exclusion Criteria. 
The reviews included prospective comparative clinical trials relevant to the question. As 
mentioned in the introduction both knee and hip patients were included in this stage of the 
research and, since the searches were integrated, this section mentions both knee and hip 
patients. All located trials were included since the initial scoping literature reviews indicated 
few existing trials.  
Participants: Patients undergoing elective primary unilateral total  knee or hip arthroplasty for 
osteoarthritis who have received a physiotherapy exercise rehabilitation intervention 
following discharge from hospital post-operatively.  
Intervention: The term physiotherapy exercise referred to any exercises or exercise 
programme advised or provided by physiotherapists/physical therapists during the 
rehabilitative period after discharge from hospital after surgery occurring in the out patient, 
community or home setting. The review is restricted to exercise rehabilitation, excluding 
other modalities such as electrotherapy which have been evaluated elsewhere. 
Comparisons: Trials were included in the reviews if they: 
a) compared a physiotherapy intervention versus usual or standard care 
b) compared two different types of relevant physiotherapy intervention. 
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Outcomes: The choice of outcomes came from those used in trials located in the initial 
literature review; reassessed after data extraction and were the following: 
i) Self report measures of Function (in terms of level of activities of daily living) 
ii) Walking; the usual measure of mobility  
iii) Muscle strength 
iv) Range of joint motion 
v) Self report measures of quality of life .    
3.3.4 Step 3. Location of Studies. 
Location was challenging due to: 
1. Terminology: multiple terms describe physiotherapy and physiotherapy interventions; 
requiring more extensive and complex searching. 
2. No single database holds all physiotherapy records (Knipschild, 1994; Main, 2003). 
Medline was insufficient (Dickersin  et al., 1994; Egger et al.,  1997).   
3. The variety in outcomes increases search complexity since searching by outcome is 
more difficult to achieve. 
4. Non English trials were included (Appendix II).  
A broad area search was therefore undertaken, followed by more specific searches to check 
that as many records as possible were identified. It was accepted that this time intensive 
approach would identify many irrelevant papers and duplications but this approach appeared 
the most comprehensive method of locating the maximum possible number of trials present. 
The strategy followed the procedures recommended by the Cochrane Handbook for 
Systematic Reviews of Interventions 4.2.5 (Higgins and Green, 2005b). The databases, 
searched in March 2005 and April 2007, were: 
The Allied and Complementary Medicine Database (AMED) 1985- 
 54
Cumulative Index to Nursing and Allied Health Literature (CINAHL) 1982- 
Excerpta Medica (EMBASE) 1974- 
KingsFund 1979- 
Index Medicus (MEDLINE)1966- 
The Cochrane library (including Cochrane reviews, Cochrane Central Register of Controlled 
Trials, DARE) 
Physiotherapy Evidence Database (PEDro)  
The Department of Health National Research Register 
 
Terms searched included: 
Knee, hip, replacement, arthroplasty, trial, exercise, physiotherapy and physical therapy, 
occupational therapy, home programme.  
Reference lists of all relevant trials identified by these literature searches were then checked 
for further trials. To check for recent and/or unpublished trials Physiotherapy (1985-April 
2007 inclusive), Physical Therapy (1985-April 2007 inclusive), and Journal of Bone and 
Joint Surgery (Britain) Conference Proceedings (1985-2006 inclusive) were hand searched. 
Few additional records were identified; the team believed further searches unlikely to identify 
further quality trials and the search halted (Higgins and Green, 2005b).   
3.3.5 Step 4. Selection of Studies. 
Two researchers (the author and a supervisor, CS), one who knew the subject area well and 
one who did not,  discussed the eligibility of identified studies to lessen any subjectivity 
regarding inclusion / exclusion decision making  (Higgins and Green, 2005b).  Any 
disagreements between the two researchers were to be settled by discussion with a third 
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reviewer. All clinical trials appearing to meet the review’s inclusion criteria were considered 
eligible for inclusion.  
3.3.6 Step 5. The Assessment of Study Quality. 
The quality of component trials is of crucial importance: if the “raw material” is flawed, then 
the findings of reviews of this material may also be compromised 
    Eggar  et al., 2001c p. 45. 
It is not easy to define trial quality (Jüni  et al., 2001a). Due to the numerous different quality 
checklists/ scales available, the model advocates assessing and presenting relevant 
methodological aspects for each paper instead, called the component approach. Jüni et al 
(1999; 2001b) considered 25 quality scoring methods finding a wide variety in scales (from 3-
34 items of varying dimensions and complexity) and component weighting. The same trial 
may score high or low depending on which scale is used; no single scale has been accepted as 
a “gold standard”. Additionally, many scoring systems downgrade the quality rating of a trial 
if it is not double blinded. For many physiotherapy trials, such as those in this review, it is 
inevitable that patients and therapists know whether they are receiving the physiotherapy 
intervention or the control and this is not an indication of low/high trial quality. In my opinion 
this unfairly penalises such physiotherapy trials.  The component approach, outlined by Eggar 
and Davey Smith (2001, p. 24-28), addresses these problems. For this protocol key aspects 
recommended by Eggar and Davey Smith (2001, p. 24-28) plus items were obtained from the 
CONSORT statement (Altman  et al., 2001) and the CASP guidelines (Critical Appraisal 
Skills Programme, accessed 14/05/05) were combined to provide a 22 item checklist 
(Appendix III).  Similar analysis of individual quality components has previously been used 
in reviews of Physiotherapy (Shamley  et al.,  2005).  
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The assessment of quality was undertaken independently by two reviewers (the author 
and a supervisor, KB). Due to the lack of consensus in the literature regarding whether 
reviewers should be masked to names of authors, journals, and institutions, sources of funding 
and acknowledgments and year of publication (see Appendix IV), the second reviewer was 
masked to these aspects but not the first reviewer, whose knowledge of the subject area made 
this process pointless. 
Reviewer 1 (CML) obscured the papers for reviewer 2 (KB) by using a permanent 
black marker to delete the names of authors, journals and institutions, sources of funding, year 
of publication and acknowledgments throughout the text of full papers. This was done twice 
and then again after the articles were photocopied before the relevant details were truly 
obscured. In addition, (see Appendix IV), reviewer 2 was requested to complete a monitoring 
form (Appendix V) to determine the extent to which masking was achieved.  
3.3.7 Step 6. Data Extraction. 
The checklist was reviewed and approved for use by KB and CS and piloted on one paper by 
the two data extractors, CML and KB, who then independently extracted all data and recorded 
this upon a form designed expressly for this purpose (Appendix VI). The checklist had 22 
items. Items could be marked as yes, no, unclear or partial. Items were marked as yes if they 
fully and explicitly met the criteria laid out in the CONSORT standards (Altman  et al.,  
2001).   CML also compiled the full intervention details of included trials to assist in the 
future development of the proposed trial intervention.  
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3.3.8 Step 7. Analysis and Presentation of Results. 
CML and KB discussed and compared the results of the data extraction. Any 
disagreements occurring were to be discussed with a third reviewer, CS. In the event this was 
not required. The two reviewers rarely totally disagreed, usually the disagreement was the 
more minor “yes” to “partial/unclear” or “no” to “partial/unclear” and 100% agreement was 
obtained upon discussion. 
  Where key study details were absent or unclear the authors were emailed and written 
to by CML requesting clarification or further information and the majority of authors replied 
with the sought information. All additional information received was also independently 
reviewed (by CML and KB) and discussed in the same way.  
Summarising the data. 
The results of the quality assessment were presented in a standardised tabulated format to 
allow for easy comparison between studies. The results demonstrating the extent to which 
reviewer 2 (KB) was successfully masked to names of authors, journals and institutions, 
sources of funding and acknowledgments were calculated.   
Inter-rater agreement. 
Percentage agreement between reviewers was calculated. Although useful as a quick guide 
and to assist in identifying whether a problem with the use of the kappa statistic has occurred 
(see below), percentage agreement is flawed because it does not account for some agreement 
occurring between the reviewers by chance or indicate where agreement/disagreement 
occurred (Altman, 1991 0. 404). The kappa statistic measures agreement whilst correcting for 
the amount of agreement that can be expected to occur by chance (Cohen, 1960). It has been 
defined as the ratio of the proportion of agreement (corrected for chance) divided by the 
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maximum number of times the raters could have agreed (also corrected for chance) (Yaffee, 
2003). The kappa statistic does not allow for the degree of disagreement between reviewers 
plus a high interobserver agreement result can exist with a correspondingly low kappa value 
due to how the correction factor for chance works within the kappa statistic formula; part of 
what has come to be known as the kappa paradox (Feinstein and Cicchetti, 1990). 
Due to the limitations of the kappa statistic, it is a controversial statistic and is not an 
unequivocal standard test to quantify agreement (Uebersax, 2002). The intraclass correlation 
coefficient (Landis and Koch, 1997), was therefore also used to inform the study about inter-
rater agreement.   ICC (2,1) was used because each subject was rated by each rater, with the 
raters being considered representative of a larger population of similar raters, and where a 
single measure was used. Unlike tests to solely measure association (such as Pearson’s 
correlation coefficient for continuous variables) where scores could show high correlation but 
little actual agreement with each other, the intraclass correlation coefficient measures the 
magnitude of an effect and is used to provide a measure of inter-rater reliability (Howell, 
2002). SPSS v12.0.1 was used throughout the review. 
Quantitative Data Analysis. 
Although variety was anticipated with regard to the participants, interventions and outcomes, 
the reviews were not anticipated to be so broad in scope that appropriate meta-analysis had 
the potential to be misleading or give an erroneous answer (Eggar  et al., 2001c p. 43) as 
might be the case if, for example, all physical treatment modalities (such as electrotherapy, 
osteopathy, exercise, acupuncture and so forth) were evaluated for pre and post operative joint 
replacement patients. Also, some diversity is useful since the generalisability and usefulness 
of meta-analyses is much improved if the component trials are not too narrow in scope 
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(Gøtzsche, 2000). In addition to narrative summaries quantitative analyses were undertaken. 
After the data was summarised, sufficient adequate data was obtained to allow the following: 
Meta-analyses.  
Meta-analyses were appropriate for knee function, walking, range of joint motion and quality 
of life. It was anticipated that the most frequent unit of analysis would be at the participant 
level, that is, the number of observations in the analysis would match the number of 
participants randomised. However, as the trials provided results for several follow up time 
periods, separate analyses were required for short (3-4 months) and long term (12 months)  
follow ups. Multiple intervention groups, which risk including some participants twice in the 
analysis (for example if control participants are included for treatment A versus control and 
treatment B versus control), were not encountered.  
For each meta-analysis a summary statistic describing the treatment effect observed in 
each individual trial was calculated for each study and then the overall treatment effect was 
calculated as a weighted average of the summary statistics. The weightings reflect the amount 
of information each trial contains and was usually the inverse of the variance of the treatment 
effect, relating closely to sample size. Forest plots have been used to graphically display the 
results for each trial. In these plots the results of component studies are shown as squares, 
which centre on the point estimate of the results of each study, with a horizontal line running 
through the square demonstrating its confidence interval (Lewis and Clarke, 2001). The area 
of the squares represents the weight of the study within the meta-analysis (Egger and Davey 
Smith, 2001 p.30) The overall estimate from the meta-analysis are represented by a diamond 
shape at the bottom of the plot; the diamond’s centre representing the pooled point estimate 
and the confidence intervals represented by the horizontal tips (Lewis and Clarke, 2001). 
Where the same measure was reported weighted mean differences were used, otherwise 
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standardised effect sizes were used (often labelled as small (0.2) medium (0.5) and large (0.8) 
(Cohen, 1969). Fixed effect models and 95% confidence intervals were used throughout. A 
fixed methods meta-analysis assumes that the true effect of treatment is the same value for 
each study and that therefore differences between study results arise by chance (Egger and 
Davey Smith, 2001 p. 34). In a random effects method, the assumption is that the individual 
treatment effects vary around an overall treatment effect (Egger and Davey Smith, 2001 p. 35) 
and these were not considered here as there was no compelling evidence of heterogeneity and 
estimating the between study variation is difficult with few studies. The differences were 
calculated so that positive differences indicate that the effect favoured treatment and negative 
that the effect favoured control/usual care. It is possible to perform sensitivity analyses where 
any studies of doubtful quality are included and then excluded in the meta-analysis and the 
results observed and discussed. If no change is observed it increases confidence in the results.  
Due to the small number of trials included in this review it was decided not to perform 
sensitivity and sub group analyses.  Statistical analysis was performed using R 2.3.1 and the 
rmeta package (R Development Core Team, 2006) by Dr Michael Dewey.  The data, data 
entry and selection of variables was provided and checked by Catherine Minns Lowe. 
 
Heterogeneity.  
An indication of the presence of statistical heterogeneity is present if the confidence intervals 
for individual trial results have poor / no overlap. Tests of heterogeneity, to assess whether 
there is greater variation between the results of trials than would arise by chance alone (X2), at 
a 5% significance level were performed but with the number of studies available in these 
meta–analyses it is accepted that these have low power. Since statistical heterogeneity is 
always likely to occur in a meta-analysis, instead of testing for the presence of heterogeneity, 
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some tests now quantify inconsistency so that the impact of heterogeneity on a meta-analysis 
can be assessed. One such commonly used test is the I2 (Higgins  et al., 2003), this was also 
calculated to give a measurement of the degree of heterogeneity between the trials in the 
meta-analysis. Statistical analysis was performed using R 2.3.1 and the rmeta package (R 
Development Core Team, 2005) by Dr Michael Dewey.  The data, data entry and selection of 
variables was provided and checked by Catherine Minns Lowe. 
 
Bias.  
The assessment of publication bias, by the use of funnel plots, was felt to be inappropriate due 
to the small number of trials available for inclusion in the review. 
3.3.9 Step 8. Interpretation of Results. 
The initial interpretation of the results of the review was undertaken by CML and, to ensure 
the review findings were appropriately placed into the surrounding clinical context, its 
accuracy and meaningfulness discussed with the other reviewers (KB, CS, MD). The review, 
plus the associated hip review, was then written up and submitted for publication (Minns 
Lowe  et al., 2007; Minns Lowe  et al.,  2009). 
 
3.4 RESULTS. 
3.4.1 SECTION OVERVIEW. 
This section will include the results of the selection and quality assessment processes, the 
characteristics of the studies included in the review, summaries of the interventions and the 
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quantitative data syntheses and analyses. The search strategies combined both knee and hip 
joint arthroplasty patients whilst the remaining results are for the knee only.  
 
3.4.2 Location of Studies. 
 
The search strategy is summarised in the table below (full details in Appendix VII). 48 
records were identified. As expected the trials identified were published in a wide range of 
journals (Knipschild, 1994).  
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Table 2.  Search Strategy for Systematic Review.  
Source Searches and Search Terms Mar-Jul 2005 
Hits* (no  of 
new relevant 
records) 
2005-Apr2007 
Hits* (no  of 
new relevant 
records) 
KA24 : 
AMED 1985 – 
CINAHL 1982-  
EMBASE 1974- 
Kingsfund 1979- 
MEDLINE 1966-    
1. “hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “rehabilitation” AND “trial$” (whole document) 
2. “hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “exercise” AND “trial$” (title) 
3.  “hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “physiotherapy” AND “trial$” (title) 
4. “hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “physiotherapy”  (title) 
5. “hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “physical therapy” (title) 
6. “hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “home programme” (title) 
7. “hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “home programme” (whole document) 
8. “hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “occupational therapy ” (whole document) 
9. “hip” OR “knee” (whole document) 
AND “occupational therapist$” (title) 
587 (25) 
 
 
 
118  (11) 
 
 
2 (0) 
 
 
 
39 (0) 
 
 
43 (8) 
 
 
 
2 (0) 
 
 
 
22 (2)  
 
 
35 (0) 
 
 
 
0 (0) 
180 (0) 
 
 
 
1 (0) 
 
 
4 (0) 
 
 
 
14 (0) 
 
 
15 (0) 
 
 
 
1 (0) 
 
 
 
27 (0) 
 
 
3 (0) 
 
 
 
3 (0) 
Cochrane library: 
Cochrane reviews 
CCRCT 
DARE 
1. Browsed by topic      musculoskeletal 
Search narrowed           osteoarthritis 
Search narrowed           rehabilitation 
2. General search term “joint replacement” 
 
 
9 
80 
 
 
11 
18 
PEDro 
physiotherapy 
evidence database 
1. “joint replacement AND rehabilitation” 
2. “joint replacement” 
1 (0) 
5 (0) 
17 (0) 
45 (0) 
Dept of Health 
National 
Research Register 
1. “joint replacement AND rehabilitation” 
2. “joint replacement AND physiotherapy” 
3. “joint replacement AND exercise” 
4. “joint replacement AND physical therapy” 
5. “joint arthroplasty AND physiotherapy” 
6. “joint arthroplasty AND rehabilitation” 
7. “joint replacement AND occupational therapy” 
0 
7  
2 (0) 
3 (0) 
0 
2 (1) 
5 (0) 
19 (1) 
9 (0) 
6 (0) 
5 (0) 
0 
2 (0) 
5 (0) 
Physiotherapy  Key journal - Hand search of contents pages  Nil new Nil new 
Physical Therapy Key journal - Hand search of contents pages  Nil new Nil new 
JBJS [Br] Hand search of all conference proceedings 2 new 1 
Reference lists Hand searching of papers included in the review 1 new  
Totals  965 (50) 
 
386 (2) 
* Numbers following use of removal of duplicates commands when available.  
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3.4.3 Selection of Studies. 
The 48 records were screened against the inclusion criteria first by CML and then by CML 
and CS at two meetings, 19th May 2005 and 14th July 2005. Consensus was reached regarding 
the inclusion / exclusion of all records (Appendix VIII) and summarised in the figure below.   
 
 
Potentially relevant RCT abstracts identified and screened for retrieval (n=48) 
 
                                                                                   27 abstracts excluded 
                                                                                   n= 10 not a rct 
                                                                                   n = 2 multiple trial reports 
                                                                                   n= 12 inpatient intervention 
                             n=1 preop plus post op intervention 
                                                                                   n=1 osteopathic manipulation intervention 
                                                                                   n=1 intervention was neuromuscular  stimulation 
 
Full papers obtained and screened for retrieval (n=21) 
 
                                                                                      7 papers excluded 
      n=1 not a trial     
       n = 3 inpatient intervention 
      n= 1 preoperative intervention 
                                                                                       n= 1 patients with injurious falls 
                                                               n= 1 comparing exercise and Continuous                    
Passive Motion machines 
 
RCTs evaluated in detail (n=14) 
 
 
 
KNEE 
RCTs suitable for inclusion in meta-analysis        RCTs not suitable for meta-analysis  
n=5      n=1 
 
HIP 
RCTs suitable for inclusion/part                RCTs not suitable for meta-analysis (n=6) 
inclusion in meta-analysis (n=2) 
 
 
 
Figure 4. Flow diagram to summarise the selection of trials included in the reviews. This diagram is based 
on the Quorom statement by Moher et al., (1999).  
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The following table gives details  for the excluded studies. Following this decision making 
process, 14 records were considered to successfully meet the inclusion criteria for the 
systematic review and were selected for inclusion. 
 
 
 
Table 3.  Studies Excluded from the knee systematic review. 
 
Reason for Exclusion Study 
Not a randomised clinical trial Tum-Sugden 1976 
Ulreich et al 1997 
Benedetti et al 2003 
Ritter et al 1989  
Waters 1974 
In patient intervention Kolarz et al 1999 
Beaupré et al 2001 
Hewitt & Shakespeare 2001 
Karst et al 1995 
Kim & Moon 1995 
Kumar et al 1996 
Montgomery & Eliasson 1996 
Hughes et al 1993  
Lang 1998 
Munin et al 1998 
Osteopathic manipulation intervention Licciardone et al 2004 
Neuromuscular stimulation intervention Stevens 2002 
Pre operative intervention Gursen & Ahrens 2003 
Comparison of exercise and continuous passive 
motion 
Worland et al 1998 
Study halted early with no results Stanley 2004 
Mockford et al 2006 Duplicate trial report 
 
 
 
3.4.4 Pilot study: The assessment of study quality. 
The data extraction form (Appendix VI) was piloted on one paper and the results discussed by 
the two reviewers. Following the good level of agreement (26 out of 33, or 79%, categories 
achieving immediate agreement with 100% agreement after short discussion) between the two 
reviewers in this pilot phase, no changes were considered necessary to this form before use in 
the main review. Several issues were identified during extraction. In item 3  “does the study 
include the setting and locations where data was collected?”, the lack of agreement reflected 
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the success of blinding for location for the second reviewer. Lack of agreement was therefore 
desirable for this one item, which was subsequently removed from kappa, ICC and percentage 
agreement calculations carried out in the main review. High percentages of agreement were 
obtained for items where factual information was extracted from papers, for example, stating 
which outcomes were used and when extracting the results. Lower levels of agreement were 
extracted for items requiring a judgement or interpretation to be made regarding the quality of 
the data, for example items 20-22 relating to the quality of the discussion sections. Where 
discrepancies existed they tended to be between “Yes” and “Partial/Unclear”, “No” and 
“Partial /Unclear” and “Partial” and “Unclear” rather than between the larger gap of “Yes” 
and “No”. Discussion between the two reviewers easily resolved these minor differences in 
opinion.  
 
3.4.5 Main review: the assessment of study quality.  
All trials underwent full quality assessment except for one trial only available in abstract form 
(Mockford & Beverland 2004). For this review, studies were considered to be of good quality 
if they were deemed sufficiently robust to appropriately include in meta-analyses. The table 
below presents quality assessment findings for each study. One study (Codine et al.,  2004) 
was excluded from the meta-analysis because participants were allocated by alternation. All 
trial outcomes were measured by assessors masked to allocation. As the table shows, most 
studies clearly reported the flow of participants through the trial, justified study sample size 
and included intention to treat analyses. Several quality indicators were not fully discussed in 
all papers, such as allocation concealment and details regarding the implementation of 
randomisation methods. 
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          Table 4. Quality component checklist and quality evaluation of trials included in the review (n=6).  
 
Does the study/author information 
adequately contain the following: 
Codine et al., 
2004 
Frost et al., 
2002 
Kramer et al., 
2003 
Mockford & Beverland 
2004  *see note 4 
Moffet et al.,  
2004 
Rajan  et al., 
2004 
Rationale for study  Y Y Y Y Y P 
Eligibility criteria  Y Y Y Y Y Y 
Recruitment method  N Y N Y Y P 
Settings and location of study  N Y Y Y Y Y 
Intervention P Y Y Y P* see note 5 N 
Objectives / hypotheses P Y Y Y P Y 
Defined outcome measures Y Y N Y Y P 
Quality enhancers (e.g. multiple observations) N Y P  N N 
Sample size determination N P * see note 3 N Y Y Y 
Randomisation * see note 1 Y Y Y Y Y 
Randomisation sequence generation N Y N Y Y Y 
Allocation concealment N Y N Y Y N 
Randomisation implementation methods N N N Y Y N 
Blinding - participant I I I I I N 
Blinding – of those administering the 
intervention 
I  I P I I N 
Blinding – outcome/assessments Y Y Y Y Y Y 
Statistical methods *see note 2 Y P Y Y Y 
Flow of participants through each stage N Y Y Y Y Y 
Recruitment and follow up dates N P N  Y Y 
Baseline demographics P Y Y P Y P 
Numbers analysed (and ITT) N Y U Y *see note 6 Y 
Summary of Results N Y Y Y Y Y 
Estimated effect sizes N Y N  N N 
Precision N N N  Y Y 
Results for each outcome Y Y Y Y Y Y 
Ancillary analyses N Y U  Y N 
Adverse events N Y P  Y P 
Interpretation P Y P  P P 
Generalisability P Y P  Y N 
Results placed into context  P Y P  Y N 
Quality. Is the study of sufficient quality 
to include in meta-analyses? 
N Y Y Y Y Y 
Key: Y = Yes, included in paper/information to meet CONSORT level standards. N = not provided in paper/information. I = considered inappropriate/impossible. P = Partially evident in 
paper/information. U = not fully provided /explained in paper/information and therefore unclear/ambiguous.  Note 1: 1st participant was drawn randomly then alternatively assigned (this process was 
witnessed).  Note 2: additional information from author stated the sample size was determined by a statistician who calculated n = 30 in each arm to be sufficient. Note 3: This was a feasibility trial 
which provided sample size calculations as part of the results section. Note 4: Published abstract and information from authors only therefore this is incomplete. Note 5: intervention described but little 
description of home exercise programme described to both groups. Note 6: ITT analysis intended and performed but a per protocol analysis was presented because the loss to follow up in the control 
group favoured the intervention gr
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3.4.6 Masking in knee systematic review:   
The masking rates for authors (80%), journals (20%), author affiliations (80%) and funding 
sources (80%) were considered successful bar journal of publication.   
3.4.7 Reviewer agreement in main review:  
The following levels of agreement between reviewers were obtained 69.09%, kappa 0.524, 
intraclass correlation coefficient (2,1) 0. 488 (95% CI 0.3 to 0.626) (Appendix IX). 
Any instances where the two reviewers were not in initial agreement regarding the quality of a 
study following independent review were discussed until consensus was reached.  Major 
disagreement was rare, usually disagreement was the more minor “yes” to “partial/unclear” or 
“no” to “partial/unclear” and 100% agreement was obtained. A third reviewer (CS) was 
available in the event of consensus not being reached but in the event this was not required. 
 
3.4.8 Study Characteristics.  
The following table summarises the characteristics of the included studies and provides 
information regarding the participants, intervention, main outcomes, and conclusions reached 
by the authors. 
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Table 5. Study Characteristics of the Trials Evaluated in the Knee Systematic Review (n=6).  TKA denotes total knee arthroplasty.  
 
     
Paper Participants 
(sample size) 
Intervention (time of intervention) Main Outcome Measures Results 
1. Codine et 
al., 2004 
Unilateral 
TKRApatients (60)  
Submaximal training of hamstring muscle using 
eccentric isokinetic strengthening versus control of 
usual care (Day 10-30 post operatively) 
Range of motion. Isometric muscle force. 
Knee Society Clinical Rating Scale  
 
Significant difference between the two 
groups for extension only; favouring the 
intervention.  
 
2. Frost et al., 
2002 
Unilateral TKA for 
osteoarthritis (47) 
Comparison of a functional exercise group versus a 
traditional exercise group (post discharge) 
Leg extensor power. Walking speed.  
Pain during walking (measured using 1 
item from the Oxford Knee Score). Knee 
flexion  
 
Feasibility study. No statistically 
significant differences between the 2 
groups; trends in favour of the functional 
group. 
3. Kramer   et 
al., 2003 
Primary unilateral 
TKA (160) total knee 
arthroplasty  
Home based exercise group versus individual clinical 
based treatment (generally beginning within 1 week)  
Knee society clinical rating scale scores. 
WOMAC. SF-36. Walk test. Knee 
flexion. 
 
No significant differences between the 
groups. 
4. Mockford 
& Beverland 
2004 
TKA (150)   Outpatient physiotherapy versus control of usual care 
(3 weeks post discharge) 
Range of motion 
 
Significant difference in range of motion 
favouring intervention.  
5. Moffet et 
al., 2004 
Primary unilateral 
osteoarthritis TKA (77) 
Functional rehabilitation sessions versus usual care (2 
months following surgery) 
Functional ability – Distance walked in 6 
minutes. SF-36. WOMAC  
Significant difference in walking 
distance for functional group. At 2 & 4 
month follow up  (but not 12) the 
functional group had less pain, stiffness 
and difficulty performing activities of 
daily living.  
6. Rajan et 
al., 2004 
Primary TKA for 
monoarticular arthrosis 
(120) 
Range of motion in degrees  Outpatient physiotherapy versus no outpatient  
physiotherapy alone (post discharge) 
No significant differences between the 2 
groups.  
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3.4.9 Summary of the Interventions and Comparisons. 
With the exception of one trial (Rajan et al., 2004) in depth details of the intervention and 
comparison groups were available from the papers and authors. These are summarised in the 
next table.  The trial interventions were similar to each other in that they provided additional 
physiotherapy exercises/treatment following discharge after total knee replacement, often 
involving functional weight bearing exercise programmes. Few details regarding the 
intervention are provided by Rajan et al., (2004). Most of the interventions included 
functional weight bearing exercises. Only one trial differed significantly from this approach, 
Codine et al., (2004) investigated the effect of eccentric isokinetic muscle strengthening  
using a CYBEX dynamometer. Interventions were usually started within two weeks of 
discharge. Out-patient programmes generally lasted up to twelve weeks while home exercise 
programmes were recommended for up to one year or indefinitely in one case (Kramer  et al., 
2003).  
The comparison groups were mainly control groups where no additional outpatient 
physiotherapy was organised. Patients were expected to continue with the traditional home 
exercise programme, namely isometric strengthening and range of movement exercises plus 
gait training/re-education, provided to all patients during their in patient stay.  
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Table 6. Summary of trial interventions and comparisons included in the knee replacement trials (n=6). 
 Early programme provided to all trial participants  Intervention details Comparison group details 
Codine et al, 2004  
 
Knee mobilisation (continuous passive motion and manual), isometric muscle 
strengthening for all knee and leg muscle groups, “proprioceptive 
enhancement,” walking exercises 
Submaximal hamstrings muscle eccentric isokinetic strengthening (passive resist 
mode). Torque produced > half of torque measured during testing. CYBEX 
dynamometer training speed of 10 degrees/s. Range of motion during flexion was 
conducted in active assist mode. Programme from day 10-30 post total knee 
arthroscopy, CYBEX 5 mins/day, 5 days/week for 3 weeks 
Nil else added 
 
Frost et al, 2004 
 
 
 Gait re-education, mobilising, and strengthening exercises 
(including active knee flexion, straight leg raises, inner range 
quadriceps, isometric quadriceps) 
Warm up: sitting knee flexions 10 repetitions. Chair rise: baseline number set and 
increased every alternate day up to 2 mins, then repeat up to 3 times/day;. Walk: 1 
min normal pace, increase 30 s/day until up to 10 mins, repeat 2-3/day. 
Leg lifts on to step/thick book: Baseline set. Increase by 1 per day until 2 min 
duration. Then repeat 2-3/day 
Long sitting: static quadriceps (5 s 
hold); straight leg raise (5 s hold), 
inner range quadriceps (5 s hold). 
Supine: knee flexion heel slides. 
Standing: knee flexion (5 s hold). 
Sitting: long arc quads (3 s hold) 
Kramer et al, 2003  
 
Performed 3 times/day until 12 week check-up, then ≥ once a day. Stage I 
supine: knee flexion and extension. Long sitting: autoassisted knee flexion, 
ankle dorsiflexion in kneeextension with calf stretch. Supine: isometric knee 
extension,inner range quadriceps. Supported sitting: hamstrings stretch. 
Sitting: active knee extension. 10 repetitions. Stretch/holds for 5 s. Stage II—
prone lying: quadriceps stretch. Standing: quadriceps stretch, soleus stretch, 
Achilles stretch, knee flexion (progress to ankle weights). Supine: straight leg 
raise. Sitting: resisted knee extension, resisted knee flexion, sit-stand-sit. 10 
repetitions, stretch/holds for 5 s. Optional exercises: exercise bike; standing 
wall sits 5-10 repetitions; standing slow short squats 10 repetitions 
Outpatient physiotherapy weeks 2-12 after surgery: up to two sessions/week, each 
session about 1 hour. Exercises could be added/modified, therapeutic modalities 
(ice, heat, ultrasound), joint mobilisations, or other measures as appropriate. 
Patients requested to complete common home 
exercise only twice on clinic session days 
 
Physiotherapist phoned patient ≥1 
during weeks 2-5 and 7-12 after 
surgery for queries, advice. Patients 
able to phone with queries 
 
Mockford and 
Beverland 2004 
 
 
Supine: active ankle dorsiflexion and plantarflexion (10 repetitions), 
isometric quadriceps and hamstrings (3 repetitions), straight leg raise 
(repetitions vary), physiotherapist assisted knee flexion (5 repetitions), heels 
slides (3 lots of 10 repetitions, 2 mins rest between each set), active knee 
extensions over roll/bar (3 sets of 10 repetitions, as able, 2 mins rest between 
each set). High sitting: proprioceptive neuromuscular facilitation. Hamstrings 
pulley with 2 kg weight (3 lots of 10 repetitions, 2 mins rest between each 
set). Gait re-education with crutches/sticks as appropriate. Stairs practice 
 
9 outpatient physiotherapy sessions in 6 weeks (2 sessions in weeks 1, 2, and 3, and 
1 session in weeks 4-6). Week 1—heelslides, isometric quadriceps and hamstrings, 
straight leg raise, active knee extension over bar/roll and hamstrings pulley—allas 
in early programme. Proprioceptive neuromuscular facilitation, physiological 
mobilisations for flexion and extension (3 sets of 10 repetitions with 2 mins rest 
between sets). Weeks 2-3—standing: weight shifts (10 repetitions), quarter squats 
(10 repetitions). Prone lying: autoassisted quadriceps stretch (10 repetitions). Sit-
stand-sit (10 repetitions). Gait re-education. Weeks 4-6—proprioceptive work in 
parallel bars. Gait re-education. Standing: stepping over cones, wobble board, step-
ups (10 repetitions). Exercise bike for 5 mins 
No outpatient physiotherapy 
Moffet et al, 2004  
 
“Simple exercises” to regain lower limb strength (quadriceps, 
hamstrings, hip abductors, and hip extensors) and to increase 
knee range of motion. Advice about knee positioning, ice 
application, and gait retraining 
12 sessions of outpatient physiotherapy in 6-8 weeks, 60-90 mins each at clinic 
visit starting 2 months after surgery. Plus individual home exercise programme. 
Warm up (5-10 mins): lower limb flexion/extension, alternate ankle dorsi flexion-
plantarflexion, hamstrings stretch. Specific strength exercises (15 mins): isometric 
knee extension in 0° and 60° flexion at visits 1-2;isometrichamstrings 60° flexion 
at visits 3-6: concentric eccentric hip abductors against gravity at visits 1 4. 
Functional task oriented exercises (15-20 mins): get up-sit down at visits 1-6; knee 
extensor strengthening in standing with Theraband at visits 1-6; controlled bilateral 
knee flexion-extension in standing at visits 1-8; unilateral knee flexion to 90° in 
standing at visits 7-10; climbing on platform/stairs at visits 3-12; walk backwards 
on slope and/or laterally while crossing lower limbs at visits 3-12: walk in place, 
with large amplitude hip and knee flexion and upper limb movements at visits 9-
12. Endurance exercises (5-20 mins): walk at visits 3-12, exercise bike at visits 4-
12. Cool down (10 mins), slow walk, strength, ice 
Usual care. 26% patients had home 
visit. No attempt made to limit 
care. 
Information about usual care 
obtained by questionnaire and by 
phone interviews with patients and 
physiotherapist 
 
Rajan et al, 2004C Outpatient physiotherapy, 4-6 sessions All patients given home exercise programme to follow on discharge. No organised physiotherapist 
 
3.5 DATA SYNTHESIS. 
3.5.1 Measures of function (5 trials, 494 participants).  
Five of the studies contained a measure of function (see study characteristics table). The 
measures used included:  
1. The 12 item Oxford  Knee Score (Mockford & Beverland, 2004) which measures functional 
ability, including pain, (scored 12-60, low score indicates high function). Frost et al (2002) 
used one item of this score.   
2. The American Knee Society Clinical Rating Score (Codine  et al., 2004;Kramer  et al.,  
2003, Mockford & Beverland, 2004)  measures pain, movement, stability and functional 
activity (scores 0-100, high score indicates favourable).  
3. The 24 item Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 
(Kramer  et al.,  2003; Moffet  et al.,  2004)  has pain , stiffness and function domains scored 
as a percentage by Moffet et al.,  and out of 0-170 for function by Kramer et al (low scores 
are favourable ).  
4.The Bartlett patellar score (Mockford & Beverland, 2004)  which measures anterior knee 
pain, quadriceps strength, and function (scores 3-30, high scores are favourable).  
Within the individual trials, three demonstrated no observed significant differences 
between groups (1-3 study characteristics table). Frost et al., (2002) showed significant within 
group differences for the treatment arm, indicating a treatment benefit.  Mockford and 
Beverland  (2004) presented no results in their published abstract but supplied summary 
statistics for their outcomes allowing us to include their study in the meta-analysis. Moffet et 
al., (2004) demonstrated significant differences between the two groups, in favour of the 
intervention, at four and six months following arthroplasty, but not at 12 months.  
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 The Forest plot below shows the three studies with data on functioning at three-four 
months and twelve months post surgery. Where studies included more than one measure of 
function it was decided to use the Oxford Knee and the WOMAC Scores since these 
encompassed all component trials. No trial included both the Oxford Knee Score and the 
WOMAC.  At three-four months the standardised effect size is 0.33 (0.07 to 0.58) and the 
confidence interval does not include zero. This effect size is considered small to moderate 
(Cohen, 1969). At twelve months, with one additional study, the effect size is now close to 
zero at –0.07 and the confidence interval includes zero.  
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Figure 5. Forest Plot showing Standardised Effect Sizes with Confidence Intervals for  
Function.  
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3.5.2 Walking (3 trials, 284 participants). 
Some form of walking outcome measurement was used in three knee replacement trials (2-3, 
study characteristics table).  The measures reported included the following: walking speed 
over a 10m distance, measured in m/sec (Frost  et al.,  2002) and a 6 minute timed walking 
test, measured in meters (Kramer  et al., 2003; Moffet et al.,  2004). The two timed walk tests 
varied in that Moffet  et al.,  report the use of a 50 m walkway.  
The results from these trials are mixed. No significant differences were observed 
between groups in one trial (Kramer  et al., 2003), differences approaching significance were 
observed in another (Moffet  et al.,  2004) trial while in the third trial significant differences 
within interventions groups were observed (Frost et al.,  2002).  
The Forest plot below, using standardised effect sizes, shows the intervention to have 
no overall influence on walking at either three or twelve months. 
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 Figure 6. Forest Plot showing Standardised Effect Sizes with Confidence Intervals for  
  Walking.  
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3.5.3 Range of joint motion (5 trials, 537 participants). 
Range of knee joint motion was used as an outcome measure for five of the total knee  
replacement trials (1-4,6, study characteristics table). Although all measurements were 
provided in degrees, the method of achieving results varied. Codine et al., (2004)  used a 
goniometer integrated into a dynamometer to measure knee flexion and extension whilst  
Mockford and Beverland (20040 measured active and passive flexion and extension using a 
goniometer. Frost  et al., (2003) and Kramer et al., (2003) both measured active flexion only 
with Rajan  et al., (2004) providing findings for a single knee range of motion. 
Once again, the results were mixed. Codine  et al.,  (2004) demonstrated a significant 
difference in knee extension between the two groups at ten days, however, despite 
randomisation, the two groups appeared by chance to have different extension at baseline. 
Mockford and Beverland (2004) concluded that there was a significant difference in active 
knee movement, in favour of the intervention group, but not in passive range. In the pilot 
study by Frost  et al.,  (2002) there was a trend that loss of range was less in the functional 
group than the traditional exercise group but no statistical significant difference was observed 
in the small study. In another two studies (Kramer  et al., 2003; Rajan  et al.,,  2004) no 
significant differences were also observed.  
All the knee joint range of movement studies used the same measure, degrees, therefore 
the following Forest plot shows the weighted mean differences (WMD) and confidence 
intervals. The three month summary shows an increase of 2.9 degrees (0.61 to 5.2) with a 
confidence interval which does not include zero. This is considered a small to moderate 
WMD. At twelve months the effect is smaller, about one degree, and the confidence interval 
includes zero at this time point.  
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 Figure 7.  Forest Plot showing Weighted Mean Differences with Confidence Intervals for  
  Range of Motion.  
 
 
 
3.5.4 Quality of life (3 trials, 387 participants ). 
Quality of life measures were included in three knee trials (3-5, study characteristics table). 
The SF-36 Health Survey provides an 8-scale profile of functional health and well-being 
scores health dimensions with low scores indicating poor health. The SF-36 was used by 
Kramer  et al., (2003)  with the French translation of the same score being used by Moffet  et 
al., (2004). The latter additionally provided the short form SF-12 Physical Component and 
Mental Component Scores, as did Mockford and Beverland.  
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No significant differences between the groups were demonstrated by Kramer et al. (2003). 
Statistical analyses for this measure were not presented by Mockford & Beverland (2004). 
Moffet  et al., (2004)  report small significant differences in favour of the intervention group 
were present for SF-36 role-physical dimension and the Physical and Mental Component 
scores at six month follow up but not at twelve month follow up.  
The following Forest plot presents the studies with data provided regarding quality of life. 
At three-four months the studies used the same measure, the SF-12, and so weighted mean 
difference results are presented. However, at twelve months post surgery not all studies used 
the same measure and therefore the analysis has reverted to the use of standardised effect 
sizes which are presented in the table.  
At three-four months post surgery the weighted mean difference is 1.7 (-1 to 4.3) with the 
confidence interval including zero. Thus there is a small effect seen in favour of the 
intervention. At twelve months the effect is close to zero with a standardised effect size of 
0.03 (-0.2 to 0.25).  
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 Figure 8.  Forest Plot showing Weighted Mean Difference (3-4 months) and Standardised  
Effect Size (12 months) with Confidence Intervals for Quality of Life.   
 
 
3.5.5 Muscle strength. 
Muscle strength itself was not directly measured in any of the trials included in the knee 
review.  
 
3.5.6 Heterogeneity.  
The next table provides the results of the analysis of heterogeneity. As can be seen no major 
problems are indicated but the results are limited by low power.  
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Table 7. Heterogeneity χ2 and I2 Test Results for Function, Walking, Joint Range of Motion and Quality 
of Life. 
 
Outcome 3-4 months post surgery 
 
12 months post surgery 
 
Function 
 χ
2 = 0.78  (df =2   p=0.68) 
I2 =  0% 
χ2 = 2.35 (df= 3  p = 0.50) 
I2 = 0% 
Walking 
 
 
χ2 = 0.54 (df =1   p=0.46) 
I2 = 0% 
χ2 = 0.41 (df = 1   p=0.52) 
I2 = 0% 
Joint range of motion 
 χ
2 = 1.46 (df=2   p=0.48) 
I2 = 0% 
χ2 = 2.28 (df = 3   p = 0.52) 
 I2 = 0% 
Quality of life 
 
 
χ2= 0.41 (df = 1  p = 0.52) χ2 = 0.91 (df = 2  p = 0.63) 
I2 = 0% I2 = 0% 
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3.6 DISCUSSION OF THE SYSTEMATIC REVIEW. 
3.6.1 SECTION OVERVIEW. 
This section presents a summary of the main findings from the systematic review evaluating 
the effectiveness of post operative physiotherapy exercise following elective joint 
replacement. The strengths and weaknesses of the review procedures are then discussed 
followed by a discussion of the clinical implications from the review.  
 
3.6.2 SUMMARY OF KEY FINDINGS. 
The systematic review provides support for the use of physiotherapy functional exercise 
interventions following discharge, over traditional home exercise and advice programmes, to 
obtain short term benefit following elective primary knee arthroplasty. A small to moderate 
standardised effect size, in favour of functional exercise, was seen for function at three-four 
months post operatively. Small to moderate weighted mean differences, in favour of 
functional exercise interventions, were seen for range of joint motion and quality of life at 
three-four months post operatively. It is interesting to note that post treatment benefits were 
not seen at one year follow-up. 
 
3.6.3 STRENGTHS AND WEAKNESSES OF REVIEW PROCEDURES.  
3.6.3.1 Location of trials. 
The search strategy is considered comprehensive and to have been successful in locating 
relevant trials for inclusion in the review. Physiotherapy literature remains a difficult area to 
search, with numerous bibliographic data bases and un-indexed journals (Knipschild, 1994), 
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and while every attempt was made to identify studies it is possible other studies exist. 
However, these reviews remain the most comprehensive to date. The success of the search 
strategy used is indicated by a systematic review simultaneously published in 2007 by Dauty  
et al. This narrative review for literature regarding physical training in rehabilitation before 
and after hip and knee arthroplasty was limited to Medline and Cochrane databases, was date 
limited (1996-2006), did not include physiotherapy/physical therapy as a search term and did 
not search other databases likely to contain allied health professional research records. 
Consequently the review identified two trials from our fourteen knee and hip trials, even 
though all would have been relevant. The time consuming approach utilised for our reviews 
appears vindicated and, until location of physiotherapy trials becomes easier, shortcuts cannot 
be successfully undertaken for these types of reviews.  The two non English language trials 
identified in the literature search were professionally translated to allow full inclusion and to 
prevent the introduction of language bias (Grégoire et al., 1995; Moher et al., 1996). 
Exclusion of non English trials would have removed one quarter of the trials later included in 
the hip review. Although the methodological quality of non English trials tends to be poorer 
(Juni  et al.,  2002; Egger  et al.,  2003) the trial identified in this literature search by Nyberg 
& Kreuter (2002) demonstrated that this cannot be assumed since this trial was of higher 
quality than some included English language trials (Minns Lowe  et al.,  2009). This supports 
the decision to include non English trials in this search strategy. 
 
3.6.3.2 Data Extraction. 
There were no apparent major problems with the data extraction processes used in this 
review; these processes will now be discussed. 
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Masking. 
Previous blinding rates have varied from 54-73 % (Appendix IV). As such, the blinding rates 
achieved in these reviews appear satisfactory except for journal of publication.  The repeated 
attempts to obfuscate study details could not disguise the layout of the journal. One way by 
which this might be achieved in the future would be to electronically scan and then edit trial 
reports prior to the review (Berlin, 1997). This was considered during protocol development 
but, with no scanner, was beyond available resources. Since reviewers may judge the quality 
of a paper by the journal in which it is published (Appendix IV) it is accepted that this may 
have affected the rating provided by the masked reviewer. 
Independent Reviewer Ratings. 
The independent reviewers showed good percentage agreement with each other and moderate 
agreements when using Cohen’s kappa (Altman 1991 p. 404) and the Intraclass Correlation 
Coefficient (Landis and Koch, 1997). This level of initial agreement was considered 
acceptable since interpretation of some checklist items, such as generalisability and overall 
evidence, can be subjective.  Following discussion both reviewers were in full agreement for 
all items for all papers.  
The kappa statistical test depends on the number of categories, in this case four. 
Higher kappa values are obtained in 2 X 2 tables and lower kappa values for tables with more 
categories (Altman, 1991 p. 409). If this study had used a Yes / No score then a higher kappa 
value would have been achieved, but at the expense of introducing error by asking reviewers 
to guess where to place unclear or inadequate data. This may also have lead to a higher 
missing data rate since reviewers may have been unwilling to commit themselves to a Yes / 
No opinion.   
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ICC (2,1): SPSS provides the option of working out whether the error involved in the 
calculation is systematic: an absolute agreement type ICC measurement checks for systematic 
error while consistency type ICC measurement does not. Both types were calculated with 
little difference seen (Appendix VII and VIII).  
3.6.3.3 Trial Quality.  
In the knee review trial quality was good overall. Of the five adequately randomised studies 
included in the meta-analyses, the majority were adequately powered with adequate allocation 
concealment strategies and outcome measurements were obtained by assessors blinded to 
treatment allocation (Altman et al.,  2001). Yet, like the majority of physiotherapy trials 
(Main, 2003), studies are relatively small with 554 participants in the five trials included in 
the meta-analyses and 614 participants included overall in the review. The most frequently 
used outcomes were function, predominantly subjective measures of functional ability, and 
range of joint motion as an objective measure. However whilst range of joint motion is 
important, its usefulness as an outcome measure of physiotherapy rehabilitation interventions 
is limited since other factors, such as prosthetic design, preoperative knee motion and surgical 
technique, also influence post operative range of joint motion (Sultan  et al.,  2003).  Muscle 
strength was not directly measured in any trial, although leg extensor power was included in 
one (Frost  et al.,  2002), instead objective measures like walking were used.   
The CONSORT statement, which was used to assist the assessment of quality of 
component trials in this review, has recently been extended to improve reporting in pragmatic 
trials (Zwarenstein  et al., 2008). This extension, like this review, accepts that blinding may 
not be done / possible within trials. Whilst this new extension is welcomed it is not believed 
that the quality of this review has been significantly lessened by being completed prior to 
publication of the extension. The need to comprehensively describe both the intervention arm 
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and the comparator arm in pragmatic trials was also emphasised as an indicator of quality in 
trial reporting in this new CONSORT extension (Zwarenstein  et al.,  2008). The direct 
approaching of lead authors for additional information regarding quality indicators and the 
kind assistance of authors of component trials has enabled us to achieve this in this systematic 
review of published trials and we are grateful for their assistance.  
 
3.6.3.4 Data Analysis. 
Meta-analysis. 
The studies included in the knee systematic review showed some variation, such as the 
exercise type, dose and timing (as shown in the table summarising trial interventions and 
comparisons).  Some reviewers believe meta-analysis is only appropriate for homogenous, 
similar or comparable data (Eysenck, 1994).  Other researchers believe that heterogenous 
results from different designs are important since it is not always known a priori which 
methodological details, such as dose and timing, are most appropriate (Shrier, 2005).  
Systematic reviews that are narrow in scope can be misleading (Gøtzsche, 2000) as well as 
overly broad ones; there is a tension between a narrowly defined question and providing a 
widely applicable answer (Montori  et al.,  2003). In this review the question was intended to 
provide a broad review including all relevant trials. Considerable thought and discussion 
occurred regarding combinability and all the review team are satisfied that the separate trials 
have been meaningfully combined and excluded in the review appropriately (Sacks  et al.,  
1987). The narrative and meta-analytic approaches have successfully summarised the current 
evidence available and generated hypotheses for future investigation. Despite the science of 
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meta-analysis remaining a matter of debate (Moore & Jull, 2006; Eysenck, 19943) their use 
here is considered to have been beneficial in usefully informing the development of the 
proposed trial.  
Heterogeneity. 
Heterogeneity of studies included in meta-analysis is unavoidable; the question is whether its 
extent seriously undermines the conclusions being drawn from the systematic review (Davies 
& Crombie, 2001). In the knee systematic review none of the eight analyses reveals major 
problems with heterogeneity from the X2 tests but these were limited by low power. The I2 
results indicated no observed heterogeneity (Higgins  et al.,  2003). Overall, therefore, it is not 
possible to explore possible sources of heterogeneity in depth in this review and this limits 
clinical understanding regarding which parameters such as dose and type of exercise,  are 
more effective (Thompson, 1994). 
 
3.6.3.5 Clinical Implications. 
Presently, given the reduction in length of hospital stay, compressed in-patient 
rehabilitation and the limitations of the available evidence, it would appear reasonable to refer 
patients for a short course of physiotherapy following discharge after knee replacement to 
provide short term patient benefit. Whilst range of motion may be limited as an outcome 
measure of physiotherapy, the small to moderate standardised effect size obtained for 
function, which favours the intervention, is considered clinically important. This reflects 
actual improvements in one or more important aspects of function reported by patients after 
                                                          
3 According to Eysenck, problems include the following: regressions are often non linear, effects are often 
multivariate rather than univariate, non homogenous data, the grouping of different causal factors may lead to 
meaningless estimates of effect, coverage can be restricted, bad studies may be included and the theory- directed 
approach may obscure discrepancies. 
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receiving the treatment intervention. No treatment benefits were seen at one year. This 
evidence is not considered conclusive. The content of the intervention could be better 
designed and further tested. Interventions to date have largely consisted of exercise 
programmes and gait rehabilitation, mainly targeting impairment and helping patients recover 
from the effects of surgery rather than specifically targeting activity limitations or 
participation restrictions. From the wider field of rehabilitation as a whole however such task 
training appears highly relevant. It was noted in a previous systematic review, assessing 
physiotherapy on functional outcome following stroke, that effective studies contained 
focused exercise programmes within which the relevant functional tasks were directly trained 
(Van Peppen  et al.,  2004). Whether a feasible physiotherapy intervention of this type, 
supplied following discharge, impacts upon patient’s functional ability at one year post knee 
replacement would appear a valid question.   
It was not possible to include pain as a main outcome in this review since the studies 
identified in this review did not tend to measure pain as a specific outcome but rather as a 
component within measures of function.  The pain patients experience from osteoarthritis and 
its influence upon function and the performance of objective measures also needs to be 
considered. With the recent introduction of a new osteoarthritis pain measure (Hawker et al.,  
2008) it is hoped that future trials will include pain as a specific outcome in its own right.  
 
3.7 CHAPTER SUMMARY. 
This chapter described the undertaking of a systematic review exploring to what extent 
is post discharge physiotherapy exercise effective, in terms of improving functional activities 
of daily living, walking, range of joint motion, muscle strength and quality of life, for 
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osteoarthritic patients following primary unilateral elective total knee arthroplasty? The 
systematic review provides support for the use of physiotherapy functional exercise 
interventions following discharge, over traditional home exercise and advice programmes, to 
obtain short term benefit following elective primary knee arthroplasty. Benefits were not seen 
at one year post operation. The results of this systematic review are not conclusive; they 
indicate however that functional exercise interventions following discharge show promise for 
this patient group. Overall, the number of available studies, their size, and their quality does 
limit this review and prevents the findings from being conclusive. It was both disappointing 
and surprising after the literature searching stage of this review to discover that so few 
published trials exist for such common areas of physiotherapy practice as knee and hip post 
arthroplasty rehabilitation. The need for further physiotherapy research for this patient group 
is evident and appears justifiable and worthwhile.  
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4 CHAPTER FOUR. COMPARISON OF POST DISCHARGE 
PHYSIOTHERAPY VERSUS USUAL CARE FOLLOWING 
PRIMARY TOTAL KNEE ARTHROPLASTY FOR 
OSTEOARTHRITIS: A RANDOMISED CLINICAL TRIAL. 
 
4.1 CHAPTER OVERVIEW. 
 This chapter will present the trial undertaken to compare the effectiveness of a post 
discharge physiotherapy intervention in improving patient self report and objective functional 
outcomes versus usual care for osteoarthritis patients undergoing primary total knee 
arthroplasty. The choice of methodological approach will be justified and the merits and 
limitations of this approach explored. The development and rationale of the trial intervention 
will be presented. Next, the protocol followed for the trial will be detailed.  The results will 
then be reported which will be followed by a discussion of the main findings, the strengths 
and weaknesses of the procedures used in the trial and the clinical implications arising from 
the trial’s findings. Finally a summary of the chapter will be presented.  
4.2 PURPOSE OF TRIAL.  
The purpose of this research was to discover whether patients undergoing primary total knee 
arthroplasty for osteoarthritis significantly benefited from receiving two additional home visit 
sessions of functional physiotherapy following discharge from hospital. Benefit was measured 
primarily in terms of self reported function. Objective measures were included as secondary 
measures: the leg extensor press to measure leg extensor power, the timed walk test to 
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measure gait and the timed sit-to-stand test to measure functional strength. The aims and 
hypotheses for the trial were presented in Chapter One.  
 
4.3 METHODOLOGICAL APPROACH. 
4.3.1 SECTION OVERVIEW. 
Experimental methods such as randomised controlled trials are commonly perceived to be the 
‘gold standard’ design of clinical studies (Black, 1996; Jones et al., 1996; Abel and Koch, 
1999). Other methodologies have consequently often been judged less worthy (Lilford et al., 
1995). This section will begin by defining the term randomised clinical trial. The strengths 
and advantages of a randomised clinical trial research methodology will be presented. An 
examination of the limitations of randomised clinical trials will follow.  
 
4.3.2 DEFINITIONS. 
The randomised controlled clinical trial has been defined as: 
 A prospective study comparing the effect and value of intervention(s) against a control in 
human beings  
       Friedman  et al.,  1998 p. 2 
Randomised controlled trials have been further divided into explanatory and pragmatic trials. 
Explanatory trials are: 
intended to provide causal understanding of the effects of the studied treatment under optimal 
conditions 
       van de Windt, 1997, p. 124 
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Pragmatic trials, however, generally measure the effectiveness of an intervention in routine 
clinical practice (Roland & Torgerson, 1998). According to Sibbald and Roland (1998) the 
key elements within a randomised controlled trial are as follows: 
1. Random allocation to trial treatment groups. 
2. Participants and trialists should remain unaware, where possible and appropriate, which 
intervention was given until study completion. 
3. Apart from the intervention itself, all participants are treated identically. 
4. Intention to treat analysis is performed, that is that patients are analysed within the group 
to which they have been allocated regardless of whether or not they received the intended 
intervention.  
5. The analysis approach focuses on the estimation of the size of the difference in 
predetermined outcomes between the intervention groups. 
 
4.3.3 THE VALUE OF RANDOMISED CLINICAL TRIALS. 
The benefits of randomised trials are outlined below. 
Assessment of effectiveness. 
Randomised clinical trials promote the assessment and quantification of treatment / 
intervention effectiveness (McPherson, 1994). McPherson (1994) opines that decisions 
regarding health care services, efficacy, equity and cost cannot be made on a scientific, 
intelligently discussed, basis if health care interventions are not adequately evaluated. While 
other study designs can detect association between interventions and outcomes, only 
randomised trials can rule out the possibility that the association was caused by another factor 
linked to the intervention and the outcome (Sibbald and Roland, 1998).  
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Furthermore trials can provide some information in order to predict the likelihood of 
an individual patient responding to an intervention in a similar way to the findings of the trial, 
providing that the trial is designed to provide data on participant characteristics likely to effect 
outcome (Mant, 1999). 
The value of randomisation.  
Randomisation is performed to form prognostically comparable groups at baseline (Koes and 
Hoving, 1998); since researchers can rarely identify and measure every prognostic variable 
for an intervention randomisation is relied upon to evenly distribute known and unknown 
prognostic factors across the groups. When patients are randomised to one of two or more 
treatments the act of randomisation aims to prevent potential bias in the assignment of 
patients by introducing unpredictability (Kunz and Oxman, 1998). Each patient is assigned a 
treatment through the play of chance rather than by advance prediction. 
The effects of randomisation were explored in a useful systematic review by Kunz and 
Oxman (1998) who examined randomised and non randomised clinical trials and trials using 
concealed random allocation versus trials using inadequate concealment to determine the 
relationship between randomisation and estimates of effect. The review discovered that failure 
to use random allocation and concealment of randomisation generally resulted in 
overestimates of treatment effect (up to 150% or more of the estimated effect) although in 
some studies this bias went in the other direction and reversed the direction of the effect (up to 
90% of the estimated effect) or masked an effect. Kunz and Oxman’s (1998) conclusion is a 
powerful one: 
Failure to use adequately concealed random allocation can distort the apparent effects of care 
in either direction, causing the effects to seem either larger or smaller than they really are. The 
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size of these distortions can be as large or larger than the size of the effects that are to be 
detected. 
The need to ensure adequate randomisation and adequate concealment in the proposed trial is 
therefore clear.  
Defence of results. 
Abel and Koch (1999) also suggest that randomisation assists researchers in the defence of 
positive results to possible sceptics since the methodology is held is such high repute. Primacy 
is given to evidence from randomised clinical trials, sometimes summarised as the “if it 
moves, randomise it” approach (Croft, 1998). 
Prestigious Design. 
As mentioned the randomised clinical trial is commonly perceived to be the “gold standard” 
for comparing and evaluating different treatments (Pringle and Churchill, 1995). The 
randomised trial is an established methodology (Oakley, 1998), occurring since the 1940s 
(Swales, 1998); trials are currently deemed highly credible, attractive to funding bodies 
(Brewin and Bradley, 1989), and publishable, since randomisation can serve as an indication 
that the research has been carefully considered and thoughtfully carried out (Abel and Koch, 
1999).  
Evidence based practice. 
In addition to the value of a single study, all studies pertaining to a specific treatment or 
intervention can undergo systematic review or meta-analysis, as in the previous chapter, to 
provide an overview of current evidence (Mulrow, 1994; Knipschild, 1994). This can then be 
used in order to promote evidence based practice (Greenhalgh, 1997; Main 2003) and, as in 
this trial, to assist the development of interventions for future studies (Knipschild, 1994). 
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Blinding.  
Blinding is also frequently considered a beneficial component of randomised clinical trials. 
This aspect of trial design is the subject of Chapter five and is described and discussed there 
in detail.  
Control / Placebo groups. 
A major design benefit is that all clinical trials must contain a control group against which the 
intervention group can be compared so that any differences in outcome may reasonably be 
attributed to the intervention under investigation (Freidman  et al.,   1998 p. 2). In laboratory 
experiments it is possible to provide or withhold an intervention, however in clinical studies 
this is often inappropriate or unethical   Placebo4controls may be used, primarily to enable 
patient attitudes to the research study to be as similar as possible in both treatment and control 
groups to minimise bias (Pocock, 1983, p. 93), but  most often a new intervention is compared 
to the most effective current treatment or usual care (Friedman  et al.,   1998 p. 2). This may 
mean the comparison group receives no intervention at all (Friedman  et al.,   1998 p. 2).  This 
is not considered disadvantageous by pragmatic trialists:  pragmatic trials help clinicians to 
decide between a new treatment and the best current treatment, therefore the introduction of 
clinician or patient biases due to the lack of a placebo are not considered detrimental but 
accepted as part of their overall response to treatment and included in the overall evaluation 
(Roland and Torgerson, 1998). As Roland and Torgerson state: 
….the treatment response is the total difference between two treatments, including both 
treatment and associated placebo affects, as this will best reflect the likely clinical response in 
practice.  
 
                                                          
4 A placebo is an inert substance/procedure appearing similar to the trial intervention (Pocock, 1983 p. 9) 
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4.3.4 LIMITATIONS OF RANDOMISED CLINICAL TRIALS. 
 
This section will identify and discuss the limitations of the randomised clinical trial as a 
research methodology. A previous commentary has attempted to redress the denigration of 
non randomised clinical trial methodologies (Black, 1996). Whilst the debate between trials 
versus observational studies continues (Ioannidis  et al.,  2001),  during his argument Black 
usefully highlighted many of the limitations inherent in trials. This influential commentary, 
plus other sources, have been used to summarise limitations of randomised studies in the 
figure below and key concerns to this trial are subsequently discussed. 
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Experimentation might be unnecessary              Experimentation may be inappropriate 
-  Dramatic results may suggest a trial is not    -     trials insufficiently large to measure  
    necessary (not true for the proposed trial)                        adverse effects 
- may be unable to evaluate interventions      
designed to prevent rare events 
- in trials where long term outcomes are 
involved 
- too expensive (funding obtained for  
proposed trial so not appropriate) 
- where random allocation reduces the 
effectiveness of the intervention 
-     where no appropriate outcome tools exist  
      (not applicable to the proposed trial)       
- for poorly understood areas of  knowledge 
where qualitative designs may be preferred. 
      
 
 
 
 
 
Limitations of 
Effects of               Randomised studies 
Randomisation               
 
 
 
 
 
 
 
Experimentation may be impossible                              Experimentation may be inadequate    
(not the case for the proposed trial) 
 - Reluctance / refusal of clinicians or consumers                    - trial patients may be unrepresentative 
    to participate  in a trial                                                          - low recruitment rate 
-  Ethical objections                                                                  - treatments may be unrepresentative 
-  Political and Legal obstacles                                                 - trial clinicians may be unrepresentative 
-  Contamination                                                                       - to prevent excessive bias. 
-  Scale (too many health care interventions to                       -  in certain sites (e.g primary care) 
   trial)                                                                                        
                 
 
 
Figure 9. A summary of imitations of randomised studies (summarised from Black, 1996; Abel and Koch, 
1999; McPherson, 1994; Peto and Baigent, 1998; Koes and Hoving, 1998). 
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4.3.4.1 Experimentation may be inappropriate. 
Trial size and rare events. 
As osteoarthritis is so common, patient availability is not considered a problem for this trial.  
However, the size of the this early phase II trial may prove to be of concern: small 
intervention groups may put the comparability of prognostic factors at baseline at risk, since 
the groups may be too small to evenly distribute the prognostic variables across all study 
groups, or to allow the identification of any adverse effects caused by the trial interventions 
(Koes and Hoving, 1998). The data analyses in the trial should be able to provide detail for 
the former but not necessarily for the latter. However, since the trial intervention includes 
established treatment components, such as exercise, it is believed that the risk of new adverse 
events occurring is unlikely.  
Long term outcomes. 
Randomised clinical trials are rarely able to evaluate long term outcomes of medical 
treatments even when the outcomes of interest reach well into the future (Black, 1996). Black 
aptly uses arthroplasty to illustrate this point. In this trial, follow up will continue to one year, 
the time by which most improvement after knee arthroplasty is seen with most improvement 
occurring within the first 3-6 months (Jones  et al., 2007).  
The influence of randomisation. 
A randomised trial may also be inappropriate where the very act of random allocation itself 
significantly reduces the effectiveness of the intervention (Black, 1996). Black’s commentary 
argues that this can arise when the effectiveness of the intervention is dependent upon the 
active participation of the subject which then depends on the subject's beliefs and preferences. 
This can result in a lack of any subsequent difference in outcome between comparison groups 
 97
thereby risking an underestimation of the benefits of the intervention. This seems to be a 
similar issue, relating to potential bias, as that discussed in the earlier section of 
placebo/control groups; the same argument, that any subsequent bias is not considered 
detrimental since it would reflect clinical practice, could be forwarded again in rebuttal.   
Effects of Randomisation. 
There is evidence to suggest the belief that patients cite their aversion to randomisation as a 
main reason for their refusal to enter a trial (Llewellyn-Thomas et al., 1991) which is of 
concern to all researchers seeking as representative a sample as possible. It was hoped that, 
because the proposed trial aimed to assess an additional intervention on top of usual care 
(with no placebo/control group) that this would not prove to be a serious issue. Randomisation 
is controversial; the feasibility of performing randomised clinical trials, the appropriateness of 
the design, ethical issues and the overall value of randomised trials in obtaining generalisable 
results are all areas of debate (Abel and Koch, 1999). This debate is not helped by 
randomisation being imbued with powers it does not necessarily possess; the erroneous belief 
that a researcher ensures comparability between treatment groups merely via randomisation 
thus ignoring differences occurring between groups following randomisation and before 
outcome / response measurement, which can adversely affect this comparability (Abel and 
Koch, 1999).  Treatment effects, random errors, and patient / clinician motivation are amongst 
factors that Abel and Koch list as causes for treatment group differences. Also a dilution of 
intervention effect may be caused when prognostically heterogenous, rather than 
homogenous, groups occur after randomisation (Koes and Hoving, 1998). Plus, randomisation 
is not the sole basis for tests of statistical significance or for causal inferences on treatment 
effects, or sufficient to guarantee blinding (Abel and Koch, 1999).  
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Ethical Issues. 
Ethical issues may also make a trial impossible to conduct. McLean (1995) states that there is 
a general acceptance that a study which is not scientifically valid is unethical;  such studies 
are an abuse to the patient group concerned and a waste of scarce research resources. The 
need to obtain ethical consent prior to performing a study, from a relevant Ethics Committee, 
is seen as a way to assess the value of the study in these terms and to protect the participants 
in studies from unacceptable harm. Often, trials which expose patients to an intervention 
which is believed to be inferior to current treatment are regarded as unethical (Sibbald and 
Roland, 1998). 
In a more subtle issue, Lilford and Jackson (1995) raise the question of whether or not 
trials are unethical without the prerequisite of equipoise. Equipoise is defined as:  
“the point where there is no preference between treatments, i.e. it is thought equally likely that 
treatment A or B will turn out to be superior” 
       Lilford and Jackson (1995) 
Lilford and Jackson (1995) argue that, whilst for many trials equipoise is desirable, there are 
times when equipoise is unachievable, an example might be when a central authority decides 
that a treatment needs evaluation for reasons of public interest.  They also argue that  
randomisation without equipoise may actually be desirable in some instances, for example 
where access to an intervention is limited through scarce resources.  
Contamination. 
Black (1996) also describes the possibility of contamination if clinicians involved in a trial 
have to provide more than one intervention arm since the way in which the arms are delivered 
to patients may be influenced from this. Whilst recognised as an issue the current trial was 
designed in such a way that this could not happen so was not a concern for this trial.  
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Number and Complexity of Interventions. 
As a further issue, health service interventions in primary care are often far more complex 
than the interventions assessed in clinical trials (Mant, 1999; Black 1996).  Assessing very 
complex interventions can make trials impossible (Black, 1996). And, even when a trial is 
possible, the generalisation of findings to patients with their own individual complexities is 
difficult (Mant, 1999). The integration of qualitative research into the randomised trial can 
assist understanding of complex interventions (Mant, 1999) but cannot fully address this 
limitation. The Medical Research Council’s Framework for the Development and Evaluation 
of RCTs for Complex Interventions to Improve Health (MRC, 2000) was developed to assist 
trials evaluating complex interventions (see next section on the development of the trial 
intervention) but cannot fully address the problem. 
 
4.3.4.2 Experimentation may be inadequate. 
A lack of consideration of external validity is a frequent criticism of randomised clinical trials 
(Black 1996; Rothwell, 2005). This raises three main issues pertinent to the current trial.  
Participants and Recruitment.  
Participants recruited to a trial may be unrepresentative of the entire patient population 
(Rothwell, 2005). Narrow eligibility criteria may mean only a small proportion of patients 
from those normally treated in everyday practice are included.  The recruitment rate of 
participants may be poor, with many eligible patients not recruited to the trial (due to patient 
preference for example, or lack of commitment by the recruitment centres) which introduces 
the potential for selection bias to occur.  Whilst recruiting / recording consecutive patients is 
recommended (Pringle and Churchill, 1995) this may not always be practical in busy 
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consultations. External validity is also decreased if patients who drop out from the trial are 
systematically different from those who complete the trial (Ward et al., 1999). Patients who 
are recruited into trials may be those with more severe symptoms or those with consulting 
patterns that differ from the majority of patients (Peto et al., 1993). Other authors, such as 
Mant (1999), argue that the eligibility criteria of patients participating in a trial are also likely 
to lead to unrepresentativeness in trials; with participating patients being more likely to be 
healthier, younger and of a higher social status that those patients ineligible to enter the trial. 
The amount of exclusions to a trial can, in some trials, be so excessive (Mant cites an 
exclusion rate of over 90% for one trial) that the findings of the study cannot be generalised to 
the majority of the patient population.  
The single location in the current trial is viewed as beneficial in maximising 
consecutive recruitment in this phase II, exploratory, trial (MRC, 2000); although the 
generalisability of findings will be limited since only one hospital Trust is involved. All those 
approached will be recorded to allow the recruitment rate to be determined and the exclusion 
criteria selected to exclude as few patients as possible. The demographic data from this trial 
can be compared against data from the National Joint Registry for England and Wales to 
assess the representativeness of the sample is for age and gender.   
Treatments. 
Secondly, the treatments / interventions that the patients receive within a trial may not be 
representative of the treatments that everyday practice patients receive (Black, 1996). Patients 
may receive a higher quality of care and attention simply by participating in a trial, receiving 
treatment from experienced staff with optimal resources. Or trial protocols can differ from 
usual clinical practice (Rothwell, 2005). In this trial, although testing a new intervention, the 
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usual care group follow the hospital Trust’s integrated care pathway which has not been 
altered in any way. 
Clinicians. 
Thirdly, clinicians consenting to being involved in a trial may have different characteristics to 
those clinicians not involved which may limit the generalisability of the results. This is 
thought to be true for GPs (Pringle and Churchill, 1995) with GPs who are already interested 
in research and who are already acquainted with trial procedures being more likely to 
participate in research trials (van de Windt,  1997).  
Location. 
There is a danger that research may become overly pragmatic by becoming so defined on 
current local circumstances that theoretical underpinning of interventions may become 
neglected affecting once again, the generalisability of results (Bradley et al., 1999).  
Zwarenstein  et al.,  (2008) helpfully suggest that explanatory and pragmatic trials should be 
viewed as a continuum rather than as a dichotomy and it does appear that a balance is required 
between explanatory and pragmatic approaches within the design of a trial. With either 
extreme, of either explanatory or pragmatism, generalisability of findings may become 
limited. What seems to be apparent is that external validity issues around a trial are, although 
often never reported in trials or assessed in systematic reviews, inherently important when 
assessing the value of either explanatory or pragmatic trials.  
Excessive Bias. 
The introduction of severe bias into a trial can render a trial inadequate and misleading 
(Altman  et al.,  2001).  This whole section has considered potential sources of bias. The 
CONSORT statement and the recent extension of the CONSORT statement for pragmatic 
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trials promote the identification and detailed reporting of trials and the minimisation of bias 
(Altman  et al.,  2001; Zwarenstein  et al.,  2008).  These statements have been referred to 
throughout the trial and the trial includes a CONSORT  flow diagram in the results section.  
 
4.3.5 HOW MUCH PRAGMATISM IS PERMISSIBLE?  
 
In all comparative trials there is a need to create a tight, precise, trial design since any 
“sloppiness” in trial design may obscure any differences which occur between the two 
interventions (Jones et al., 1996). Trials can be criticised as being too pragmatic if the 
interventions are described as being totally at the discretion of the health professional and if 
no clear definitions of the interventions are provided (Koes and Hoving, 1998). Without 
standardising or defining the interventions precisely then the generalisability of the results of 
a trial cannot be adequately assessed. Therefore, the description/treatment algorithm/protocol 
for a trial must be precisely stated for each trial. In addition, since many practitioners and 
patients want to know if the average trial results can be used to predict an individual outcome, 
trials need to be designed which provide sufficient information about the characteristics of 
patients which are likely to effect their outcome from an intervention (Mant, 1999). The 
“balancing act” required when executing a pragmatic trial between meeting rigorous 
methodological standards and implementing a feasible, achievable trial is challenging (Jansen  
et al.,  2006).  For musculoskeletal rehabilitation trials however, it is usually possible for 
researchers and clinicians to carefully define a package of possible modalities from which the 
clinician providing the intervention can select appropriate treatment for patients; adherence to 
this package can be checked by completing case report forms, which provide a breakdown of 
treatment times and modalities, or video (Mullis et al.,  2006). The defining and refining of 
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the intervention, prior to the trial, is considered key to the quality and success of the trial by 
the author.  
 This is the approach utilised in the randomised clinical trial in this chapter; it is a 
pragmatic trial, considered feasible for the NHS to consider implementing should the 
intervention prove to be effective, but care has been taken with the development and 
description of the intervention. This forms the basis of the next section.  
 
4.3.6 SECTION SUMMARY 
 
The randomised clinical trial is a valuable, rigorous tool in determining the efficacy of an 
intervention.  But it cannot be assumed that the use of a trial design in itself guarantees 
research quality and the provision of valid and reliable results for use with patients. Clinical 
decision making in practice involves many more factors than effectiveness alone.   Trials are 
valuable where they address an appropriate question, where all stages of the trial are 
conducted and reported to a high standard and where the limits of the trial are clearly 
described. A trial design may be unsuitable and inappropriate for some research questions, 
settings and patient groups. Whilst a pragmatic design is considered appropriate to measure 
the effectiveness of the rehabilitation intervention proposed in this trial, the intervention must 
be defined with sufficient precision to allow the generalisability of the results to be assessed. 
The trial must also provide sufficient information about the characteristics of patients likely to 
effect outcome to be of use to clinicians making clinical decisions about their patients when 
the trial is reported. Insufficient attention to these issues risks an unethical trial demeaning 
patient involvement and exposing participants to any risks of potential harm from being in the 
trial for no purpose.   
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4.4 THE DEVELOPMENT OF THE TRIAL INTERVENTION. 
 
The most challenging part of evaluating a complex intervention – and the most frequent weakness in 
such trials – is defining the intervention 
                            MRC, 2000 
 
4.4.1 SECTION OVERVIEW. 
This section explains the challenges and issues encountered during the decision making 
processes required to develop the intervention for the trial. It will justify and clarify the 
decisions made and make the limitations of the intervention explicit. The section uses three 
headings, based on those recommended by Wade (2005), necessary to describe rehabilitation 
programmes/interventions, namely, the need to describe the theoretical model/basis of the 
intervention, the specific actions and activities of the intervention and the organisation of the 
intervention. 
 
 
4.4.2 THE THEORETICAL MODEL/BASIS OF THE INTERVENTION.  
The majority of musculoskeletal physiotherapy trials reviewed during this research do not 
explicitly state their underpinning theoretical framework.  This is interesting since new 
developments are occurring which are intended to promote the ease and ability with which 
this may be done. One such development is the International Classification of Functioning, 
Disability and Health, or ICF as it is known (World Health Organisation, 2002). This 
framework has the potential to provide a universal language with which to describe health and 
its related areas, within a framework designed to encompass how people live with any health 
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conditions they experience as well as disease (Jette, 2006).  Although further work is needed 
to clarify the ICF’s concept and category differentiation, to develop tools to measure the ICF 
domains satisfactorarily (Jette, 2006) and to adequately represent non Western cultures (Xie  
et al.,  2006), the ICF is believed to be a promising development since it conceptualises a 
“complex, multidimensional interaction that does not follow any predictable linear 
progression” (Bornman, 2004). The ICF is based upon a biopsychosocial model of health 
(WHO, 2002) and accepts that health conditions can be reversible (Bornman, 2004).  
 The ICF has been used in the development of a model of rehabilitation (Wade, 2005) 
which in turn has been used here to facilitate the description of the trial intervention. This 
model is summarised in the figure below which has been adapted to include the current trial to 
illustrate how it fits within this model.  
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A SUMMARY OF WADE’S MODEL FOR REHABILITATION 
 
 
Stage 1. The problem is presented 
Patient consents to be in trial 
 
⇓ 
 
Stage 2. Assessment 
Data collected to: Identify problems 
 Understand genesis of problems 
                                            Identify prognostic factors 
                                                                    Understand patient’s wishes/expectations 
Participant is assessed 
 
⇓ 
 
Stage 3. Goal setting 
Negotiation to determine short, middle and long term goals 
This will include highlighting individual rehabilitation issues during patient treatment as well 
as including the trial intervention package goals 
 
⇓ 
 
Stage 4. Intervention 
 I. To collect data &/or to provide support &/or to give treatment 
         For this trial: to collect data and to give treatment (i.e. to act to alter the  
natural history of recovery post knee replacement) 
 
II. Intervention to be in 1 or more of ICF domains  
Patient Domains: Pathology, Impairment, Activities, Participation,  
Contexts: Personal context, choice 
  Environment Domains: Social context, physical context, temporal context 
For this trial the intervention will aim to impact upon the activities, participant and 
physical domains. 
 
⇓ 
 
Stage 5. Evaluation. 
Comparison of patient state against goals set  
Identify if any resolvable problems remain. 
Decide if further action is required and either discharge or return to stage 1 as 
appropriate. 
For the trial this stage incorporates the data analysis phase 
 
 
Figure 10. An Adaptation of the rehabilitation model suggested by Wade (2005). Italics are used to 
highlight information regarding the proposed knee replacement trial. 
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Using the ICF and Wade models, the theoretical underpinning for stage 4 of the trial can 
begin to be outlined. The ICF identifies three levels of functioning; at the body / body part 
level, at the whole person level and at the person in a social context level (WHO, 2002). 
Varying levels of disability can occur at one or more of these levels. Of particular relevance to 
the trial are the following: 
1. Impairments; problems in body function or structure,  
2. Activity limitations; difficulties an individual may have in executing activities, 
3. Participation restrictions; problems an individual may experience in involvement in 
life situations, (WHO, 2002).  
Whilst surgery may alter the level of impairment for trial participants, the trial intervention 
primarily aims to impact upon the level of activity limitations experienced by knee joint 
replacement patients following discharge from surgery. As the trial intervention aims to 
improve function, the level of participant restrictions may also be reduced. In addition, it is 
expected that the intervention will include the progression of walking aids for some 
participants, changing the physical context within the environment within Wade’s model of 
rehabilitation (Wade, 2005).  
The ICF (WHO, 2002) also makes a distinction between performance and capacity; 
the former describes what an individual actually does -the lived experience- whilst the latter 
describes an individual’s ability to execute an action/task. This important distinction 
recognises that whilst a person may be capable of an activity they may, for various reasons, 
not actually do it in daily life. The proposed trial therefore includes tools to measure both self 
reported measures of function (although the possibility of a person saying they do an activity 
whilst not, in fact, actually doing it is also recognised as a limitation) plus measures of 
capacity.   
 108
 A further framework which is considered both valuable and pertinent for this trial is 
the Medical Research Council’s Framework for the Development and Evaluation of RCTs for 
Complex Interventions to Improve Health (MRC, 2000). Complex interventions have been 
defined as follows: 
Complex interventions in health care, whether therapeutic or preventative, comprise a number 
of separate elements which seem essential to the proper functioning of the intervention 
although the “active ingredient” of the intervention that is effective is difficult to specify 
        MRC, 2000 
It has been said that “Rehabilitation is perhaps the archetypal complex intervention” (Wade, 
2005) and certainly this trial meets the criteria for a complex trial intervention.  In addition to 
the physiotherapy package itself are components such as the patient-physiotherapist 
interaction, the reassurance that post operative home visits may create, the home environment  
and specific advice the physiotherapists might offer. The MRC framework discusses all 
phases of work from early pre-clinical work right up to phase IV long term surveillance 
clinical trials.  The framework is summarised below.  
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A SUMMARY OF THE MRC FRAMEWORK FOR THE TRIALS OF COMPLEX 
INTERVENTIONS 
 
Pre-clinical phase. Theory: explore relevant theory to facilitate intervention choice and 
predict confounders and design issues 
 
⇓ 
 
Phase I. Modelling to identify intervention components and underlying mechanisms of action 
to provide evidence to enable relationships and interactions to be predicted 
 
⇓ 
 
Phase II. Exploratory trial describing the intervention components and a feasible protocol for 
comparing the intervention to an appropriate alternative. 
 
⇓ 
 
Phase III. Definitive RCT comparing a fully-defined intervention to an alternative using a 
theoretically defensible protocol in an adequately controlled and appropriately powered trial 
 
⇓ 
 
Phase IV. Long term implementation studies to determine whether others can reliably 
replicate the intervention and results in uncontrolled settings 
 
Figure 11. Summary of MRC Framework for Trials of Complex Interventions (Adapted from the MRC, 
2000). 
 
 
The MRC framework is designed to provide a continuum of increasing evidence for complex 
interventions. The proposed trial will provide evidence for the early phases of this continuum 
for a new intervention package. It is not intended, or possible with one exploratory trial, to 
address phases III or IV. The pre-clinical phase uses all the available previous evidence and 
information to assist the identification of the study design and intervention type. For this 
study, a change in organisational structure which led to changes in the care provided to 
patients provided the initial impetus for this research. 
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 The systematic review was used to identify intervention components likely to be 
clinically effective and to highlight important issues pertinent to the development of the 
intervention. Paper modelling of the proposed components identified a gap between the ICF 
and Wade models’ and previous knee replacement interventions. Previous interventions 
mainly consist of home exercise programmes and gait rehabilitation and mainly target 
impairment. They do not usually include specific task training at the activity level. From the 
wider field of rehabilitation as a whole however task training appears highly relevant. It was 
noted in a previous systematic review, assessing physiotherapy on functional outcome 
following stroke, that effective studies contained focused exercise programmes within which 
the relevant functional tasks were directly trained (Van Peppen, 2004). In contrast, although 
studies focusing on reducing impairments (such as muscle strengthening or range of motion) 
did reduce such impairments, these changes did not lead to improved functional ability. Since 
previous knee replacement rehabilitation programmes have tended to target impairment rather 
than tasks/activities, an obvious question would be to ask whether the introduction of 
task/activity training would benefit musculoskeletal knee replacement patients as well as 
neurological stroke patients.  It was therefore decided that task training should be included in 
the intervention to bridge this gap. 
 Although the trial intervention itself is new, its components are drawn from previous 
physiotherapy practice.  Obtaining the opinions of physiotherapy clinicians and researchers to 
achieve a consensus opinion regarding the content of the intervention therefore seemed an 
appropriate way to add to the informal evidence base for the intervention as suggested by the 
MRC Framework. Additionally, the value of obtaining the views of participants’ receiving the 
interventions was acknowledged and, in response,  a future qualitative study  was planned to 
explore participant’s views regarding the intervention components and the content, level of 
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perceived value and acceptability of the intervention if it proved beneficial. As the MRC 
Framework (2000) opines, such qualitative research is useful in gaining understanding why 
something happens and in identifying the effective “active” components of an intervention.  
 The value of an exploratory trial is also discussed in the Framework (MRC, 2000). 
Such trials can test the feasibility of the trial design and intervention components, provide 
information for a larger trial regarding sample size calculations and trial monitoring 
procedures and also identify issues still to be addressed, such as intervention modifications or 
refining the intervention dosage. All these points are relevant to the proposed trial. 
In summary, it therefore seemed possible to successfully integrate all three 
frameworks discussed in this section to theoretically underpin the development of the 
proposed trial.  The figure below summarises how these frameworks have been amalgamated 
to achieve a theoretical basis for the processes used during the development of this trial 
intervention.  
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A SUMMARY OF STRATEGIES USED TO ACHIEVE A THEORETICAL BASIS 
FOR THE DEVELOPMENT OF THE TRIAL INTERVENTION 
 
Pre-clinical phase. Theory: explore relevant theory to facilitate intervention choice and 
predict confounders and design issues. 
A comprehensive literature review has been performed to highlight important issues for the 
intervention. The need for a systematic review of the intervention area was identified and 
undertaken. 
 
⇓ 
 
Phase I. Modelling to identify intervention components and underlying mechanisms of action 
to provide evidence to enable relationships and interactions to be predicted.  
The systematic review of previous relevant trials was used to assist this modelling phase and 
to identify possible content for the intervention. The intervention is a treatment i.e. a package 
intended to act to alter the natural history of recovery post knee replacement. The intervention 
will aim to impact upon the activities, participant and physical ICF domains.  Paper 
modelling, using flowcharts, was performed to model the intervention components and 
interrelationships.A consensus meeting with clinicians and researchers was held to agree a 
final intervention package. 
 
⇓ 
 
Phase II. Exploratory trial describing the intervention components and a feasible protocol for 
comparing the intervention to an appropriate alternative. 
The trial will explore the effectiveness of the initial intervention. This is an exploratory trial 
exploring the feasibility of the intervention and to inform future work (for example by 
enabling the power of a main larger trial to be calculated). It is recognised that further phase II 
work in the future, for example to test alternative forms or ‘doses’ of the intervention would 
be required before a phase III trial is possible. A future qualitative study will explore 
participant’s views regarding the intervention components and the content, level of perceived 
value and acceptability of the intervention. 
 
 
Figure 12. A Summary Of Strategies Used To Achieve A Theoretical Basis For The Development Of The 
Trial Intervention (based upon the MRC Framework (2002) ICF (2002) and Wade’s model of rehabilitation 
(2005). 
 
 
4.4.3 THE SPECIFIC ACTIONS AND ACTIVITIES OF THE INTERVENTION. 
A pragmatic intervention package was planned with the therapeutic interaction occurring 
during each visit being accepted as part of the intervention. The intervention consisted of two 
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home visits. This number was decided upon as economically feasible for the NHS to 
implement should the trial show the short intervention to be effective. The first visit occurred  
within two weeks of discharge and the second 6-8 weeks post operatively. The timing of the 
start of the post discharge interventions was determined using the best available evidence. 
Interventions have begun within a week (Kramer et al.,  2003), 10 days post operatively, 
(Codine  et al.,   2004), within three weeks of discharge (Mockford and Beverland, 2004) or 2 
months postoperatively (Moffet  et al.,  2004). Therefore an early intervention, within two 
weeks of discharge and three weeks post operatively was chosen.  The 6-8 weeks time point 
was a pragmatic decision; patients routinely undergo a check  at this time to make sure they 
are progressing satisfactorily and they commonly change walking aid around this time as 
well.  In addition post operative pain relief often takes some time to occur postoperatively (6-
12 weeks) which gives some time for pain to lessen. (Jones  et al.,  2007).  
                During each visit the physiotherapist assessed the participant’s function and 
progressed each participant’s rehabilitation programme as appropriate. Objective 
reassessment of range of movement, muscle strength and observation of functional activities 
(including transfers, gait, posture and balance) enabled this progression of treatment. Gait re-
education and progression/removal of walking aids occurred and a daily home exercise 
programme was provided and practiced with each patient.  
                 The intervention package was defined using the systematic review (Minns Lowe  et 
al.,   2007),  the frameworks outlined in part one of this section above and a concensus 
approach incorporating the opinions of clinical, lay and research people.  Consensus methods 
are appropriate “where unanimity of opinion does not exist owing to a lack of scientific 
evidence” since they allow the extent of agreement to be explored and disgreement resolved 
or identified (Jones and Hunter, 1995).   An iterative process was used as follows: 
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1. Catherine Minns Lowe collated all available, relevant information regarding 
possible intervention components to be used to begin discussions during the 
concensus process.  
2. This material was discussed with the PhD supervisors and revised.  
3. The revised material was then discussed for an hour with the lay member 
associated with the trial. Issues such as dosage and the acceptability of possible 
content were discussed at this meeting. The material underwent further 
revision during and after this meeting which was subsequently approved by the 
lay member by post. 
4. A concensus meeting of experienced senior staff was then held at a specialist 
orthopaedic centre. Approximately 25 senior staff attended this meeting. The 
staff groups represented included research staff, inpatient and outpatient 
musculoskeletal staff and rehabilitation staff from the Oxford Centre of 
Enablement.  The format of the hour long meeting was as follows: a 
powerpoint presentation of the project to date was given, participants were 
given time to think about and rate possible components, full discussion of all 
possible elements and dosage parameters of the intervention then occurred, 
suggestions for revisions, improvements and additional content were invited 
and discussed. The intervention package, refined during this meeting, was 
rated and granted approval at the end of this meeting by the participants.  
5. The refined intervention package, including all paperwork and exercise 
booklets, was then also discussed in three further separate meetings with a) 
research colleagues at a Physiotherapy Research Unit Meeting, b) the PhD 
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supervisors and c) the lay member. No further changes were suggested at this 
time and all meetings approved the refined version of the intervention package 
which was subsequently accepted as the final package.  
                 The final package included exercises common to several programmes and 
considered practical to perform in patients’ homes. The exercises have been reproduced in 
exercise booklets (See Appendix X)  the repetition rate, frequency and progression of the 
exercises were left to the physiotherapist’s discretion. Ideally, patients initally aimed for 10 
repetitions of exercises 1-6 twice a day, building up to 20 repetitions and 5 repetitions of 
exercises 7-9 with 5 second “holds”.  Patients were asked to follow the programme for a 
minimum of three months. Again, these details were taken from the programmes used in the 
systematic review.  
The functional exercises, in addition to walking,  were follows:  
 
1. weight shifts progressing to 1 – legged standing balance, progressing to eyes closed if 
appropriate, 
               
Illustration 6.  Photograph of Exercise 1. 
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2. partial knee bends/quarter squats,  
 
Illustration 7.  Photograph of Exercise 2. 
 
 
 
 
 
3. Standing “wall sits”, knee flexion and extension leaning against wall, 
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Illustration 8. Photograph of Exercise 3. 
 
 
 
4. bilateral heel raises progressing to unilateral heel raises,  
 
Illustration 9. Photograph of Exercise 4. 
 
 
5. knee raises with alternate arm raises,  
 
Illustration 10. Photograph of Exercise 5. 
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6. step overs (alternate leading leg), 
 
Illustration 11. Photograph of Exercise 6. 
 
 
7. Achilles stretches in standing, 
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Illustration 12. Photograph of Exercise 7.  
 
 
 
 
8. Soleus stretches in standing, 
 
Illustration 13. Photograph of Exercise 8.  
 
 
 
9. Quadriceps stretch in prone lying/standing  (as able). 
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Illustration 14. Photographs of Exercise 9. 
 
 
 
It should be noted that sit-to-stand and step ups were also commonly used exercises in the 
review. However these exercises are already included in the Usual Care patient information 
booklet used in the hospital at which the trial is based and which were provided to both 
groups. These exercises therefore were not included in the intervention package. Additional 
stretches were also included in the intervention package since only supported hamstrings 
stretches are included in the usual care patient booklet. Patients were taught how to stabilise 
their trunk and pelvis prior to lower limb movement and the quality of each movement was 
emphasized. Controlling the postural alignment of the trunk and pelvis is important since 
ideal postural alignment faciltates optimal lower limb movement and optimal muscle 
performance (Sarhmann, 2002 p 3-4, 367-368).  Visit duration was timed.  
             The other trial arm received the usual care currently provided by the hospital with no 
additional input. Usual care included no routine physiotherapy organised post discharge. All 
trial participants followed the Trust’s intergrated care pathway and received the knee advice 
booklet used by the hospital to standardise the advice provided. These booklets were designed 
via multidisciplinary concensus, are used by all consultants and are in accordance with the 
 121
American Academy of Orthopaedic Surgeons guidelines. The advice and exercises contained 
in these booklets are essentially similar to those used as controls in previous trials. The 
exercises included non weight bearing exercises to regain range of movement plus isometric 
strengthening exercises and several exercises in weightbearing. The usual care exercises were 
as follows: 
1. Static/isometric quadriceps contractions 
2. Lying: Inner range quadriceps with rolled towel under knee 
3. Lying: Knee flexion 
4. Sitting: knee flexion and extension 
5. Sit-to-stand 
6. Placing operated foot onto a step and off again 
4.4.3.1 Repetitive task training.  
Task training. In addition intervention group patients underwent the following task training:  
 
Getting in/out of a car  
 
Illustration 15. Photograph of getting out of a car. 
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Getting up from a chair at a table (similar to getting up after a meal) 
 
Illustration 16. Photograph of getting up from a chair at a table. 
 
Walking outside (e.g. similar to going to the shops and going out of the house) 
 
Illustration 17. Photograph of walking outside. 
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Stairs 
 
Illustration 18. Photograph of descending stairs. 
 
These tasks were identified and chosen using the six month post operative Oxford Knee 
Scores (OKS) provided by Dawson  et al., (1998) for each of scoring categories within each 
of the OKS functional questions. These scores showed that 48% of participants still had 
moderate/extreme difficulty with getting in/out of a car or using public transport; 31 percent 
found getting up after a meal moderate/extremely difficult/impossible; 53% found descending 
stairs moderate/extremely diifficult/impossible; 43% found shopping moderate/extremely 
diifficult/impossible. Since only 22% of patients reported similar difficulties washing and 
drying it was decided not to include training for this task in the intervention. Also, although, 
87% of participants reported kneeling to be moderate/extremely difficult/impossible, some 
patients are specifically told to avoid kneeling  following surgery and so kneeling was also 
excluded from the training package. However, kneeling could be practiced, as appropriate,  as 
part of the individualised treatment provided to participants (see below).   
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4.4.3.2 Individual Concerns. 
Finally, the physiotherapists answered/addressed any individual concerns from patients 
receiving the intervention. For example; if patients reported difficulties washing/dressing then 
these were practiced. These were noted to see if any common themes occurred. 
              All participants receiving the intervention were asked about activity limitations and 
participation restrictions so that these could be included in treatments and addressed where 
possible and appropriate.  
 
4.5 TRIAL PROCEDURES.  
4.5.1 ETHICS.  
Approval for this research project was obtained from Oxford Local Research Ethics 
Committee (Reference: A03.018). The main ethical issue presented to the committee was the 
need to ensure potential participants received sufficient time to consider participation prior to 
their attendance at the Pre Operative Assessment Clinic. A minimum of 24 hours notice was 
agreed. Appendix XI contains copies of the ethics approval and sponsorship and indemnity 
letters that pertain to this trial.  
 
 
4.5.2 DESIGN. 
A single blind randomised phase II controlled trial. The trial design incorporated the 
recommendations of the CONSORT statement (Moher et al.,  2001) and followed MRC 
guidelines for best practice. 
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4.5.3 PARTICIPANTS AND SETTING. 
All patients undergoing an elective primary total knee arthroplasty for osteoarthritis residing 
within the community of Oxfordshire were eligible to participate providing they had none of 
the following exclusion criteria: patients undergoing bilateral arthroplasty, minimally invasive 
surgery and metal-to-metal implants, patients where further joint surgery was planned within 
the following twelve months, patients with inflammatory arthritis, patients whose existing co-
morbities prevented them from participating in the proposed treatment intervention and 
patients who were unable to provide informed consent. While the latter was an ethical issue 
all other criteria were excluded because of their influence upon outcome. No other 
restrictions, such as age or obesity were included to attempt to make the trial participants are 
as representative as possible of patients undergoing knee replacement for osteoarthritis 
(Pocock, 1983 p. 35-38.). The trial was restricted to Oxfordshire to ensure reasonable 
travelling distances for the physiotherapist supplying the home based intervention.  
 
4.5.4 SAMPLE SIZE.   
As already mentioned, insufficient sample size may lead to misleading results (Peto and 
Baigent, 1998) but at the time of developing this early study there was little information 
available from which to calculate sample size. The sample size was based upon the use of the 
Oxford Knee Score as the primary outcome variable. 1000 simulations were performed to 
determine the sample size by the trial statistician Dr Michael Dewey. The simulations were 
carried out using a standard deviation of 10 from unpublished data from the original paper 
(Dawson  et al., 1998), obtained from the developers of the OKS (personal communication), 
autoregressive of order 1 correlations and allowed for the baseline and 3 follow up time 
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points. The developers of the OKS suggested a clinical difference of  2.5, one quarter of the 
standard deviation, would be reasonable  given the lack of available evidence (personal 
communication). As will be described later the OKS is a self administered 12 item 
questionnaire whereby the patient rates, from 0-4, the difficulty and pain associated with 
performing activities of daily living, such as walking and putting on socks/tights. A score 
from 0-48 is obtained. A three point difference was chosen for this trial since this signifies 
that at least one or more functional activities have become easier and less painful to perform. 
For a three point clinical difference and power of 80%, n=40 completers for each arm were 
required. To allow for 10% drop out the total sample size was set at 88. The NOC expected 
approximately 576 primary knee replacements per year at the time of the study so recruitment 
numbers appeared feasible.  
 
4.5.5 BLINDING. 
Since it was not possible to mask the participants, or the physiotherapists providing the 
interventions, to treatment group allocation following randomisation the study is a single 
blind trial. However, all outcome measurements were provided by physiotherapists blinded to 
treatment allocation and participants were repeatedly requested not to mention which 
treatment they received during follow up outcome measurement appointments. Additionally, 
the physiotherapists performing the assessments were asked to record the extent to which 
masking was successful on each patient assessment form. This subject is the topic of chapter 
five. 
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4.5.6 OUTCOME MEASURES.   
Copies of all outcomes can be seen in the trial questionnaires contained in Appendix XII. 
 
4.5.6.1 Primary Measure: The Oxford Knee Score (OKS). 
Purpose of the Score and reason for its inclusion in the trial. The Oxford Knee score was 
specifically designed and validated to measure function and pain following knee joint 
arthroplasty (Dawson  et al.,  1998). The OKS is in widespread use, is a recommended 
measure for use in assessing outomes in knee patients (Garratt  et al.,   2004; Liow  et al.,   
2003) and has the advantage of being used in previous arthroplasty physiotherapy trials 
(Mockford and Beverland, 2004; Frost et al., 2002).  
Completion. The scores have been found to be easy to complete with an average completion 
time  of 9.6 minutes by patients (Dunbar  et al.,   2001). Response rates are usually high,  
ranging from  85.9 -90%; greater than for the WOMAC or Lequesne (Dunbar  et al.,   2001; 
Robertsson and Dunbar, 2001; Whitehouse  et al.,   2005).    
Scoring Approach.  The OKS is a short, practical self administered 12 item questionnaire 
whereby the patient rates, from 0-4, the difficulty and pain associated with performing 
activities of daily living, such as walking and putting on socks/tights (Dawson  et al.,  1998). 
The total score is a summation of the 12 individual question ratings. Initially the score ranged 
from 12 (high level of function) to 60 (low level of function) but this was found to be 
counterintuitive and was revised (Murray  et al.,   2007).  The revised method has been used 
for this trial . Each item is scored from 0-4 and summated to give a score from 0-48, with 48 
being the best outcome.  
Validity. The score has been extensively validated against 10 measures (Garrett  et al.,  2004). 
It was originally validated favourably against the American Knee Score, the Stanford Health 
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Assessment Questionnaire and SF36 (Dawson  et al.,  1998) and since then favourably against 
the disease specific WOMAC and Lequesne Scores amongst others (Dunbar  et al.,  2001).   It 
has also been correlated with patient satisfaction (Spearmans non parametric correlation 
coefficient 0.68) (Robertsson and Dunbar, 2001). 
Reliability. The Score demonstrates high internal consistency, with a preoperative Cronbach’s 
alpha score of 0.87 and post operative score of 0.93, and high test-retest correlation r=0.92 
(Dawson  et al.,  1998). High internal consistency scores have since been repeated,  
Cronbach’s alphas of 0.93 (Dunbar  et al.,  2001)  and 0.92, leading some to believe that the 
scale includes redundancies (Whitehouse et al.,   2005). However, the quick completion time 
means this does not appear overly onerous for patients (Dunbar  et al.,   2001). Intraclass 
correlation coefficient values range from .94 (Dunbar  et al.,  2001). 
Specificity. Like most knee scores, the coexistence of hip or spinal pathology can  impact 
upon , and contribute to,  OKS scores (Harcourt  et al.,   2001) although the developers of the 
score believe the OKS to have greater specificity than other knee scores (Murray,  et al.,  
2007). 
 Responsiveness  to change. A small study (six observers and 29 patients) by Liow  et al.,  
(2003) found the OKS produced the greatest score ranges,  normalised mean scores of 10.4-
100, when compared against  the American Knee Society Score, normalised mean scores of 
17.1-97.2,  and the British Orthopaedic Association score,  normalised mean scores of 36.5-
99.4. The OKS therefore was the most responsive to change.  Dawson  et al.,  (1998) 
calculated an effect size from the pre and post op OKS scores, reporting an effect size of 2.19 
and finding that change scores were significantly greater for those patients reporting the 
greatest improvements. 
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Floor and Ceiling  effects. Dunbar  et al.,  (2001) determined the floor effect of the OKS to be 
6.76 and the ceiling effect to be 0.1%. These scores were similar to the Lequesne score  and 
superior to the WOMAC.  
4.5.6.2 Secondary Measures: 
4.5.6.3 The Knee injury and Osteoarthritis Outcome Score (KOOS.)  
Purpose of the Score and reason for its inclusion in the trial. Measurement instruments rarely 
achieve universal acceptance and approval and critics of the OKS suggest that the scale lacks 
detail and should not be used where detailed assessment of outcome is required (Whitehouse  
et al.,   2005). It was therefore decided to include the KOOS, a more detailed knee function 
score, (Roos and Lohmander, 2003) to supplement the measurement of self reported knee 
function. The KOOS is a self report knee-specific instrument designed to evaluate both short 
and long term knee conditions, including osteoarthritis (Roos and Lohmander, 2003). Like the 
OKS, the KOOS is recommended as a measure to assessing outcome in knee patients (Garratt  
et al.,   2004). 
 
Scoring Approach.  The KOOS consists of 42 items in the five subscales of pain, other 
symptoms, function in daily living, function in sport and recreation and knee related quality of 
life. The Koos is scored 0-100 (100 indicating no symptoms and best outcome) for each 
subscale. A change of 8-10 points or more is considered a clinically significant change 
following anterior cruciate ligament surgery however this has not been explored with knee 
arthroplasty  (Koos and Lohmander, 2003). 
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Validity. Content validity. When knee arthroplasty patients were asked to report the 
importance of the subscales when deciding to undergo surgery,  91-95% of patients felt all 
subscales were extremely or very important except for the sport and recreation subscale which 
only 515 believed to be extremely or very important (Roos and Toksvig-Larsen, 2003). 
Construct Validity. The KOOS has been validated against the SF-36 score with knee 
arthroplasty patients showing moderate to strong correlations in the KOOS scales and SF-36 
subscales designed to measure similar constructs, such as pain (Spearman’s correlation 
coefficient rs=.62), and  weak correlations for SF-36 domains not included in the KOOS, such 
as mental health (Koos and Toksvig-Larsen, 2003). A further benefit of the KOOS is that the 
score houses the established Western Ontario and McMaster Universities Osteoarthritis 
(WOMAC) Index (Bellamy et al., 1988) within it enabling  WOMAC index scores to also be 
calculated.  
 
Reliability. Test – retest data were tested in in one study of patients undergoing knee 
arthroplasty (Koos and Toksvig-Larsen, 2003). Intraclass correlation coefficients (ICC2,1) 
ranged from .78-.97 across the domains.  
 
Responsiveness to change. Effects sizes across the subscales ranged from 1.24-2.86 at six 
months and 1.59-3.54  at one year after knee arthroplasty (Koos and Toksvig-Larsen, 2003); 
the most responsive scale being quality of life and the least responsive scale being the sport 
and recreation subscale.  
 
Floor and Ceiling effects. In a study of 105 knee joint arthroplasty patients from pre operation 
up to one year post operation floor effects across the domains  were generally between 0-16 
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percent, except for the sport and recreation domain which showed  a 48% floor effect at pre 
operation (Koos and Toksvig-Larsen, 2003). Ceiling effects ranged from 1-22%. 
 
4.5.6.4 The Leg extensor press (LEP).   
Purpose of the measure and reason for its inclusion in the trial. The geneneration of adequate 
power,  the rate at which muscles develop force, is  required to successfully achieve 
functional tasks (Activity and Health Research Limited, 1990).  Power is the product of force 
and velocity of contraction and the Leg extensor press which measures the explosive power in 
a single leg extension (Bassey  et al., 1990; Frost et al., 2002) was included in this study.  The 
intention of using the LEP was to provide a measurement  relevant for functional activities 
which require speed as well as force (such as sit to stand) as well as slower controlled 
functional activities (such as stair climbing) (Bassey and Short, 1990).   
 
Measurement Approach and Scoring. The LEP is designed  to be a safe method of measuring 
explosive power, unlike other methods such as two-legged jumping on a force plate (Bassey 
and Short, 1990). The seat position is adjusted for leg length (Bassey and Short, 1990); 
important both for the production of power and to allow for the presence of fixed flexion 
deformities of the knee joint in our trial participants.  Adherence to a strict test protocol to 
minimise measurement errors is required  (Robertson  et al.,   1998). 
The mean number of repetitions required for participants to reach their maximum LEP 
has been reported as 5.2 (Robertson  et al., 1998; Bassey and Short, 1990). Usually up to 
maximum of 10 repetitions, with 15 second rest periods, are used for patients with knee joint 
pathology (Robertson  et al., 1998; Frost  et al., 2002). Since  a relationship has been found 
between pain and function (Lamb et al., 1995; Robertson  et al., 1998) it was predicted that 
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not all participants  would be able to achieve 10 repetitions.   The most common scoring 
approach is to use the highest recorded power value for each participant (Robertson  et al., 
1998; Bassey  et al.,  1992; Frost  et al., 2002). 
 
Validity. LEP measurements in the elderly have previously found to be strongly associated 
with functional activities such as stair climbing (Bassey  et al.,   1992) .  The LEP has also 
previously been used in a physiotherapy trial comparing exercise programmes following knee 
arthroplasty (Frost  et al., 2002) which, given the lack of comparable trials available, is 
considered advantageous.  
 
Reliability. The level of repeatability of using the LEP for patients with osteoarthritis of the 
knee has been shown to be acceptable with coefficients of variation ranging  from 9-16%  
being reported for this patient group (Robertson  et al., 1998). The same researchers also 
report Bland and Altman method for repeatability results; error of the standard deviation =.17  
(95% of differences expected within + .47).  
4.5.6.5 The Timed Walk Test.  
Purpose of the Score and reason for its inclusion in the trial. Timed walk tests are common 
outcomes in randomised clinical trials (Steadman  et al., 2003); measuring functional physical 
activity in the elderly for conditions such as osteoarthritis (Lin et al., 2001) and, like this trial, 
to measure change physical function following knee arthroplasty (Shields  et al., 1995). 
Unlike the LEP, the timed walk and the STS below are both physical function tests which 
incorporate a number of elements such as strength, power and stability. 
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Scoring Approach.  The test can be either the distance walked during a set time (such as 6 or 
12 minutes) or the time taken to walk a set distance. In this trial the latter approach was 
chosen since patients may be unable to walk for long durations pre operatively or soon after 
surgery. The set distance used in previous research has varied from 2.44 m  (Shaubert and 
Bohannon, 2005) to 8 feet (Lin  et al.,   2001), 3 or 4 m (Wolinsky  et al.,  2005) to 4.57 m 
(Shields  et al., 1995). A commonly used distance is 10 metres (Steadman  et al., 2003; 
Whitehead  et al., 2003). This distance was chosen since it was believed to be achievable for 
trial participants whilst being of sufficient duration to minimise the impact of any small 
stopwatch start/stop measurement errors.  
 Timed walk tests can be performed as fast as possible (Lin  et al., 2001) or at a normal 
comfortable speed (Schaubert and Bohannon, 2005; Wolinsky  et al.,2005).  To optimise 
patient safety in the immediate post operative period, the latter approach was chosen. No 
verbal encouragement was used since this is known to influence test performance (Guyatt  et 
al., 1984). 
 
Validity. Walking speed has long been acknowledged and accepted as a valid outcome 
measure following lower limb joint surgery; it is known to be a key measure for the analysis 
of gait (Bowker and Messenger, 1988).  
Reliability. The coefficient of repeatability for an 8 feet test at natural speed  been reported as 
.44 seconds with an intraclass correlation coefficient of 0.96 (Lin  et al.,  2001). A variation of 
7.3%  has been found over nine  maximum speed 10m tests which the authors considered to  
be relatively inconsequential when compared to normal biological systems (Howe and 
Oldham, 1995).   
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4.5.6.6 The timed sit to stand (STS) test.  
Purpose of the Measure and reason for its inclusion in the trial. The sit-to-stand  (STS) test is 
an objective functional measure of strength (Schaubert and Bohannon, 2005). It is included in 
the trial both as an objective measure of function, since it is fundamental to transfers and the 
initiation of gait (Eriksrud and Bohannon, 2003), and because of its correlatation with other 
functional activities (see below). 
Measurement approach and scoring. STS tests either measure the time taken to complete a 
specified number of STSs (Lin  et al.,   2001; Wolinsky  et al.,   2005) or record the number 
of STSs within a specified time period (Jones  et al.,   1999). The former can be problematic 
in that a floor effect is often present with participants not being able to perform the 5 or10 
required number of STSs (Jones  et al.,  1999). Previous research assessing physical function 
in the elderly found 24% (n=25) of participants with lower limb osteoarthritis were unable to 
complete this form of the test (Lin  et al.,   2001).  
Chair height influences the performance of the movement (Janssen  et al.,   2002)  so 
the same chair was used throughout the trial; used with its back legs braced against a wall to 
minimise chair movement (Jones  et al.,   1999). Since patients with poor quadriceps strength 
are believed to compensate for this weakness by using their arms to get in and out of a chair 
(Lin  et al.,   2001) patients were asked to perform the test with their arms folded. Although 
arm folding may, by influencing the body’s centre of mass, require more adjustment at the 
ankle joint by patients than their usual movement (Carr, 1992) this approach was used 
because it has been calculated that the reduction of the extension moment required to STS is 
up to 50% if arm rests are used (Janssen  et al.,  2002).  
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Validity.  The STS has been moderately correlated ( r=0.71-0.78) to weight adjusted 1-RM 
(maximum) leg-press strength (Jones  et al.,   1999) although it is appreciated that other 
factors,  such as sensation, speed, balance and pschological status, are involved in its 
execution. (Lord  et al., 2002). The STS also correlates with knee extensor strength, 
ambulatory independence, walking speed and stair climbing performance (Bohannon, 1998; 
Bohannon and Eriksrud, 2001; Ikezoe  et al.,   1997) and is a predictor of hospital length of 
stay post arthroplasty (Barker  et al., 2003).   It is known that knee arthroplasty patients find 
STS a difficult maneouvre compared to normals of the same age group and compensate, both 
pre and post operation, by taking more weight through the non affected side and by increasing 
forward leaning (Su  et al., 1998).  
Reliability. The test-retest reliability for the number of STSs performed in 30s has been 
reported to be high  (r=0.89) and enables wide variations in ability levels to be reliably 
assessed (Jones  et al.,   1999). The coefficient of repeatability for 5 STSs performed as fast as 
possible has been reported as 5.74 seconds, with an intraclass correlation coefficient of 0.96 
(Lin  et al.,  2001).  
4.5.6.7 Additional Measures. 
In addition to outcomes the following tools were included to inform the interpretation of the 
trial results and assist the assessment of internal validity of the trial. 
The Intervention. 
The physiotherapists providing the intervention completed a case report form for each home 
visit immediately following each treatment (see Appendix XIII). The form recorded the time 
spent on the visit, and asked the physiotherapist to estimate the time (in minutes) spent upon 
each element of the intervention. Space was available for physiotherapists to add in any 
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additional treatment components incorporated into a treatment and to record any concerns 
participants raised. I have developed and successfully used this approach previously to check 
adherence to a pragmatic physiotherapy trial protocol (Mullis et al. 2006). 
Patient diaries. 
A patient resource use diary (Rivero-Arias et al.,  2005) was used to enable participants to 
record any additional non trial physiotherapy received following discharge from hospital and 
12 month follow up (Appendix XII). Location, number of sessions, and source (NHS or 
privately funded) were recorded.  
Joint range of motion.  
The value of using joint range of knee range of motion as an outcome measure in rehabiliation 
trials is questionable (Minns Lowe  et al., 2007). Many variables influence post operative 
range of motion in addition to rehabilitation and these limit its usefulness as a measure of 
rehabilitation (Minns Lowe  et al., 2007): Lam  et al.,   (2003) summarise these variables and 
list implant design, surgical technique and approach and previous level of fixed flexion 
deformity in addition to rehabilitation. Joint range of motion therefore was not included as an 
outcome in this trial. However  joint range has been recorded in all previous physiotherapy 
knee arthroplasty rehabilitation trials (Codine  et al.,   2004; Frost  et al.,   2002; Kramer  et 
al.,   2003; Mockford and Beverland, 2004; Rajan  et al.,  2004) bar one (Moffet  et al.,   
2004).  To facilitate comparison with these other trials and because knee range of motion does 
affects performance and functional abilility (Rowe  et al.,   2000) and is a useful characteristic 
to meaningfully describe trial participants as required (Mant, 1999), this measurement was 
also included in the trial. Knee joint range of motion was measured via goniometry, a quick, 
easy, inexpensive way to measure motion which is more reliable than methods such as visual 
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estimation (Watkins  et al.,   1991; Brosseau  et al.,  2001) and which was also frequently 
used in the other trials.   
4.5.7 PROCEDURE AND INTERVENTION:  
4.5.7.1 STAGE I. Recruitment of patients.  
An invite letter and trial information sheet were posted to patients prior to their attendance at 
the Pre Operative Admission Clinic (POAC). This was usually 10-14 days prior to attendance. 
Patients were requested to either return a reply slip in a pre-paid envelope if they were 
interested in participating or to inform the POAC staff at their appointment. The trial was 
fully verbally explained to interested patients at the POAC and informed valid consent sought.  
Baseline Assessment Procedures.  
 
Baseline data was collected for participants using self report questionnaires and standardised 
data recording forms (See Appendix XII). If, for any reason, only partial baseline 
measurements were obtained the reasons were recorded. Participants were also provided with 
their resource use patient diaries.  
Self Report Questionnaires.  
 
Patients were requested to read the questionnaires and to follow the instructions outlined.  
Participants were provided with a black pen to complete the questionnaire since this colour 
pen is read most accurately by the Optical Mark Recognition software (Remark Office version 
6) used in the trial.  
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Joint Range of motion. 
 
Knee joint range of motion was measured using the approach of Norkin and White (2003).  
The standardised explanation, instructions to participants, and procedure can be found in 
Appendix XIV.  
 
Timed Walk Test. 
A pre-measured 10m walkway was used for the test. During the test the assessor stood to one 
side and slightly behind the patient (to avoid pacing). A count down of “three, two, one, go.” 
was used. Timing commenced upon “go” and ceased when the patient crossed the 10m mark. 
The time was recorded in seconds (to two hundredths of a second) in the patient assessment 
questionnaire. All participants wore shoes for the test and were allowed to use their usual 
walking aid. If used, the type of aid was recorded in the patient assessment questionnaire.  
The standardised explanation, instructions to participants, and full procedure can be found in 
Appendix XIV. 
 
Leg Extensor Press.  
 
The patient sat on the LEP seat with their back was positioned against the back rest. All 
participants wore shoes and folded their arms during the tests. The seat position was adjusted 
for each participant by their placing one foot on the fully depressed footplate and pushing the 
seat back slowly until the leg was extended as fully as comfortable possible. The seat position 
was clamped in place after adjustment and measured and recorded in centimetres (up to 2 
decimal places) on the questionnaire. Measurement was from the distance from the front base 
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of the seat (labelled yellow marker 1) to the back end of the runner (labelled yellow marker 2) 
and this measurement was used throughout the baseline plus all follow up assessments. 
 
 
Illustration 19. Photograph showing the leg extensor press in use. 
 
 
 
Measurements were obtained for both legs, starting with the leg not undergoing knee 
replacement.  Participants were instructed to place their foot upon the footplate with their free 
foot resting on the floor and push the foot pedal as hard and as fast as possible after the count 
down of “three, two, one, push”.  Two warm up attempts were allowed for each leg. A 
relaxation period of 15 seconds occurred between each test. If pain did not halt testing, at least 
five tests (not including the warm ups) were carried out on each leg and recorded. If the 
patient still showed signs of improvement they were allowed to continue up to a maximum of 
10 tests per leg if they were able to do so. The weight of each person on calibrated SECA 
bathroom scales was obtained and recorded in Kgs to use in analysis. The standardised 
explanation, instructions to participants, and full procedure can be found in Appendix XIV. 
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Timed Sit-To-Stand. 
 
The standardised chair seat height for this test was 44 cm (including 4 cm of foam padding) 
and the seat depth was also 44 cm. The chair was without armrests. All participants wore 
shoes for this test. Participants started the test in the sitting position and were asked to 
perform the test with their arms folded.  A count down of “three, two, one, go” was used and 
timing commenced upon the word go. No verbal encouragement was given. The number of 
times the patient completed a sit to stand was counted until 30 seconds passed at which time 
the timing was stopped and the patient told to cease the test. The number of completed sit-to-
stands was recorded; no rating of partial movements was included. If the patient was unable to 
do any sit-to-stands then 0 was recorded.  
The standardised explanation, instructions to participants, and full procedure can be found in 
Appendix XIV.   
 
4.5.7.2 STAGE II. Randomisation and Allocation Concealment. 
The well established randomisation procedure outlined by Pocock (1983 p. 66-79) was used. 
A  randomisation list was prepared using random permuted blocks to prevent wide 
imbalances between the number of participants allocated to each treatment arm. A block size 
of 10 was used since this was considered sufficiently large to reduce predictability whilst 
ensuring that the number of participants requiring the intervention at any one time remained 
manageable. Randomisation was  independently performed by the Director of the 
Physiotherapy Research Unit and the physiotherapists assessing and treating patients were not 
involved. The randomisation list was transferred to a sequence of sealed envelopes to promote  
allocation concealment from participants and assessing physiotherapists during baseline 
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assessments prior to randomisation, thus minimising selection bias (Altman  et al.,  2001). 
Each envelope was sequentially numbered and contained the name of the next treatment on a 
card.  Envelopes were opaque and were sellotaped after sealing. The envelopes were securely 
stored in a locked office and used in strict consecutive order. Upon completion of baseline 
collection measures, the next envelope was fetched and opened by the patient and replaced in 
the envelope by them. The study number of the patient was then written on the resealed 
envelope and returned to the trial co-ordinator.  
4.5.7.3 STAGE III. Surgery.  
Patients  received  elective surgery and usual hospital care via the implementation of the 
integrated care pathway already in use at the Nuffield Orthopaedic Centre, Oxford. Each 
patient’s operation notes were reviewed and the grade of surgeon performing the operation 
noted. Any operative or post operative complications were  recorded from the operation notes 
and, at a later stage, during the follow up assessments.  
4.5.7.4 STAGE IV. The Intervention. 
The intervention group patients received 2 physiotherapy home visits with the intervention 
package earlier described.  The date, time and duration of each visit was recorded in minutes. 
Following each visit the physiotherapist wrote up the visit and also estimated the time (in 
minutes) spent on each of the activities on a form designed for the purpose (Appendix XIII). 
This was to enable both adherence to the trial protocol to be checked and to enable the 
intervention to be sufficiently described for future readers of the research. 
The Usual Care Group received no additional home visits. 
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4.5.7.5 STAGE V. Follow up.  
All trial patients underwent reassessment, using all outcome measures performed at baseline, 
at three and twelve months post operatively by a physiotherapist blind to trial arm allocation. 
The three month timepoint was chosen as an end of treatment time, allowing time for 
participants to practice exercises and tasks practiced during the second visit. The final twelve 
month timepoint was chosen since the most improvement following knee arthroplasty occurs 
within the first year, with the largest gains being in the first six months (Jones  et al.,  2007). 
All patients were also followed up at six months post operatively by postal questionnaire 
containing the Oxford Knee score and the KOOS. The use of postal assessment in this way 
has previously been demonstrated to be a feasible method for rehabilitation trials (Parker and 
Dewey, 2000). To promote compliance with full completion of the patient diaries,  each 
participant was reminded to complete their diaries verbally at follow up visits,  by telephone 
when arranging visits or following up patients by telephone if they were unable to attend the 
hopsital for follow up and in the letter sent to the patient with their 6 month follow up 
questionnaire.  
 
4.5.8 DATA ANALYSIS.             
4.5.8.1 Missing or multiple data. 
Oxford Knee Score.  One or two missing values were substituted with the average value for 
the score; if more than two items were missing the score was deemed invalid (Murray et al., 
2007). If two boxes were marked the worst outcome was chosen (Murray et al., 2007). 
KOOS. One or two missing values were substituted with the average value for that subscale; if 
more than two items were missing the subscale was deemed invalid (KOOS User’s Guide, 
2003). If two boxes were marked the worst outcome was chosen (KOOS User’s Guide, 2003). 
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All other missing data was assigned the value 999. Data for tests which participants 
attempted but were unable to perform were given a value of 0. 
 
4.5.8.2 Data Analysis. 
An intention to treat approach was used for data analysis. In this type of analysis the data 
from each participant are analysed in accordance with the treatment arm to which they have 
been randomised (Sim and Wright, 2000 p.330).  
The results first underwent descriptive analysis to describe the characteristics of the 
sample and to check the variables for any violations of the assumptions underlying the 
planned statistical tests (Pallant, 2007 p. 53). The exclude cases pairwise option was chosen; 
this includes a case in all analyses for which they have data and only excludes a case if they 
are missing the data required for a specific analysis. Kolmogorov-Smirnov statistics were 
calculated to further assess the normality of the distribution scores and assist confirmation of 
significant deviations from the norm (Field, 2000 p.47-48). 
The baseline characteristics were examined to ascertain the extent to which 
randomisation was effective and how similar the groups appeared at baseline (Altman, 1991 
p.38-39). Following this descriptive analyses were performed for both trial arms at all time 
points using numbers and percentages for categorical variables and means and standard 
deviations for continuous variables (Altman, 1991 p.38-39). Within group comparisons of 
primary and secondary outcomes were performed between each timepoint: paired t-tests were 
used for the outcomes comparing normally distributed data and Wilcoxon Signed Ranks test 
for outcomes comparing non normally distributed data (Campbell and Machin, 1993, 75-84). 
Outcome scores between each group were then compared between each timepoint. 
Independent samples t-tests were used for the outcomes comparing normally distributed data 
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and Mann-Whitney U tests were deployed for outcomes comparing non normally distributed 
data (Altman, 1991 p.194-195). One-way repeated measures analysis of variance tests were 
then used. Since responses to treatment may show large variations by virtue of differences 
across individuals, this test allows responses to treatment to be compared for each person, 
thus minimising the variability across people (Sim and Wright, 2000 p. 309). These tests 
provide greater power to detect effects; however, since scores at each timepoint are likely to 
be related because they come from the same subjects, the accuracy of the F-test is adversely 
effected (Field, 2000 p. 323-326). This means that an additional assumption has to be made, 
of sphericity, where it is assumed that the relationship between pairs of experimental 
conditions is similar (Field, 2000 p. 323-326). To assist ease of readability and clarity further 
details regarding specific analyses are provided in the results section to prevent repeated 
flicking back and forwards over many pages.  
 In addition to making statistical comparisons of follow up scores, change 
scores were also calculated to allow the changes in outcome scores to be explicitly stated 
(Vickers and Altman, 2001). Finally, since subgroup analyses are unreliable in small studies, 
no subgroup analyses were undertaken in this trial (Friedman et al., 1998 p. 304-306). 
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4.6 RESULTS. 
4.6.1 FLOW OF PARTICIPANTS THROUGH THE TRIAL.  
The consort flow diagram for the trial is shown here.  
 
 
 
 
 
 
 
 
 
 
Randomised n= 107 
Allocated to usual physiotherapy 
n=51 
Received allocated surgery n=47 
Had UKA rather than TKA n=2 
Received allocated intervention n=47 
 
Allocated to home visit physiotherapy 
n=56 
Received allocated surgery n=47 
Had UKA rather than TKA n=2 
Received allocated intervention n=47 
 
Assessed for eligibility 
n=315 
 
Excluded: 
Not meeting inclusion criteria n=90 
Clinic appt cancelled/DNA/pt not 
seen n=34 
Operation cancelled/delayed n=10 
Declined to participate 
n=57 
Unable to provide informed consent 
n=4 
Other reasons: 
Did not receive invite n=6 
Undecided re: surgery n=2 
Moving out of are n=1 
Transport unable to wait n=2 
Accepted but unable to stay for 
assessment n=2 
Follow up 
Lost to follow up n=1* 
Withdrawal and discontinued 
intervention n=1 (baseline data analysed only) 
3/12 follow up primary outcome n=46  
6/12 follow up primary outcome n=42 
12/12 follow up primary outcome n= 47 
 
[*Not all were followed up at every time point due 
to illness, non attendance, non response]  
Analysed n= 49 
Excluded from analysis: 0 
Missing data for primary outcome: 
baseline n=1; 3/12 n=2; 6/12 n=5; 
12/12 n=3
Analysed n=49 
Excluded from analysis: 0 
Missing data for primary outcome: 
baseline n=1; 3/12 n=3; 6/12n=5; 
12/12 n=3
Follow up  
Lost to follow up n=0* 
1 died after 3/12 
3/12 follow up primary outcome n=47 
6/12 follow up primary outcome n=44 
12/12 follow up primary outcome n= 48 
 
[*Not all were followed up at every time point due to 
illness, non attendance, non response, death]  
Figure 13. CONSORT flow diagram,
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Although patients were not asked to provide a reason for declining to participate in the trial 
42% of those declining spontaneously cited travel and transport issues as their prime reason 
for non participation because the follow up visits necessitated 2 extra hospital visits. A further 
two potential participants could not seen in clinic due to hospital transport time constraints.   
 
 
4.6.2 COMORBIDITIES, MORTALITY AND COMPLICATION RATES  
REPORTED DURING THE TRIAL. 
4.6.2.1 Comorbidity and mortality. 
 
In the home visit group one patient was diagnosed and treated for multiple myeloma, another 
was diagnosed and operated upon for hydrocephalus, one participant was diagnosed and 
treated for rheumatoid arthritis and a further participant had been referred to the spinal team 
for possible surgery for stenosis. One participant in the home treatment group became 
progressively cognitively impaired following surgery and unable to comply with full follow 
up assessment procedures. 
 
Overall less co-morbidities were developed by usual physiotherapy group participants. One 
participant was diagnosed and treated for anaemia and one participant reported progressive 
sensory loss due to diabetes. However one patient in the usual physiotherapy group died 
during the trial; the cause of death was unrelated to their knee operation.  
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4.6.2.2 Complications Reported By Participants At Three Month and Twelve Month 
Follow Up Assessments.  
 
Eleven participants reported a total number of 17 major complications occurring in the first 
three months. A total of 83 minor complications were reported by 56 participants with a 
minority of 36 participants reporting no minor complications. Details can be found in the 
tables below. 
 The reported number of major complications within the first three months was 
checked against the medical records for the relevant participants to enable comparison of rates 
with existing published data from available publications. The medical records made no 
mention of deep infections for the two participants reporting them, and no mention of the two 
DVTs. The records confirmed the presence of a pulmonary embolus for the participant 
mentioning this (and also interestingly records the presence of a DVT the participant had not 
mentioned). The reported intra-operative fracture was confirmed by the medical notes. The 
three chest infections reported by participants were not mentioned in their medical records. 
The myocardial infarction was confirmed as was the foot drop with associated nerve damage.  
Of the three strokes/trans ischaemic attacks reported, one major stroke was confirmed, one 
TIA was confirmed whilst the medical records for the third were not available. Of the three 
pressure sores reported by patients, whilst only one was confirmed by medical records, 
confirmation of the others was obtained via the patient resource diaries which listed multiple 
visits to have pressure sores dressed.  
 The number of major complications reported from the start of month four until the end 
of twelve months increased to 24 in 22 participants, largely due to 16 participants reporting 
chest infection during this time. Importantly two revisions had already taken place with a 
further two participants exploring the possibility of further surgery.   
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Table 8. Post operative major complications related to knee replacement surgery for 0-3 months (n=92) 
and 4-12 months following surgery (n=93).  
 
 
Complication 
                        0-3 Month Follow up  
No of participants with             Percentage of no  
complications/ no of                   of participants for  
participants for which               for which data was 
data was obtained                      obtained 
                    4-12 Month Follow up  
No of participants with             Percentage of no  
complications/ no of                   of participants for  
participants for which               for which data was 
data was obtained                      obtained 
                
Deep infection 2/91 2.2% 0  
Deep vein 
thrombosis 
2/91 2.2% 0  
Pulmonary 
embolus  
(requiring 
anticoagulants) 
1/92 1.1% 0  
Intra-operative 
fracture 
1/92 1.1% 0  
Chest infection 3/92 3.3% 16/93 17.2% 
Heart attack 1/92 1.1% 1/92 1.09% 
Stroke /TIA 3/92 3.3% 2/92 2.17% 
Pressure sores 3/92 3.3% 0  
Nerve damage 
with foot drop 
1/92 1.1% 1/89 1.12% 
Patellar button 
moved –
awaiting further 
investigations 
  1/89 1.12% 
TKA revisions   2/89 
[1: tibial component 
slipped, revised, 
fractured 2/52 later 
2: sudden onset burning 
pain- TKA required 
revision] 
2.25% 
Daily knee 
locking – 
awaiting 
investigation 
  1/89 1.12% 
Total number of  
major 
complications 
17  in 11participants Overall major 
complication rate 
=18.48%  
Percentage of 
participants reporting 
major complications = 
11.96% 
24 in 22 participants Overall major 
complication rate 
=25.81%  
Percentage of 
participants reporting 
major complications = 
23.66% 
 
 
 
The reported number of major complications were then separated into home and usual 
physiotherapy groups and the results can be seen in the table below. Overall, the rates 
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between the two groups appeared similar although both revisions and the majority of strokes 
were in the home treatment group. 
 
 
Table 9. Table to show treatment arm allocation for post operative major complications related to knee 
replacement surgery for 0-3 months (n=92) and 4-12 months following surgery (n=93).  
 
 
Complication 
                        0-3 Month Follow up  
No of participants                No of participants in 
in home visit group             in usual physiotherapy 
                                              group 
                    4-12 Month Follow up  
    No of participants                No of participants in 
in home visit group             in usual physiotherapy 
                                              group            
Deep infection 1 1 0  
Deep vein 
thrombosis 
1 1 0  
Pulmonary 
embolus  
(requiring 
anticoagulants) 
1  0  
Intra-operative 
fracture 
1 0 0  
Chest infection 1 2 8 8 
Heart attack 0 1 0 1 
Stroke /TIA 2 1 2 0 
Pressure sores 1 2 0  
Nerve damage 
with foot drop 
0 1 0 1 
Patellar button 
moved –
awaiting further 
investigations 
  1  
TKA revisions   2 0 
Daily knee 
locking – 
awaiting 
investigation 
  0 1 
Total number of  
major 
complications 
 
8 9 13 11 
 
 
 
The minor complications reported by participants can be seen in the table below. The number 
of minor complications reported lessened over time, with 32 complications reported by a 
minority of 23 patients. The most common of these were 7 participants complaining of 
continued knee pain and 6 with swelling/inflammation. 
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Table 10. Post operative minor complications related to knee replacement surgery within three months 
following surgery according to patients (self report closed and open question data n=92). 
Complications  
 
0-3 Months Follow Up 
Number of participants reporting  
complication (Percentage of number of 
participants for which data was 
obtained for closed questions only) 
4-12 Months Follow Up 
Number of participants reporting  
complication (Percentage of number of 
participants for which data was 
obtained for closed questions only) 
Superficial wound infection 
(requiring antibiotics) 
15 (16.3%) 4 (4.3%) 
Haemorrhage requiring additional/ 10 (10.9%)  
unexpected transfusion 
Clips/Stitches (undissolved, left in, 
difficult to remove, causing ulcer) 
6  
Excessive pain/nerve pain &/or bruising 6   
Falls 5  
Swelling & inflammation 4 6 
Limited flexion/ROM/MUA 4  
Ankle pain and/or swelling limiting 
mobility 
3  
Drain not working/falling out 3  
Haemarthrosis, haematoma 3  
Anaemia requiring medication (not 
transfusion) 
2  
Blisters  2  
Cellulitis 2  
Depression,  panic attacks 2 1 
Heat in knee since operation 2 1 
Numbness 2 1 
Chest pain 1  
Angina 1  
Foot coldness since operation 1  
Hamstring clicking during extension 1  
Ineffectual nerve block 1  
Joint clicking with pain 1  
Leg length discrepancy 1  
Post operative hypotension 1  
Problematic scar tissue 1  
Stomach bug 1  
Varicose eczema 1 1 
Wound Bleeding 1  
Continued pain   7 
Knee cap rubbing on prosthesis  1 
Tibia and foot pain – awaiting scan 
results 
 1 
Knee itchiness  1 
Knee ligament injury after twisting knee  1 
Intermittent redness  1 
Opposite knee arthritis  1 
Partial Achilles rupture opposite leg  1 
Knee giving way  1 
Rash on knee  1 
Ruptured Bakers cyst  1 
Scar tissue in lateral ligament  1 
Total 83 complications in 
56  participants  
32 complications in 23 participants 
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 4.6.3 Further Interventions and Hospital Admissions Following Surgery.  
The table below shows the number of further interventions or operations and further 
admissions required by participants during the trial. Six participants required further 
interventions in the first three months following their surgery. Three of these participants 
underwent knee joint manipulations under anaesthetic (home visit group n=1, usual 
physiotherapy group n=2), one home visit participant had a clip removed from the bottom of 
their wound (patient admitted three times into the bone infection unit), one usual 
physiotherapy underwent nerve conduction studies and one home visit had an MRI for severe 
back and leg pain following surgery.  Seven further patients were admitted into hospital at 
least once during the first three months following surgery: one following discharge with a 
DVT and pulmonary embolus (home visit group), one after a fall (n=1 usual physiotherapy 
group ), one after a slip and major stroke (n=1 home visit group), bleed into joint (n=1 usual 
care group), knee pain (n=1 home visit group), pulled tendon (n=1home visit group) and chest 
pain (n=1, three admissions, home visit group). 
Five participants required further interventions from the start of month 4 to twelve 
months post surgery; two patients in the home visit group underwent revisions, one in the 
usual physiotherapy group had a biopsy (results not known), one usual physiotherapy 
participant had fluid removed from the knee and one usual physiotherapy participant reported 
3-4 courses of antibiotics. 
Four patients were admitted into hospital between 4-12 twelve months, two for 
revision arthroplasties, one with multiple myeloma and one due to rheumatoid arthritis. All  
were in the home visit group. 
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Table 11. Number of self reported interventions and hospital admissions within 0-3 (n=93) and 4-12 
months (n=93)  following surgery.   
 
Intervention/Admission 0-3 months 4-12 months 
Number of participants with 
complication/Number of 
participants for which data was 
obtained 
Number of participants with 
complication/Number of 
participants for which data was 
obtained 
Number of further operations or 
interventions related to this joint 
replacement only  
6/93   or 6.45% 5/92 
Post operative complication/s 
which required the patient to be 
transferred to another hospital 
1/93   or 1.1% 0 
Number of readmissions to 
hospital  
12/93 (total of 17 admissions) 4/93 
or 12.9% or 4.17% 
 
 
4.6.4 Further Joint Replacement Surgery. 
In addition to the two revisions already mentioned, five participants underwent total knee 
arthroplasties to their other knee (n=4 home visit and one usual care participant), and one 
further participant a unilateral knee joint arthroplasty to their other knee (usual physiotherapy 
group), during the twelve month follow up period. Three other participants reported hip 
procedures: two hip arthroplasties (both home visit group) and one hip resurfacing procedure 
(usual care group). Overall, of the 12 procedures, 9 were undertaken by home visit group 
participants and 3 by usual physiotherapy group participants.   
 
 
4.6.5 BASELINE CHARACTERISTICS.  
4.6.5.1 Descriptive statistics for the primary outcome at baseline. 
Descriptive statistics were used to describe the characteristics of the sample and to check the 
variables for any violations of the assumptions underlying the planned statistical tests (Pallant, 
2007 p. 53). The exclude cases pairwise option was chosen; this includes a case in all analyses 
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for which they have data and only excludes a case if they are missing the data required for a 
specific analysis. Appendix XV contains additional information regarding all the results 
provided in this chapter. 
Initial description of the baseline primary outcome data. 
The table below provides an initial description of the baseline data for the primary outcome, 
the Oxford Knee Score. Baseline scores show wide variation from 4-41 out of a possible 0-48;  
plus the kurtosis value of  -0.245 also indicates a slightly flattened distribution (Pallant, 2007 
p. 56). The 5% trimmed mean value of 19.98 is close to the mean of 20.11, indicating that 
extreme scores are unlikely to be unduly influencing the mean (Pallant, 2007 p. 59). A table 
of extreme values is in Appendix XV. The standard deviation of 7.857 is lower than other 
published data for this patient group (Dawson  et al.,  1998). The slight positive skewness 
value of 0.145 indicates an absence of serious skew problems with this data (zero indicates 
normally distributed data) (Altman, 1991 p. 36). 
 Table 10. Table to describe the data obtained for the primary outcome at baseline (n=105). 
 
  Statistic Std. Error   
Mean 20.11 .767 
Lower Bound 18.59   95% Confidence 
Interval for Mean Upper Bound 
21.63   
5% Trimmed Mean 19.98   
Median 20.00   
Std. Deviation 7.857   
Minimum 4   
Maximum 41   
Interquartile Range 11   
Skewness .145 .236 
Ox_Score 
Kurtosis -.245 .467 
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Further assessment of Normality within the baseline Oxford Knee Score data. 
The histogram below shows the distribution of scores for the primary outcome, the Oxford 
Knee Score. Apart from the dip observed around scores of 24-26, the data on the histogram 
appears approximately normally distributed. A Kolmogorov-Smirnov statistic was calculated 
to further assess the normality of the distribution scores (Appendix XV). The statistic value of 
0.048 with 105 degrees of freedom gave a lower bound value for the true significance of 
0.200. This non – significant value indicates data normality.  
 The box-whisker plot below does identify one outlier (ID 1072). Since this outlier is 
close to the upper whisker it is not considered extreme and the decision was made not to 
exclude this point from analysis. 
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Figure 14. Histogram to show the distribution of scores at baseline for the primary outcome, the Oxford 
Knee Score (n=105). 
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Figure 15. Box-whisker plot of the Oxford Knee Score data showing the 2 ½ , 25, 50, 75 and 95 ½ 
cumulative relative frequencies (centiles) plus one outlier ID 1072.  
 
 
Assessment of Normality for the secondary outcomes at baseline.  
The distribution of data was also explored for the secondary outcomes (see Appendix XV). 
The symptoms, pain, functional activities of daily living, subscales of the KOOS provided 
data which were normally distributed. The sport and recreation and quality of life subscales 
data were not normally distributed. Similarly the data from the maximum leg extensor press 
values/weight in kg, for the timed walk test and for the timed sit to stand were also not 
normally distributed. 
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4.6.6 Baseline characteristics for the two trial groups. 
The baseline characteristics for the two groups of the trial are summarised in the table below. 
The two trial arms generally appear relatively similar in terms of baseline characteristics 
although more participants in the home visit group had their left knee replaced whilst more 
participants in the usual physiotherapy group had their right knee replaced. Although it might 
appear that the mean duration of symptoms is greater for the usual physiotherapy group than 
for the home visit group, when months are converted to years the groups demonstrate greater 
similarity (home visit group mean =11.2 years; usual care group mean = 12.3 years). Since 
there were some extreme outliers present the median value is also provided for symptom 
duration. The p values are included solely as a means of checking that effective randomisation 
occurred in the trial. Since none of the p values show significant differences between the 
groups it is assumed that randomisation was successful. 
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Table 11.  Baseline characteristics of the Home Visit and the Usual Physiotherapy Groups. 
 
Characteristics at Baseline Home Visit 
Group (no of 
participants 
providing data) 
Usual 
Physiotherapy  
(no of participants 
providing data) 
P values 
t-test for equality of 
means#  OR 
Mann Witney U for 
non parametric§ OR 
Chi-square* 
Total number of participants 
randomised to each group 
56 51  
Gender: males 
              females 
24 
32 
21 
30 
1.00* 
Mean age (years) 
Standard Deviation 
67.84 (n=56) 
SD (8.45) 
70.76 (n=51) 
SD (9.45) 
.094# 
Knee being replaced: left 
                                 right 
                         undecided (no 
operation) 
31 
24 
1 
22 
29 
** 
Median Functional Comorbidity Index 
Interquartile range 
2  
IQ =1 
2 
IQ=1 
.611§ 
Mean Body Mass Index 
Standard deviation 
31.32 (n=56) 
SD 6.28 
29.27 (n=51) 
SD 5.82 
.082# 
Mean Duration of symptoms (months) 
Standard deviation 
Median Duration of symptoms 
(months) 
133.91 (n=55) 
141.53 
84 
147.92 (n=51) 
146.84 
96 
.618# 
Mean Range of  max knee joint flexion 
(degrees) 
Standard deviation 
105.26 (n=53) 
SD 10.15 
105.38 (n=51) 
SD 19.92 
.976# 
Mean Range minimum flexion 
(degrees) 
Standard deviation 
9.27 (n=53) 
SD 11.464 
9.93 (n=51) 
SD 8.732 
.810§ 
Number of participants with symptoms 
in the other knee 
37 (n=53) 29 (n=51) .243* 
Number of participants with previous 
other arthroplasties 
21 (n=55) 22 (n=51) .419* 
Number of participants with a history 
of diabetes 
7 (n=55) 3 (n=51) ** 
Number of participants with a history 
of cardiac disease 
13 (n=55) 17 (n=50) .338* 
Number of participants who have ever 
smoked 
28 (n=55) 25 (n=50) 1.00 
Number of participants who currently 
smoke 
4 (n=56) 2 (n=51) ** 
Number of participants who currently 
drink alcohol 
39 (n=53) 34 (n=50) .684 
** Since 1or more cells had an expected count less than 5 these Chi-square tests were violated and values are not 
provided. 
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 4.6.7 Baseline Outcomes for each group. 
The baseline outcomes for the two groups of the trial are summarised in the table below.  The 
two trial arms appeared relatively similar in terms of baseline outcomes. Once again, the p 
values are included solely as a means of checking that effective randomisation occurred in the 
trial. The tests were not performed to see if the groups were random samples from the same 
population (the null hypothesis) since this was already known. Also, because the groups were 
allocated at random, it was already known that any differences are due to chance variation 
alone. Since none of the p values show significant differences between the groups it is 
assumed that randomisation was successful. 
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Table 12.  Baseline Outcome scores for the Home Visit and the Usual Physiotherapy Groups. 
 
Baseline Outcome scores Home Visit Group 
(no of participants 
providing data) 
Usual Physiotherapy  
(no of participants 
providing data) 
P values 
 t-test for equality of 
means#  OR 
Mann Witney U for 
non parametric§ 
Mean Oxford Knee Score 
Standard deviation 
20.43 (n=55)  
SD 7.20 
19.76 (n=50) 
SD 8.58 
p=.66# 
Mean KOOS symptoms 
subscale 
Standard deviation 
 
Mean KOOS pain 
subscale 
Standard deviation 
 
Mean KOOS ADL 
subscale 
Standard Deviation 
 
Median KOOS sport & 
recreation subscale 
Interquartile range 
 
Median KOOS quality of 
life subscale 
Interquartile range 
41.66 (n=56) 
SD 18.43 
 
 
39.65 (n=56) 
SD 16.81 
 
 
45.51 (n=54) 
SD 14.40 
 
 
12.5 (n=42) 
 
25 
 
21.88 (n =56) 
 
25 
41.29 (n=51) 
SD 22.29 
 
 
38.53 (n=51) 
SD 17.29 
 
 
45.01 (n=48) 
SD 20.57 
 
 
10 (n=33) 
 
37 
 
25.0 (n=50) 
 
31 
p=.36# 
 
 
 
p=.74# 
 
 
 
p=.89# 
 
 
 
p=.78§ 
 
 
 
p=.99§ 
Median leg extensor 
press maximum power 
values /weight in kg for 
operated leg 
Interquartile range 
 
Median leg extensor 
press maximum power 
values /weight in kg for 
non operated leg 
Interquartile range 
.39  (n=49) 
 
 
 
.48 
 
 
.52 (n=51)     
 
 
.66                      
.34 (n=48) 
 
 
 
.57 
 
 
.57 (n=50) 
 
 
.67 
p=.882§ 
 
 
 
 
 
 
p=.449§ 
 
 
  
Median timed walk test 
Interquartile range 
11.73 (n=54) 
5.42 
11.88 (n=51) 
6.04 
p=.974§ 
Median no of completed 
STSs in 30 sec 
Interquartile range 
4.5 (n=55) 
 
5.42 
4 (n=50) p=.846§ 
 
6.04 
NB: OKS scoring 0-48 with 48 being the best outcome. 
KOOS each domain scored 0-100 with 100 being the best outcome 
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4.7 POSTOPERATIVE FOLLOW UP DATA AT THREE, SIX AND 12 
MONTH TIMEPOINTS. 
4.7.1 Assessment of Normality within the Oxford Knee Score primary outcome follow 
up data. 
As for the baseline data, the Oxford Knee Score follow up data underwent descriptive analysis 
(Appendix XV). The table below summarises these findings. The median values show steady 
improvement from baseline to 12 months, although the minimum values show that not 
everyone follows this trend. The next table presents the results from Kolmogorov-Smirnov 
statistical tests at each time point. Whilst a non significant value, indicating normality, was 
obtained for the baseline data the significant values for all subsequent time points indicate the 
data was not normally distributed throughout the follow up period.  
Table 13. Table to describe the data obtained for the primary outcome at all timepoints (n=105). 
 
 Baseline OKS 
(n=105) 
3 months OKS 
(n=93) 
6 months OKS 
(n=86) 
12 months 
OKS 
(n=94) 
Mean (standard 
error) 
20.11 (.767) 32.48 (.898) 35.06 (.982) 36.82 (.919) 
95% confidence 
interval for mean 
18.59 to 21.63 30.69 to 34.26 33.11 to 37.01 34.99 to 
38.64 
5% trimmed 
mean 
19.98 32.85 35.55 37.45 
Median 20 34 36 40 
Standard 
deviation 
7.857 8.656 9.106 8.908 
Minimum 4 9 11 8 
Maximum 41 47 48 48 
Interquartile 
range 
11 13 12 10 
Skewness 
(standard error) 
.145 (.236) -.628 (.25) -.693 (.26) -1.093 (.249) 
Kurtosis 
(standard error) 
-.245 (.467) -.114 (.495) -.011 (.514) .674 (.493) 
NB: OKS scoring 0-48 with 48 being the best outcome. 
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Table 14. Kolmogorov-Smirnov statistical test results for the Oxford Knee Score at all timepoints.  
 
 Kolmogorov-
Smirnov(a) statistic 
Degrees of 
freedom 
Significance 
Baseline .048 105 .200(*) 
3 months .099 93 .025 
6 months .101 86 .030 
12 months .150 94 <.000 
 
*  This is a lower bound of the true significance. 
 
 
4.7.2 Distribution of secondary outcome follow up data.  
The distribution of follow up data was also explored for the secondary outcomes (see 
Appendix XV). No outcome was normally distributed across all timepoints. The  KOOS 
symptoms subscale showed normal distributions at baseline and three months but not at 6 or 
12 months. The KOOS pain and quality of life subscales showed normal distribution at 6 
months but not at three or twelve months. The KOOS ADL subscale showed normal 
distributions at all timepoints except 12 months.  The KOOS sports scale data showed normal 
distributions at 3, 6 and 12 months but not at baseline. The leg extensor press values showed 
normal distribution for 3/12 for not for 12/12. The other outcomes at all other timepoints were 
non normally distributed.  
 
4.7.3 Descriptive analysis of primary and secondary outcome follow up data.  
The table below summarises the descriptive analyses for outcome data for both trial arms at 
all time points; since the data were not normally distributed across all timepoints the medians 
and interquartile ranges are presented in this table (means are included in Appendix XV). In 
addition, for the few timepoints and outcomes where data was normally distributed the means 
and standard deviations have also been presented. 
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Table 15.  Outcome scores for the Home Visit (HV) and the Usual Physiotherapy Care (UPC) Groups at 
baseline, 3, 6, and 12 months. 
 
Outcome 
 
Baseline 
H V                  U PC  
(no of pts) 
3months 
H V             UPC 
(no of pts) 
6 months 
HV             UPC 
(no of pts) 
12 months 
HV            UPC 
(no of pts) 
Median Oxford 
Knee Score  
IQ range 
20  
(n=55) 
10 
19.5 
(n=50) 
12 
33.5 
(n=46) 
13 
34  
(n=47) 
12 
36 
(n=42) 
12 
36 
(n=44) 
13 
40 
(n=46) 
10 
38.5 
(n=48) 
13 
Mean KOOS 
symptoms subscale 
Standard Deviation 
Median  
IQ range 
 
Median KOOS pain 
subscale  
IQ 
 
Mean KOOS ADL 
subscale  
Standard deviation 
Median  
IQ range 
 
 
Median KOOS sport 
 & recreation 
subscale, IQ 
 
Median KOOS 
quality of life 
subscale, IQ 
41.66  
(n=56) 
18.43 
39.29 
21 
 
41.15  
(n=56) 
22 
 
45.51  
(n=54) 
14.398 
45.45 
21 
 
 
12.5  
(n=42) 
25 
 
21.88  
(n=56) 
25 
41.29 
(n=51) 
22.29 
39.29 
36 
 
38.89 
(n=51) 
19 
 
45.01 
(n=48) 
20.572 
43.93 
28 
 
 
10 
(n=33) 
37 
 
25  
(n=50) 
31 
66.07 
(n=46) 
17.90 
67.86 
29 
 
69.1 
(n=46) 
28 
 
70.56 
(n=42) 
16.747 
69.85 
21 
 
 
41.67 
(n=18) 
25 
 
53.13 
(n=46) 
25 
68.34 
(n=47) 
19.01 
71.43 
29 
 
72.22 
(n=47) 
29 
 
73.43 
(n=44) 
18.897 
75 
31 
 
 
31.67 
(n=22) 
57 
 
56.25 
(n=47) 
31 
 
(n=42) 
 
76.79 
21 
 
75 
(n=42) 
25 
 
 
 
(n=41) 
78.13 
26 
 
 
50 
(n=28) 
44 
 
59.38 
(n=42) 
31 
 
(n=44) 
 
71.43 
29 
 
75 
(n=43) 
31 
 
 
 
(n=41) 
72.06 
34 
 
 
35 
(n=30) 
35 
 
59.38 
(n=44) 
41 
 
(n=44) 
 
82.14  
18 
 
80.56 
(n=44) 
36 
 
 
 
(n=41) 
85.29 
21 
 
 
60 
(n=33) 
41 
 
63 
(n=44) 
43 
 
(n=48) 
 
78.79 
31 
 
90.33 
(n=48) 
33 
 
 
 
(n=46) 
89.43 
23 
 
 
50 
(n=25) 
55 
 
62.5 
(n=48) 
42 
Median leg extensor 
press of maximum 
W/kg for operated 
leg 
 IQ 
 
Median leg extensor 
press of maximum 
W/kg for non 
operated leg 
 IQ 
.39 
(n=49) 
.48 
 
 
 
.52 
(n=51) 
.66 
.335 
(n=48) 
.57 
 
 
 
.57 
(n=50) 
.67 
.7 
(n=42) 
.85 
 
 
 
.725 
(n=42) 
.9 
.72 
(n=39) 
.67 
 
 
 
.88 
(n=40) 
.87 
N/A 
 
 
 
 
 
N/A 
 
 
 
 
N/A 
 
 
 
 
 
N/A 
.87 
(n=38) 
.77 
 
 
 
.855 
(n=36) 
.76 
.865 
(n=42) 
1.07 
 
 
 
.83 
(n=43) 
1.03 
Median timed walk 
test in seconds  
IQ 
11.72 
(n=54) 
5.42 
11.88 
(n=51) 
6.04 
9.93 
(n=42) 
2.74 
10.26 
(n=43) 
4.18 
N/A N/A 9.18 
(n=40) 
3.01 
9.09 
(n=43) 
2.37 
Median number of 
completed sit to 
stands in 30 seconds 
IQ 
 4.5 
(n=55) 
 
5 
4 
 (n=50) 
 
6.04 
7  
(n=43) 
 
4 
7 
(n=43) 
 
6 
N/A N/A 7 
(n=41) 
 
8 
8 
(n=43) 
 
6 
NB: OKS scoring 0-48 with 48 being the best outcome. 
KOOS each domain scored 0-100 with 100 being the best outcome 
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4.7.4 Within group comparisons of primary and secondary outcome follow up data.  
Outcome scores within each group were compared between each timepoint. Paired t-tests 
were used for the outcomes comparing normally distributed data and Wilcoxon Signed Ranks 
test for outcomes comparing non normally distributed data.  The results can be seen in the 
table below.  
This table shows that the within group change scores are significantly different at 
baseline and three months, and baseline and twelve months, in both groups for all outcomes. 
The values for both groups look similar.  
At the 3-6 months time points the groups show some differences. The KOOS 
symptom subscale showed a significant value for the home visit group but not for the usual 
care group.  The KOOS ADL and sport and recreation subscales values for each group are 
dissimilar. The Oxford knee score, KOOS pain and KOOS quality of life scores showed non 
significant changes.  
At the 6-12 months timepoints there is a significant difference in Oxford Knee Scores 
for the home visit group but not for the usual physiotherapy group. Both groups show a 
significant difference in scores for the KOOS symptoms. The usual physiotherapy group 
shows significant differences in KOOS pain, functional activities of daily living and sports 
and recreational scores where as the home visit group does not. Neither group shows a 
significant difference for KOOS quality of life scores.  
At the 3-12 months timepoints, for outcomes not collected at 6 months,  both groups 
show significant differences for the leg extensor press scores and the timed walk scores and 
both show non significant differences for the time sit to stand scores. 
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Table 16. Table presenting the comparisons of scores within groups at baseline, 3, 6, and 12/12 timepoints.  
 
Outcome Baseline to 3/12  
P values 
Paired t-test #  OR 
Wilcoxon Signed Rank§ 
 
Home                   Usual   
Visit       Physiotherapy    
 3/12  to 6/12 P values 
Paired t-test #  OR 
Wilcoxon Signed Rank§ 
 
Home                   Usual   
Visit        Physiotherapy   
6/12 to 12/12  P values 
OR 3 to 12/12 p values 
(in italics) 
Paired t-test #  OR 
Wilcoxon Signed Rank§ 
Home                  Usual    
Visit        Physiotherapy   
Baseline to 12/12  
P values 
Wilcoxon Signed Rank§ 
 
 
Home                   Usual   
Visit       Physiotherapy    
Oxford 
Knee Score 
p <.000§            p <.000§      .074§                 .095§ .026§                .080§  p <.000§       p <.000§ 
 
KOOS 
symptoms 
 
KOOS pain 
 
KOOS 
ADL 
 
KOOS 
sport & 
recreation 
 
KOOS QoL 
p <.000#      p <.000# 
 
 
p <.000§       p <.000§ 
 
p <.000#      p <.000# 
 
 
p <.000§       p <.000§ 
 
 
p <.000§       p <.000§ 
.038§                           .457§ 
 
 
.158§                .109§ 
 
.101#                .871# 
 
 
.099#                .828# 
 
 
.471§                         .605§ 
.007§                          .003§ 
 
 
.181§                   .002§ 
 
.074§                 .003§ 
 
 
.123#                        .018# 
 
 
.080§                    .163§ 
p <.000§       p <.000§ 
 
 
p <.000§       p <.000§ 
 
p <.000§       p <.000§ 
 
 
p <.000§       p <.000§ 
 
 
p <.000§       p <.000§ 
LEP op leg p <.000§       p <.000§ 
 
N/A .009§                        .002§ p <.000§       p <.000§ 
 
Timed 
Walk 
.012§                 .004§ N/A .009§                  p<  .000§ p <.000§       p <.000§ 
 
Timed Sit 
to Stand 
.001§                       .001§ .672§                      .154§ .005§                     p< .000§N/A 
 
 
The change scores in means or medians, as appropriate, are provided in the tables below. 
 
Table 17. Table presenting the primary outcome Oxford knee score median change scores within the two 
groups for all time points.  
 
Outcome Baseline and 3/12     
Mean/ median           
change  
(Difference  
between gps) 
Home         Usual 
n=45           n=46 
3/12 and 6/12  
Mean/  median          
change  
(Difference  
between gps) 
Home         Usual 
n=40           n=42 
6/12 and 12/12 
Mean/ median       
change  
(Difference  
between gps) 
Home      Usual  
n=42       n=44 
Baseline and 6/12 
Mean/ median           
change  
(Difference  
between gps) 
Home      Usual 
n=41       n=43 
Baseline and 12/12   
mean/  median 
change  
(Difference             
between gps) 
Home           Usual 
n=46            n=47 
Median 
Oxford  
Knee Score  
 
95% 
Confidence 
Interval * 
lower, upper 
11            14 
(3) 
 
 
 
 
 
8, 14.5       10,16.5    
3              1.5 
(1.5) 
 
 
 
 
 
0, 4             -.5, 4 
2           1 
(1) 
 
 
 
 
 
.5, 4.5      0, 4 
15         16 
(1) 
 
 
 
 
 
12, 18       12, 18.5 
16            17 
(1)  
 
 
 
 
 
14 , 20     13.5, 20 
* for the median 
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Table 18. Table presenting the secondary outcome mean / median change scores within the two groups 
for all time points.  
 
   
Outcome Baseline and 3/12     
Mean/ median           
change  
(Difference  
between gps) 
Home         Usual 
3/12 and 6/12  
Mean/  median          
change  
(Difference  
between gps) 
Home         Usual 
6/12 and 12/12 
Mean/ median           
change  
(Difference  
between gps) 
Home      Usual  
Baseline and 6/12 
Mean/ median           
change  
(Difference  
between gps) 
Home      Usual 
Baseline and 12/12   
mean/  median 
change  (Difference   
between gps) 
Home           Usual 
Mean KOOS 
symptoms 
subscale 
Median  
 
 
Median KOOS 
pain subscale  
 
 
Mean KOOS ADL 
subscale  
 
Median  
 
 
Median KOOS 
sport 
 & recreation 
subscale  
 
Median KOOS 
quality  
of life subscale 
n=46          n=47 
26.4           26.26 
(0.14) 
32               28 
(4) 
 
n=46           n=47 
28               28 
(0) 
 
n=40          n=41 
24.5           29.24 
(4.74) 
25.5           30 
(4.5) 
 
n=17         n=18 
25              20 
(5) 
 
 
n=46         n=46 
31              31 
(0) 
 
 
n=40           n=42 
7                   1.5 
(6) 
 
n=40         n=41 
3.5            3 
(0.5) 
  
 
 
n=35       n=37 
5              0 
(5) 
 
n=14         n=19 
11.5          0 
(11.5) 
 
 
n=40        n=42 
0              0 
(0) 
 
 
n=40       n=44 
3.86        6.86 
(3)   
 
n=40        n=43 
2.94         5.33 
(2.39) 
 
 
 
n=36        n=40 
2.71         6.5 
(3.79) 
 
n=23        n=21 
5              5 
(0) 
 
 
n=40         n=44 
6.13          6 
(.13) 
 
 
n=42          n=44 
36              33.5 
(2.5) 
 
n=42         n=43 
34.5          36 
(1.5)    
 
 
 
n=39         n-39 
31              28 
(3) 
 
n=24         n=23 
43.5           15 
(28.5) 
 
 
n=42         n=42 
32              38 
(6) 
 
 
n=44          n=48 
39.36         35.79 
(3.57) 
 
n=44         n=48 
40.56        46.94 
(6.38) 
 
 
 
n=39        n=43 
33.53        35 
(1.47) 
 
n=26        n=18 
45             27.5 
(17.5) 
 
 
N=44         n=47 
40.63          37 
(3.63) 
Median leg 
extensor press of 
maximum W/kg 
for operated leg 
 
Median leg 
extensor press of 
maximum W/kg 
for non operated 
leg 
n=39         n=38 
.28            .275 
(.005) 
 
 
 
n=41         n=40 
.130          .1900 
(0.06) 
N/A 
 
 
 
 
 
N/A 
N/A 
 
 
 
 
 
N/A 
N/A 
 
 
 
 
 
N/A 
 
 
 
n=36          n=40 
.41              .395 
(.015) 
 
 
 
n=36         n=42 
.205           .195 
(.01) 
 
Median timed 
walk test in 
seconds  
n=42        n=43 
-1.34        -.87 
(.47) 
N/A N/A N/A n=40         n=43 
-1.93         -1.94 
(0.01) 
Median number of 
completed sit to 
stands in 30 
seconds  
n=42         n=43 
2               1 
(1) 
N/A N/A N/A n=41        n=43 
3               2 
(1) 
 
 
 166
For the Oxford Knee Score it can be seen that there is only a one point difference between the 
two groups baseline to 12 months scores. There is a 3 point difference, in favour of the usual 
physiotherapy care group, at the baseline to 3 months period. 
 For the KOOS, there are no large differences between the groups except for the sports 
and recreation subscale. Here there are differences of up 28.5 in favour of the home visit 
physiotherapy group. However, as the table shows, completion of this subscale was low. The 
majority of participants did not complete this subscale at baseline and three months and many 
still found it inappropriate at 6 and 12 months.  The two groups appeared similar for all other 
outcomes at all other time points.  
4.7.5 Between group comparisons of secondary outcome follow up data.  
Outcome scores between each group were compared between each timepoint. Independent 
samples t-tests were used for the outcomes comparing normally distributed data and Mann-
Whitney U tests for outcomes comparing non normally distributed data.  The results can be 
seen in the table below. 
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Table 19. Table presenting the comparisons of scores between groups at baseline, 3, 6, and 12/12 
timepoints.  
 
Outcome 3/12 FOLLOW UP P 
values 
Independent t-test #  OR 
Mann-Whitney U§ 
6/12 FOLLOW UP P values 
Independent t-test #  OR 
Mann-Whitney U§ 
 
12/12 FOLLOW UP P 
values 
Independent t-test #  OR 
Mann-Whitney U§ 
Oxford Knee 
Score 
.288§ .681§ .937§ 
KOOS symptoms 
 
KOOS pain 
 
KOOS ADL 
 
KOOS sport & 
recreation 
 
KOOS QoL 
.549# 
 
.330§ 
 
.330#  
 
.739#  
 
 
.679§ 
.539§ 
 
.334# 
 
.894# 
 
.087# 
 
 
.834# 
.991§ 
 
.271§ 
 
.577§ 
 
.894#  
 
 
.600§ 
LEP op leg .919# N/A .765§ 
Timed Walk .589§ N/A .852§ 
Timed Sit to 
Stand 
.811§ N/A .302§ 
 
As can be observed, there are no significant differences between the groups for any outcome 
at any timepoint. 
 
4.7.6 One-way Repeated Measures Analysis of Variance. 
 
The findings from the repeated measures tests are summarised below in the table and visually 
represented via profile plots in the graphs below. The graphs show the changes over time for 
both groups and show the lines for the two groups generally to be close together with the 
results indicating the variables to be  non significant. The groups on the sports and recreation 
subscale and timed walk test graphs are the farthest apart; the differences in seconds for the 
latter at 3 and 12 months follow up are still small.   
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Table 20. Table to show results from repeated measures tests for all outcomes. 
 
Outcome Mauchly’s 
test of 
sphericity 
Levene’s test 
of equality of 
error variances 
p values 
Box’s test 
of Equality 
of 
Covariance 
Matrices 
Interaction 
Effect 
Wilk’s 
Lambda p 
values 
Main effect 
Wilk’s 
Lambda p 
values 
Between-
subject 
tests 
P values 
Oxford 
Knee Score 
.001 Baseline     .076 
3/12           .494 
6/12           .714 
12/12         .874 
.337 .986 p<.000 0.434 
KOOS 
symptoms 
 
 
KOOS pain 
 
 
 
KOOS ADL 
 
 
 
 
KOOS sport 
& recreation 
 
 
KOOS QoL 
p<.000 
 
 
 
p<.000 
 
 
 
p<.000 
 
 
 
 
.206 
 
 
 
.013 
Baseline     .056 
3/12            .802 
6/12            .137 
12/12          .133 
 
Baseline      .734 
3/12             .361 
6/12             .195 
12/12           .535 
 
Baseline       .054 
3/12              .228 
6/12              .255 
12/12            .283 
 
 
Baseline       .022 
3/12             .004 
6/12             .327 
12/12           .103 
 
Baseline       .793 
3/12              .280 
6/12              .465 
12/12            .503 
 
.128 
 
 
 
.736 
 
 
 
.845 
 
 
 
 
.483 
 
 
 
.444 
.622 
 
 
 
.822 
 
 
 
.490 
 
 
 
 
.221 
 
 
 
.855 
p<.000 
 
 
 
p<.000 
 
 
 
p<.000 
 
 
 
 
p<.000 
 
 
 
p<.000 
.753 
 
 
 
.336 
 
 
 
.713 
 
 
 
 
.614 
 
 
 
.720 
LEP op leg .002 Baseline       .248 
3/12              .861 
12/12            .936 
.710 .8 p<.000 .796 
Timed Walk p<.000 Baseline       .052 
3/12             .098 
12/12           .032 
p<.000 .545 .002 .256 
Timed Sit to 
Stand 
.025 Baseline       .433 
3/12              .139 
12/12            .712 
.231 .438 p<.000 .510 
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Figure 16. SPSS graph to show the one-way repeated measures analysis of variance for the Oxford Knee 
Score across all timepoints for both groups.  
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Figure 17. SPSS graph to show the one-way repeated measures analysis of variance for the KOOS 
Symptoms subscale across all timepoints for both groups.  
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Figure 18. SPSS graph to show the one-way repeated measures analysis of variance for the KOOS Pain 
subscale across all timepoints for both groups. 
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Figure 19. SPSS graph to show the one-way repeated measures analysis of variance for the KOOS ADL 
subscale across all timepoints for both groups. 
 
 171
 
 
 
4321
sportrec
70
60
50
40
30
20
10
Es
tim
at
ed
 M
ar
gi
na
l M
ea
ns
usual care
treatment
RANDOMISAT_1
Estimated Marginal Means of MEASURE_1
 
 
Figure 20. SPSS graph to show the one-way repeated measures analysis of variance for the KOOS Sports 
and Recreation subscale across all timepoints for both groups. 
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Figure 21. SPSS graph to show the one-way repeated measures analysis of variance for the KOOS Quality 
of Life subscale across all timepoints for both groups. 
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Figure 22. Graph to show the one-way repeated measures analysis of variance for the Leg Extensor Press 
(operated leg) subscale across baseline, 3 and 12 month timepoints for both groups. 
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Figure 23. Graph to show the one-way repeated measures analysis of variance for the Timed Walk test 
across across baseline, 3 and 12 month  timepoints for both groups. 
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Figure 24. Graph to show the one-way repeated measures analysis of variance for the Timed Walk test 
across across baseline, 3 and 12 month  timepoints for both groups. 
 
 
Mauchly’s tests for sphericity were significant for all outcomes bar the KOOS sports and 
recreation subscale. For significant results it is assumed that there are significant differences 
between the variances of differences and thus the subsequent F-ratios produced become 
dubious (Field, 2000 p.323-6). Although violations can be compensated it is considered more 
sound to inspect the multivariate statistics instead, as follows (Pallant, 2007 p.272).  
Levene’s test of equality of error variances were checked to see if the assumption of 
homogeneity of variances were violated (Pallant, 2007 p.272). No outcomes had significant 
values for all timepoints and most were non significant across all timepoints. It is concluded 
that this assumption has not been violated. 
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Box’s test of equality of covariance matrices then tested the null hypothesis that the 
observed covariance matrices of the dependent variables are equal across groups (Pallant, 
2007 p.272). All results were not significant bar timed walk where this assumption is violated.  
The one-way repeated measures analyses of variance showed that there were no 
significant interactions between group type and timepoint.  Interaction effects were non 
statistically significant throughout. There were however significant effects for time across 
both groups and for all outcomes. All tests of between-subject effects were non significant so 
it is concluded that the main effect for group is not significant. The lack of sphericity however 
lessens the dependability of these results. 
 
4.7.7 Range of Knee Joint Motion. 
The data regarding knee joint range of motion is summarised below. As can be seen the 
groups appear similar at each timepoint except that the home visit group have slightly more 
flexion than the usual care group. 
 
Table 21. Table to show average knee joint range of motion in degrees for operated leg at baseline, 3 and 
12 months timepoints 
 
Group Baseline  
Extension        
Flexion 
 
3 Months 
Extension          
Flexion 
 
12 Months  
Extension          
Flexion 
 
Home Visit 
Physiotherapy  
 
FFD 9.3           105.3 FFD 6.39            105 lacks 3.83           108.4 
Usual 
Physiotherapy 
 
FFD 9.9           105.4 FFD 6.1             102.9 lacks 4.64           107.6 
FFD = fixed flexion deformity (i.e. >5 degrees lack). 
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4.7.8 THE PHYSIOTHERAPY INTERVENTION. 
Every visit to trial participants receiving the trial intervention was recorded on a case report 
form (Appendix XIII). 49 participants received visit one and 48 received visit two (the 
remaining participant withdrew from the trial before visit two stating she was doing very well 
and did not need any further treatment).  The content and estimated times (in minutes) spent 
on each treatment component were detailed. The tables below present the summarised data for 
each of the two trial visits. Apart from the duration of visit one, the rest of the data were not 
normally distributed (see Appendix XV) so the medians are presented rather than the means. 
The most time intensive component was the general subjective and objective assessment of 
patients and progression of walking aids. The median times spent on the specific components 
of the intervention were 10-11 minutes in visit one and 8-13 minutes in visit two. The 
individualised components of treatment, linked to activity restrictions and participation 
restrictions were generally included in the task specific training summary time since they 
included practicing/altering activities. Examples of such activities include using public 
transport, cleaning rayburns and getting in and out of armoured vehicles.   
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Table 22. Summary of the content and time (in minutes) of the home visit treatments provided in the trial 
intervention.  
 
Content Visit One: within 2/52 of 
discharge 
                      no of participants 
                          with data 
Visit Two: 6-8 weeks after 
discharge 
                   no of participants 
                       with data 
Duration of Visit 
Median (Interquartile range) 
Range 
 
45 (15)             n=49 
25-70 
 
40 (31)            n=46 
20-79                         
General (subjective and 
objective reassessment) 
Median (Interquartile range) 
Range 
 
 
19 (12)             n=49 
9-42 
 
 
14 (14)            n=47 
6-40 
Exercises (Teaching, checking, 
progressing) 
Median (Interquartile range) 
Range 
 
 
10 (7)               n=49 
5-22 
 
 
8 (4)               n=47 
(4-18) 
Task Specific Training 
(car, rising from chair,walking 
outside, stairs) 
Median (Interquartile range) 
Range 
 
 
 
11 (5)               n=49 
2-23 
 
 
 
13 (7)             n=47 
5-30 
Manual Therapy  
Median (Interquartile range) 
Range 
 
0 (5)                 n=49 
(0-9) 
 
0 (0)               n=47 
0-7 
Other (eg. rest, listening) 
Median (Interquartile range) 
Range 
 
 
2 (5)                (n=49) 
0-18 
 
 
1 (5)            n=48 
0-23 
   
The two physiotherapists who carried out the home visits also listed key concerns 
raised by patients during home visits and these are summarised in the table below. Thirty five 
participants raised concerns during their first home visit and 28 during visit two. The main 
concerns in visit one were complications or issues relating to the knee operation (19/66 or 
29%), rate of recovery (14/66 or 21%) and range of knee joint motion (10/66 or 15%). By 
visit two these concerns were expressed less frequently and the most frequent concern had 
shifted to returning to activities of daily living (12/39 or 31%). 
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Table 23. Summary of the concerns raised by participants and recorded by physiotherapists during the 
home visit treatments provided in the trial intervention.  
 
Concern Visit One: within 2/52 of 
discharge 
(no of participants raising 
concern) 
Visit Two: 6-8 weeks after 
discharge 
(no of participants raising 
concern) 
Complications: swelling n=6 numbness n=1 
DVT n=1 
calf muscle soreness n=1 
open wound n=4 
itchiness n=1 
cellulitis n=1 
bruising n=2 
stiffness n=1 
redness n=1 
swelling n=1 
stiffness n=1 
scar tissue n=1 
heat in knee n=1 
open wound n=1 
calf pain n=1 
depression n=1 
 
2  Fatigue 
3 4 Pain and aching 
10 5 Range of knee joint motion 
Knee instability  1 
Rate of recovery overall rate of recovery n=8 how much weight bearing n=2 
walking aid progression n=3 
overdoing it n=1 
1 
 
1 
Lack of Confidence in knee 3 1 
Activities  
 
return to driving n=1 
stairs n=1 
shower n = 1 
flying n=1 
using bus n=1 
kneeling n=1 
return to work n=1 
return to driving n=1 
cycling n=1 
swimming n=1 
bath transfers n=1  
kneeling n=7 
return to work n=1 
1 1 Poor balance and fear of 
falling 
Question regarding operative 
procedure 
2  
Co-morbidities other knee n=1 
shoulder pain n=1 
lymphoedema n=1 
other mobility problems n=1 
other knee pain n=1 
other joint pain n=1 
varicose veins n=1 
law back pain since op n=1 
Medication query 1  
Awaiting hospital follow up  2 
Total number of concerns 66 39 
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4.7.9 ADDITIONAL PHYSIOTHERAPY PROVIDED TO PARTICIPANTS 
DURING THE TRIAL. 
 
The patient resource diaries requested information regarding all non trial physiotherapy 
contacts from participants because of the impact this could have upon trial results. This 
information is summarised in the table and histograms below. More physiotherapy contacts 
(n=119) were recorded by the usual physiotherapy care group than in the home visit treatment 
group (n=93).  The majority of visits (157 or 74.06%) occurred in the first three months, with 
29 (13.68%) in 3-6 months and 26 (12.26%) for 6-12 months post operatively. 
 
Table 24. Table to show the total number of non trial physiotherapy visits occurring between discharge 
from hospital after their knee replacement and one year follow up. 
 
 Home visit group (n=144 diaries) Usual physiotherapy group (n=147 
diaries) 
No of visits (no and % of diaries) 
No of visits in group (no and % of 
diaries) 
73 visits (n=26; 18.06%) 76 (n=25; 17.01%) Number of hospital outpatient visits  
13 visits (n=2; 1.39%) 15 (n=6; 4.08%) Number of general practice visits 
1 (n=1; 0.69%) 0 Number of home visits  
6 (n=2; 1.39%) 5 (n=2; 1.36%) Number of private health care visits 
 9 (n=1; 0.68%) Number of visits during nursing 
home care 
 7 full days* (n=1; 0.68) Police intensive rehabilitation 
programme 
Total number of physiotherapy 
contacts 
93 119  
A conservative estimate of two sessions a day has been used in the calculation of the total number of 
physiotherapy contacts. 
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Figure 25.  Histogram showing the number of outpatient physiotherapy visits for the home visit 
physiotherapy group. 
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Figure 26.  Histogram showing the number of outpatient physiotherapy visits for the usual physiotherapy 
group. 
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It became apparent that participants were recording their research trial and follow up 
visits. All trial visit dates were checked against the diary data allowing these visits to be 
removed prior to analysis. Five participants wrote that some of their outpatient hospital 
appointments were for hydrotherapy. Hydrotherapy visits ranged from 1-6 and totalled 16 in 
total; all five participants were in the usual physiotherapy group. It also became apparent that 
at least three of the hospital outpatient physiotherapy appointments recorded by participants 
(intervention n=1 and usual physiotherapy n= 2) were for the orthopaedic outpatient discharge 
clinic rather than for physiotherapy treatment.  
 
4.7.10 SAMPLE SIZE. 
As so little information regarding sample size previously existed Altman’s nomogram to 
calculate sample size or study power was used to estimate the power of this study and to 
produce a power calculation for future work from the data this trial produced (Altman, 1991 
p. 456-457). 
4.7.10.1 Power.  
For a clinical difference of 2.5 points between groups on the Oxford knee score the 
standardised difference is as follows: 
2.5 divided by 1 standard deviation = 2.5 divided by 7.857 
     = 0.318 
For a trial size of 100, the nomogram estimates the power of the present study to be 35%. 
4.7.10.2 Sample Size. 
For a standardised difference of 0.318, 90% power and a significance level of 0.05 a sample 
size of 400, or 200 in each treatment arm, would be required. 
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4.8 DISCUSSION.   
4.8.1 SECTION OVERVIEW.  
This chapter contains the discussion of the methodology and findings of the trial comparing 
post discharge physiotherapy versus usual care following primary total knee arthroplasty for 
osteoarthritis. The chapter begins with a summary of the main findings of the trial. It then 
provides a discussion of the strengths and limitations of the trial’s procedures followed by a 
discussion of how this trial compares to previous trials. Following this the clinical 
implications of the study and directions for future research are presented.  
 
4.8.2 SUMMARY OF MAIN FINDINGS. 
The alternate hypotheses for the trial, that participants receiving two home physiotherapy 
visits after discharge from hospital would show greater improvement in outcomes than those 
participants were receiving usual physiotherapy, were rejected. The null hypotheses, that there 
would be no statistical differences in outcomes between the two groups, were accepted.  
4.8.2.1 Between group differences. 
There were no significant differences observed between the home visit physiotherapy group 
and the usual physiotherapy group for any outcome at any time point in this phase II trial. 
However, as will be discussed, the trial was under powered which, when considering the 
small treatment effect size expected from an intervention like physiotherapy, may have meant 
the trial was too small to have picked up any treatment effect which might have existed. In 
addition, important factors such as the development of major co-morbidities and further lower 
limb surgery during the trial, were seen to affect the home visit physiotherapy group more 
than the usual physiotherapy group which could have obscured group differences in this trial.   
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4.8.2.2 Within group differences. 
The baseline to three months scores within group scores are significantly different for 
all outcomes in both groups. The values for both groups appear similar.   
At the 3-6 months time points the KOOS symptom subscale showed a significant 
difference within the home visit group but not within the usual care group.  The KOOS ADL 
and sport and recreation subscales values for each group also appeared dissimilar.  
At the 6-12 months time points there was a significant difference in Oxford knee 
scores within the home visit group but not within the usual physiotherapy group. Both groups 
showed a significant difference in scores for the KOOS symptoms. The usual physiotherapy 
group shows significant differences in KOOS pain, functional activities of daily living and 
sports and recreational scores whereas the home visit group did not.  
At the 3-12 months time points, for outcomes not collected at 6 months,  both groups 
showed significant differences for the Leg extensor press scores and the timed walk scores 
and both showed non significant differences for the time sit to stand scores. 
4.8.2.3 Repeated measures.  
The one-way repeated measures analyses of variance showed that there were no 
significant interactions between group type and timepoint.  Interaction effects were non 
statistically significant throughout. There were however significant effects for time across 
both groups and for all outcomes. All tests of between-subject effects were non significant so 
it is concluded that the main effect for group is not significant. The lack of sphericity however 
lessens the dependability of these results. 
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4.8.3  STRENGTHS AND LIMITATIONS OF THIS RESEARCH. 
4.8.3.1 Trial procedures. 
The rigorous and comprehensive trial procedures used in this trial are believed to have added 
to its quality, allowing a high standard of reporting. The provision of additional procedures 
and information regarding issues influencing the internal validity of the trial, which are often 
left unreported in the space restrictions of trial reports, enable the trial to be placed into 
context more meaningfully than any previously published similar physiotherapy after  knee 
joint arthroplasty trial. These procedures will now be discussed.  
 
4.8.3.2 Randomisation and allocation concealment.  
As can be seen from the results, the two trial arms appeared relatively similar in terms of their 
baseline characteristics. The randomisation processes used in the trial therefore appeared 
successful. However, as will be seen in the complications section below, this did not mean 
that the groups remained similar after randomisation. Important differences,  believed to be 
unrelated to the intervention, did subsequently arise between the two groups.   
The mean ages and standard deviations of the two groups reflect the most common 
age groups undergoing total knee arthroplasty according to the National Joint Registry 4th and 
5th Annual Reports. Whilst age affects likelihood of revision, with younger patients being 
more likely to undergo revision, the existing evidence does not suggest that age affects 
functional outcome (Santaguida  et al.,  2008; Dinah and Mears, 2008).  
The functional co-morbidity mean at baseline appears low especially when, by the 
nature of their having osteoarthritis, all participants had to score at least one (Groll  et al., 
2005). A greater number of comorbid conditions is associated with worse short-term pain 
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relief and poorer functional outcome post operatively (Jones  et al.,  2007).  Solomon  et al., 
(2006) report that 36.7% of patients in their study have at least  one co-morbid condition, less 
than the current trial, although comorbidity is defined differently using an index for use with 
ICD codes.  Roos and Toksvig-Larsen (2003) report an average similar to this trial of 1.3 co-
morbid conditions amongst their total knee arthroplastry sample.  The mean BMI scores at 
baseline were in the obese category for the home visit group and close to the obese category 
for the usual physiotherapy group. Since obesity is known to be a significant risk factor for 
osteoarthritis these means are considered usual for this patient group, and are even slightly 
lower than the mean of 32.6 in patients underoing primary total knee joint arthroplasty found 
in a recent retrospective review  by Fehring et al. (Hunter and Felson, 2006; Fehring  et al., 
2007).   
Few participants in this trial reported they smoked (n=6) therefore smoking, known to 
influence outcome and complication rates following lower limb arthroplasty (Cowie  et al.,  
2009; Møller  et al.,  2002) , was unlikely to have impacted upon the findings of this trial. 
Less than 10% of participants had diabetes mellitus, a condition increasing the risk of 
complications such as stroke and pneumonia (Bolognesi  et al., 2008). The number of patients 
reporting a cardiac history was higher at 28.6%. No attempt was made to confirm more 
precise diagnoses, so this figure may be an overestimate. Cardiac problems are a risk factor 
for cardiovascular complications following joint arthroplasty (Basilico  et al., 2008) but, as 
will be seen in the complications section below, there were no significant differences between 
the groups with regard to cardiac complications.  
The knee joint ranges of motion for the operated leg were similar for both groups. 
Both groups reduced their average fixed flexion deformities from 9-10 degrees at baseline to 
3.8-4.6 degrees at twelve months post operatively. This range still exceeds the normal range 
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of knee extension, extension limitations of two degrees are considered normal for adults, and 
is close to five degrees which is the range at which limitations in extension become a fixed 
flexion contracture (Norkin and White, 2003 p.224). Knee flexion increases slightly from 105 
at baseline to 107-108 at twelve months. This is slightly above the 105 degrees of optimal 
range of knee flexion postoperatively (Jones  et al.,  2007).  
There were no instances of participants knowing their allocation, or thus being able to 
reveal this to the physiotherapist undertaking the baseline assessment, prior to the baseline 
assessment being completed.  All allocation envelopes were used in their correct sequence. 
Allocation concealment from assessing physiotherapists and participants was therefore 
maintained until after the baseline assessment as intended. Although the participants then 
needed to be aware of their group allocation a high level of outcome assessment blinding was 
recorded for the trial; this is the subject of the next chapter and will be discussed in depth 
there.  
 
4.8.3.3 Sample size. 
The results show the trial to be underpowered. Altman’s nomogram to calculate sample size 
(Altman, p. 456-7) estimates that a sample size of 400, 200 in each treatment arm, would be 
required to achieve a study with 90% power. The current trial suggests that this number would 
really need to be substantially greater. To allow for attrition and drop out, to allow for those 
participants who receive a uni compartmental arthroplasty rather than a total and to allow for 
participants subsequently deciding to have a second arthroplasty within the follow up period 
the sample size would need to be increased by at least 20%, or an additional 40 participants in 
each arm.  
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4.8.3.4 Complications rates.  
There is a general lack of data regarding postoperative complications following total knee 
joint arthroplasty in the UK. This trial provides self report data from trial participants 
regarding major and minor complications. Major complications occurring within the first 
three months were then checked against patients’ medical notes.   The trial is therefore able to 
report more fully regarding complications than any previous physiotherapy trial following 
knee joint replacement. Before commenting upon the complication rates from this trial, I 
would like to mention several reflections regarding complication rate measurement which this 
trial raised. It became apparent that patients report what they perceive to be important to them 
and their recovery. Many of their concerns were also repeated/reflected in the concerns raised 
by participants during treatments and listed in the case report treatment forms. Such 
perceptions may and did vary from medical opinions. Many of the medically considered 
“minor” complications were given great import by patients. The opposite was also seen when 
one participant did not mention a medically considered important deep vein thrombosis.  
 There was no one accurate source of post operative complications in this trial. The 
hospital notes often did not include serious complications developed by patients. For example 
two out of three patients reporting the development of pressure sores did not have this 
mentioned in their hospital notes; supporting evidence for the existence of these sores was 
obtained via the resource diaries listing multiple district nurse visits for pressure sore 
dressing. Also, complications arising in primary care after discharge did not always get 
recorded in medical notes and it may be that surgeons remain unaware of them.  
So the question of what complications to measure, and how to measure complication 
rates thus becomes very interesting. Should we be measuring and reporting the wide range of 
complications patients believe to be relevant to their recovery or should we measure the post 
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surgical complications surgeons are interested in? Surely there is need for both? Where is the 
best source of information to be found? Should we examine primary care records as well as 
hospital ones?  
Within this small trial the complication rates for those complications for which 
existing data is available were generally high. This is despite studies suggesting that patients 
managed at specialist orthopaedic hospitals by surgeons with high arthroplasty caseloads have 
lower risks of perioperative adverse events (Katz  et al.,  2004; Katz  et al.,  2008). The 
revision rates within one year of surgery for England and Wales (National Joint Registry 5th 
Annual Report) is 0.3%. In this trial the revision rate was 2.1% (n=2/93). This may be high 
due to the one participant obtaining an intra-operative fracture and requiring revision. Such 
fractures are rare; there were only 102 in 2007 in England and Wales out of 61,389 patients 
on the joint registry. The increase in complication rates may be by chance, or may be partially 
be explained by the fact that even so called straightforward knee joint arthroplasties occurring 
at a specialist orthopaedic centre may transpire to be more problematic referrals than the 
national norm. 
 Not all complication rates were above average. The National Joint Registry 5th Annual 
Report reports a 0.5% mortality rate at three months post operation. In this trial no patients 
died within the first three months. The 4th Annual Report reports the mortality rates within 
one year of surgery for England and Wales to be 1.6%. For this trial the mortality rate was 
1.03% (n=1/97) for this time period.  
 Although a recent review examining post operative complications in the over 70s age 
group concludes there is a lack of research available (Dinah and Mears, 2008) there is some 
additional information regarding complication rates from outside the UK, mainly from the 
US. Parvazi  et al., (2007) report a 0.37% rate of stroke following knee and hip replacement 
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during hospitalisation and the first 6 weeks post discharge;  in the current small trial the rate 
was much higher (3.3% in the first three months and then 2.17% until one year) although both 
stroke and transischaemic attacks were included in the current trial. 
 Previously reported superficial wound infection rates range from 0.26% in the first 
three months (Peersman  et al.,  2001) to 10.5% post knee replacement (Gaine  et al., 2000). 
The Scottish authors of the latter study say their higher figure is due to their encompassing 
grading system. The current trial rate is even higher at 16.3%; these figures are self report 
figures rather than healthcare records and may also be raised by antibiotics being used 
prophylatically, when a superficial infection is suspected, rather than following confirmed 
bacterial growth. For deep infections, Solomon  et al., (2006) report a 0.3% rate in the first 90 
days and a 0.89% rate in the first year has just been reported for Finland (Jämsen  et al., 2009) 
; the lack of agreement between patient self-report and the medical notes make it hard to 
calculate a rate for the current trial. Soohoo  et al.,  (2006) report an infection rate of 0.71% 
although the level of infection is not clear. 
For pulmonary emboli Solomon  et al., (2006) report a 0.9% rate in the first 90 days 
post operation,  similar to the current trial value of 1.1%. Soohoo  et al., (2006) report a lower 
0.43% for the same time period.   
Solomon  et al.,  (2006) provide an  adverse event rate for the first 90 days post 
operation (including pulmonary emboli, myocardial infarction, pneumonia, deep wound 
infection and death) as 3.6%. A similar adverse event rate for the current trial is hard to 
calculate, for example the chest infections may not have been tested for pneumonia, but 
would be somewhere between 2.09-7.26%. However, the narrowness of complications 
included in the rate reported by Solomon  et al., for example excluding stroke, can not be 
forgotten.  
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4.8.3.5 Retention/follow up.   
As reported in the CONSORT flow diagram there was little loss to follow up in the trial. In 
the usual care group there was no loss to follow up at one year. The primary outcome was 
collected for 48/49 participants who underwent surgery (one participant died). In the home 
visit the primary outcome was collected for 47/49 participants who underwent surgery (one 
withdrawal and an Oxford knee score could not be calculated for one person who did not 
answer sufficient items). It has been shown previously that loss to follow up does matter for 
joint arthroplasty patients at this hospital Trust; over time patients lost to follow up have a 
worse outcome than those who continue to be assessed (Murray et al., 1997). Reluctance to 
attend for follow up cannot be underestimated; loss to follow up at 12 months in one previous 
physiotherapy feasibility trial was nearly 50% (Frost  et al., 2002). 
 However, one striking follow up finding was that more patients would have been lost 
to the trial if the primary outcome measure had not been the self report Oxford knee score. As 
can be seen from the lower numbers of participants for whom secondary outcomes were 
obtained at one year, participants were less willing to attend for face-to-face follow up at the 
hospital and some postal and telephone follow up assessments were required to prevent 
withdrawals from the trial. Interestingly, as stated in the results, many patients stated 
reluctance to travel as their main reason for non participation in the trial. Preventing travel for 
follow up assessments may well prove to be a successful strategy in the recruitment and 
retention of patients therefore: the need for such strategies is recognised (Frost  et al.,  2002). 
 
4.8.3.6 The Intervention.   
As stated in Chapter four, trials can be criticised as being too pragmatic if the interventions 
are described as being totally at the discretion of the health professional and if no clear 
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definitions of the interventions are provided (Koes and Hoving, 1998). Without standardising 
or defining the interventions precisely then the generalisability of the results of a trial cannot 
be adequately assessed. Adherence to the trial protocol is a further issue. If both the content 
and consistency in delivery of the intervention is lacking then the internal validity of the trial 
may be undermined (Mullis  et al., 2006). This trial is one of the few physiotherapy trials to 
use case report forms. In these forms the two physiotherapists providing the intervention 
estimated the treatment time spent upon each component of the intervention for each patient 
in each home visit. I assisted in the development of such case report forms for use in a 
previous trial where they were validated against video analyses of treatment and found to 
have moderate to very good agreement; kappas=0.45-0.82 (Mullis  et al., 2006). A slight 
tendency whereby the time spent on content in the case report forms was underestimated 
compared to the video analyses was observed. In the current trial the case reports showed that 
all trial participants received the intervention. An estimated average time of 11 minutes was 
spent on task specific training in visit one and 13 minutes in visit two. An estimated average 
of 10 minutes was spent on functional exercises in Visit one and 8 minutes in visit two. If 
similar to the previous trial, these times may also be slight underestimates. One explanation 
for the lack of difference found between the two groups may be dosage. The time spent on the 
intervention may have been insufficient to affect outcome during the follow up time period. 
 A further issue thought likely to influence the internal validity of the trial was 
regarding any additional physiotherapy trial participants might received during the trial. 
Patients were therefore asked to list the number and location of any additional physiotherapy 
they received in a resource diary. Again, this is one of few trials to try and measure this aspect 
of the trial. Nearly a fifth of participants did receive additional physiotherapy with a total of 
212 visits being recorded. However, it became apparent whilst data entering that patients 
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were, against instructions, also listing their trial follow up research visits. These were 
removed before analysis. Since it is possible, however, that some people attended out patient 
physiotherapy on the same day they attended their trial follow up assessments this may have 
lead to an underestimate of physiotherapy treatments. It also became apparent that at least 
three of the hospital outpatient physiotherapy appointments recorded by participants 
(intervention n=1 and usual physiotherapy n= 2) were for the orthopaedic outpatient discharge 
clinic rather than for physiotherapy treatment and it is likely that this number is an 
underestimate. It is therefore not known precisely how many of the outpatient appointments 
were routine follow up checks and how many were specific physiotherapy treatments. 
Also, the diaries only collected the number of physiotherapy visits and it would be 
interesting to know the content of such visits. For example none of the home visit group 
mentioned receiving hydrotherapy, unlike the usual physiotherapy group. The format of the 
resource diary therefore requires amendment before future use to improve the accuracy and 
usefulness of the data captured.  
 
 
4.8.4 Use of Outcome Measures. 
4.8.4.1 Oxford Knee Score. 
The Oxford knee score was found, as Dunbar et al., (2001) have found previously, to be easy 
for patients to complete. This ease of completion was reflected by the completeness of data 
for this outcome: as can be seen in the CONSORT flow diagram very little missing data 
occurred in this trial for this outcome with response rates higher than the 85.9 -90%  
previously seen (Dunbar  et al.,   2001; Robertsson and Dunbar, 2001; Whitehouse  et al.,   
2005).   The preoperative mean for the current trial,  of 20.11 (SD 7.857),  and mean at one 
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year follow up (36.82, SD 8.908) are slightly better than those cited  by Murray  et al.,  (2007) 
of 18 pre operatively (SD 7.5) and 34.2 (SD 10) at one year.  
One theoretical concern regarding the Oxford knee score was whether a short 12 item 
score designed to measure outcome post arthroplasty would be sufficiently sensitive to 
measure the effects of physiotherapy.  In previous knee joint arthroplasty trials (Frost et al., 
2002; Mockford and Beverland, 2008) no between group differences have been found using 
the Oxford knee score. However, its sister score, the Oxford hip score, has been used 
successfully to demonstrate between group differences in a previous physiotherapy trial 
(Trudelle-Jackson and Smith, 2004) and lack of sensitivity was not anticipated to be a serious 
problem for the trial. The far more detailed KOOS was included in the trial to provide more 
detailed examination of the domains of pain, symptoms and function and to supplement the 
Oxford knee score if required. Since both the detailed KOOS and the Oxford knee score 
showed no significant differences between groups at all time points it is believed that lack of 
sensitivity within the Oxford knee score did not adversely effect the findings of this trial.  
 During the time of this study several of the known issues with the Oxford knee score 
lead to a slight revision of the score.  The wording of item 4 (walking) and item 7 (kneeling) 
had been criticised as being ambiguous (item 4) and inappropriate (item 7) (Whitehouse  et 
al.,   2005). Susequently the score was slightly revised in response (Murray  et al.,   2007).  
Item 4 now clarifies the “not at all” response by adding “pain severe when walking” to 
prevent patients from inferring the opposite meaning intended (of no pain). For items, such as 
item 7 (could you kneel), the word “could” is now in bold print to alert patients who have 
been told not to kneel that they need to fill this in hypothetically (Murray  et al.,   2007). 
Although not believed to have significantly affected the study findings, it is accepted that the 
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use of the original score  may have created some difficulties for patients when completing the 
score.  
 During the time of this study the score developers also published a recommendation 
that the minimum number of patients required in trials using the Score as the primary outcome 
should be at least 100 and usually many more (Murray  et al.,  2007).  The score developers 
aim to produce MCID estimates (minimal clinically important difference estimates, i.e. the 
smallest change in scores which patients perceive, and clinicians use, as a meaningful change) 
but suspect that such differences may be lower than 3 points on the Oxford knee score. 
Another indication, as subsequently shown, that the current trial is underpowered.   
 A further development since this study took place has been the publication of new 
research measures designed, unlike the Oxford knee score, to reflect all three of the main ICF 
components of impairment, activity limitation and participation restriction (Pollard  et al.,  
2009). Had measures like these been available at the time the trial took place it is believed 
these would have been, with the new osteoarthritis pain measure already mentioned (Hawker  
et al., 2008), more appropriate outcomes for this trial. Research since the trial started has 
shown that the Oxford knee score mainly measures impairment and does not measure 
participation restriction (Pollard  et al.,  2006). As participation restriction was included in the 
trial it is acknowledged that the Oxford knee score’s inability to measure this means the score 
is less likely to have shown an intervention treatment effect in this trial.   
One final point about the Oxford knee score data is that a normal distribution of data 
was seen at baseline. A similar finding, using the WOMAC score rather than the Oxford hip 
score, has recently been observed for patients awaiting total hip replacement (Dieppe  et al., 
2009). This normal distribution suggests that many patients reported mild functional disability 
before having their knee replaced, even though, as in the Dieppe  et al.,  study,  their X-ray 
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findings showed severe radiological changes. Dieppe  et al.,  thus comment upon the 
complexity involved in decision making regarding arthroplasty and when to perform surgery; 
likely to also include factors such as social circumstances, psychological status and 
motivation.  
4.8.4.2 KOOS. 
Subjectively it was noted that many participants balked and verbally commented regarding 
the length of the KOOS. Despite this the score was generally well completed except for the 
sports and recreation subscale which less than half the participants completed at most time 
timepoints. Participants said that the questions were inappropriate. These missing data rates 
initially appear hugely in excess of the 3.2% of total knee arthroplasty participants claimed by 
the scores developers (Roos and Lohmander, 2003). On closer examination however the 
reported 3.2 % missing data rate excludes the sports and recreation subscale and relates only 
to the remaining four subscales. As in this study, sports and recreation subscores could not be 
calculated for over half the participants (n= 58/105) used (Roos and Toksvig-Larsen, 2003). 
The authors argued that whilst irrelevant to many, the sports and recreation subscale remains 
useful by evaluating functions considered important to every second patient undergoing 
arthroplasty. In the current trial this subscale did show some interesting within group 
differences, for example there was a significant difference for the usual physiotherapy group 
at 6-12 months but not for the home physiotherapy group, but with so much missing data the 
group sizes become small.   
 The baseline KOOS and change subscale scores for the current trial and the only 
earlier knee joint arthroplasty trial reporting the KOOS (Roos and Toksvig-Larsen, 2003) 
were examined.  Differences in means between the two trials varied by around 1-7 except for 
the sports and recreation subscale means at twelve months where the current trial’s mean was 
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56.98 (Appendix XV) and was 46 in the trial by Roos and Toksvig-Larsen (2003). It has been 
suggested that 8-10 points represent minimal perceptible clinical improvement for KOOS 
subscales (Roos and Lohmander, 2003). The 10 point difference in means from the two 
different trials is therefore interesting; once again however, whether patients in the current 
trial did improve more in this aspect is difficult to ascertain given the amount of missing data 
and underpowering of both trials.  For similar reasons it is difficult to judge whether the value 
of using the more detailed KOOS in physiotherapy trials, in addition to using the quick 
Oxford knee score, outweighs the time taken for its completion.   
4.8.4.3 Leg Extensor Press. 
The results show that not all participants were able or willing to undergo leg extensor press 
measurement. Pain was the predominant reason for being unable to do the test. The outcome 
assessment physiotherapists also noted that some participants appeared/stated they were afraid 
of the test despite verbal reassurance and the warm up test practices.  
When compared against the results of the Allied Dunbar National Fitness Survey 
(1990) the trial results for the operated leg (ranging from median values .52 to .88 W/kg) 
show that the participants are well below the average values for the corresponding 65-74 age 
group (Activity and Health Research Limited, 1990 p. 81). The Allied Dunbar averages were 
approximately 3 W/kg for men and 1.9 for women, with 2 W/kg being the power necessary 
cited to climb stairs without assistance. Most trial participants provided values  below this  
2W/kg limit and the results reflect the difference in power and function between total knee 
joint arthroplasty patients and their non-arthroplasty peers.  
 Leg extensor press values following knee arthroplasty have been presented by Lamb 
and Frost (2003) (n=79). A preoperative mean for the operated side of 62 watts and 3/12 
postoperative mean of 71 watts were obtained. These correspond with a preoperative mean of 
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46.6 watts and 3/12 mean of 69.5 watts for the current trial; the pre operative means were 
therefore lower whilst the 3/12 means were similar.   
One limitation of the test was caused by the test procedure. The seat position was 
standardised for each patient. However, the post operative power values from patients with 
significant pre operative fixed flexion deformities (usually lessened during surgery) appeared 
adversely impacted upon by using this preoperative seat position.  
The main disadvantage of using the leg extensor press however was its lack of 
portability. Of all the outcomes used in the trial the leg extensor press was the only one 
requiring hospital based follow up assessment. As already mentioned, the need to travel to 
hospital both prevented potential participants agreeing to participate in the trial and raised the 
risk of withdrawals from the trial. The need to offer flexible follow up arrangement, with 
home assessment where necessary, is considered more important to a future trial than the 
inclusion of the leg extensor press.  
4.8.4.4 Timed walk.  
The timed walk test was able to be completed by the majority of participants. Missing data 
was from participants unable to attend for follow up rather than from participants being 
unable to perform the test. Since the test is portable, it could be performed in any follow up 
assessment setting unlike the leg extensor press. The physiotherapy outcome assessors spoke 
of the seemingly high face validity of the test; participants appeared to strongly agree that 
measuring walking was meaningful. 
 It is difficult to find comparable trials using this outcome after knee joint arthroplasty. 
Frost et al., (2002) used a 10 meter timed walk test (n=47) but timed people walking as 
quickly as possible. Their baseline walking speed of 1.18 m/s and 12/12 speed of 1.49 m/s 
was therefore expected to exceed the comfortable walking speeds measured in this trial. This 
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was a correct assumption, the current trial’s walking speed was  0.71m/s  at baseline and  
1m/s  at twelve months. Moffet  et al.,  (2004) used a six minute walking test which is 
discussed in the section comparing the current trial to previous trials below. 
4.8.4.5 Timed sit to stand. 
The value of the sit to stand test has been already highlighted in its introduction in the 
preceding chapter. It is fundamental to transfers and the initiation of gait (Schaubert and 
Bohannon, 2005) and correlates with leg press strength (Jones  et al.,  1999), knee extensor 
strength, ambulatory independence, walking speed and stair climbing performance 
(Bohannon, 1998; Bohannon and Eriksrud, 2001; Ikezoe  et al.,   1997).    
The physiotherapy outcome assessors, like previous researchers, observed that  knee 
arthroplasty patients find sit to stand a difficult maneouvre and compensated, both pre and 
post operation, by taking more weight through the non affected side and by increasing 
forward leaning (Su  et al., 1998).  
Again it is difficult to find comparable trials using this outcome after knee joint 
arthroplasty. The preoperative mean of 4.64 compared to a previous older community resident 
adults means of 12.7 (women) and 13.7 (men) again reflect the poorer functioning of this 
group compared to their non joint arthroplasty peers (Jones et al., 1999).  
By using the timed sit to stand version of the test, rather than the time taken to perform 
a specific number of repetitions, all participants who underwent objective testing (n=105) 
were able to provide test scores unlike 24% of knee osteoarthritis sufferers in previous 
research (Lin  et al.,  2001). 
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4.8.5 HOW DOES THIS TRIAL COMPARE TO PREVIOUS TRIALS?  
As stated in the systematic review of trials investigating the effectiveness of physiotherapy 
exercise following total knee joint arthroplasty for osteoarthritis, there are not many 
previously existing trials in this area. 
 This trial differs from previous ones in that it is the first trial to include both task 
specific training and functional exercises in the content of the intervention. Some previous 
trials have included descriptions of functional weight bearing exercises (Frost  et al.,  2004; 
Kramer  et al.,  2003; Mockford and Beverland, 2004; Moffet  et al., 2004). Whilst gait re-
education and sit to stand are sometimes included in these descriptions the training in specific 
activities of daily living, such as car transfers and walking outside, have not been included 
previously. These activities were included since they had been identified as problematic 
activities for this patient group from published post operative Oxford knee scores (Dawson  et 
al.,  1998).   
In addition to the content being different, the dosage of the physiotherapy provided in 
the current trial is much briefer than in previous trials. Whilst the recommended repetition rate 
and frequency of exercises programmes were similar in this trial to previous trials, the 
physiotherapy – patient face to face contact time was far less.  The data from the case report 
forms completed by the physiotherapists treatment patients provides medians of 10 and 11 
minutes of estimated times spent with patients on functional exercises and task specific 
training respectively in visit one, and 8 and 13minutes in visit two. In the only previous trial 
demonstrating significant between group differences for function the dose was 12 outpatient 
physiotherapy sessions in 6-8 weeks; of 60-90 minutes duration per session (Moffet  et al.,,  
2004). This amount of physiotherapy, given the numbers of knee arthroplasties occurring each 
year, would add up to be a significant proportion of out-patient physiotherapy time for the 
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NHS to find. The current trial intervention, as a starting point, was deliberately designed to be 
a brief physiotherapy intervention which would be feasible for the NHS to consider 
implementing should it prove to be effective. No treatment differences have been found and, 
as mentioned, it may be that the dosage was insufficient and requires amendment.  
The non significant findings in the current trial differ from the results of the systematic 
review of previous trials included earlier in this thesis and this discussion provides reasons for 
this finding. The earlier feasibility study by Frost  et al., (2002) suggested functional exercise 
may be superior to traditional exercise and the trial by Moffet  et al., (2004) showed 
significant differences in walking test distance, pain, stiffness and difficulties performing 
activities of daily living for their intervention group. In addition to the factors already 
discussed, a further difference between Moffet  et al.,  and the current trial may be the choice 
of tool/approach used to measure outcomes. For example, Moffet et al.,  used a six minute 
walk test rather than a timed 10 m walk test as used in the current trial. The much lengthier 
test of endurance may have been more sensitive in picking up changes between participants 
than the short 10 m version. The objective 6 minute timed walk test was also the primary 
outcome in the Moffet et al.,  trial, rather than the self report Oxford knee score used in the 
current trial, and perhaps the use of sufficiently sensitive objective functional measures  may 
be preferable when measuring physiotherapy interventions over a general knee measure of 
orthopaedic surgery? It is difficult to speculate when the current trial was underpowered. As 
highlighted in the systematic review, the need for further high quality trials addressing the 
questions surrounding physiotherapy after knee joint arthroplasty appears evident. 
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4.8.6 IMPLICATIONS FOR CLINICAL PRACTICE. 
The trial’s findings showed no differences between the two types of physiotherapy provided 
in this trial so what does this mean for clinical practice? Although this early trial was never 
expected to provide definitive results regarding the type and dose of physiotherapy there are 
still some interesting considerations regarding clinical practice to consider. 
The patients in this trial were believed to have no physiotherapy routinely organised 
following discharge, as per hospital protocol. Usual physiotherapy care was expected to mean 
that patients continued with the advice and exercises provided to them during their hospital 
stay. It was expected that a few percent of patients with complications might occasionally be 
treated /reviewed after discharge as appropriate. The results from the patient resource diaries 
however showed that 17-18% of patients in both groups received further physiotherapy. A 
conservative total of 212 visits were recorded; an average of over 4 per person receiving 
treatment. The size of this number of additional treatments, and the variety of sources from 
which additional rehabilitation was obtained, was a surprise. No readily available data could 
be found regarding the amount, sources or costs of physiotherapy currently provided to 
following discharge after knee joint arthroplasty in the UK. Whilst anecdotally it is known 
that some Trusts routinely provide 6 sessions of outpatient physiotherapy to patients 
following discharge and some purport to provide none routinely, the true amount of 
physiotherapy currently provided is not only unknown but impossible to guess. This research 
suggests that the costs, even for areas not routinely planning post discharge physiotherapy, 
may be being spread amongst many different sources and be much greater than currently 
believed. The true cost of rehabilitation to the NHS and to patients/employers funding 
rehabilitation is unknown. Whilst it is known that knee joint arthroplasty patients experience 
considerable functional impairment post operatively when compared with their peers (Noble  
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et al.,  2005) research is needed to establish both the current costs and the cost benefits of post 
knee joint arthroplasty rehabilitation  to determine whether rehabilitations costs are 
worthwhile in terms of benefit to patients.  Until it is known if, or how much, post discharge 
physiotherapy is required to benefit patients the NHS cannot decide whether this cost is 
acceptable and reasonable or not worth funding in the future.  
With regard to the intervention itself, it is still believed that this is a potentially 
promising approach which needs further research before its value can be accepted or refuted. 
The approach was based upon a systematic review (Minns Lowe  et al., 2007) and was as 
evidence based as it was possible to make at the time. Whilst there were no differences 
observed between the two trial arms, the trial was impacted upon by some important factors 
which could potentially have masked any treatment trends occurring in the home visit group. 
By chance, the majority of serious co-morbidities developing during the trials affected the 
home visit group. These co-morbidities, for example hydrocephalus and rheumatoid arthritis 
were all of a type to severely impact upon participants’ function and activities of daily living. 
Similarly, the breakdown of major complications occurring in both groups shows the home 
visit group to contain more complications likely to affect outcome (for example, both knees 
requiring revision surgery, more strokes) than the usual physiotherapy group (more chest 
infections and pressure sores). Also, although the trial excluded participants planning further 
joint arthroplasty during the trial period, twelve patients subsequently underwent such 
surgery; nine of whom were in the home visit group. Whether this was because participants in 
this group felt they recovered more quickly and were thus ready for further surgery, as some 
participants stated to the trial physiotherapists, was not investigated in this study. However, 
such surgery was also likely to impact upon the outcomes recorded for these participants at 
follow up assessments.   When all these factors are considered together it may perhaps be 
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thought surprising that the home visit group did not fare worse than the usual physiotherapy 
group. The possibility that trends/treatment effects might have been present but were obscured 
by these differences occurring between the two groups has arisen but it is beyond the scope of 
the current work to explore this further at this time.  
 
4.8.7 FUTURE RESEARCH. 
It is planned to use the current trial data to update the systematic review in chapter three. It is 
also believed that the current trial has demonstrated the need for a future adequately powered 
trial investigating the role of physiotherapy upon functional outcome following discharge 
from hospital following physiotherapy.  Any single trial is on a limited number of patients, is 
liable to encounter some methodological difficulties and usually requires replication (Pocock, 
1983 p 93). This is certainly true for the current underpowered early trial. The current trial is 
considered to have served as a successful pilot trial to inform the development of such a 
future trial. It is believed to have done this in the following ways: 
1. By providing information to enable adequate sample size to be determined.   
2. By considering a more flexible approach to assessment follow up. By enabling follow 
ups to occur at patient’s homes as well as hospitals, at the patients preference, 
recruitment and retention is likely to be optimised. 
3. By refining the intervention. There are several options for a future trial.  Firstly, to run 
a trial along similar lines as the current trial that is adequately powered. However, 
with concerns regarding the dosage of the intervention, it is worth considering 
amending the intervention so that a higher dose is received by participants.  A further 
option, since the trial shows some patients do receive additional physiotherapy, would 
be to design a comparison of two active physiotherapy intervention groups, rather than 
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using a no routinely organised group. This would rather depend on the results of a 
possible survey (see below). 
4. By refining the choice of outcomes. As mentioned it is believed that the alteration of 
the 10 m timed walking test to a six minute walking test may be indicated. Also, to 
remove the leg extensor press to remove the necessity of hospital based follow up. The 
use of hand held muscle dynamometry could be explored instead. 
 
The current trial showed that a significant proportion of patients receive additional 
physiotherapy from a variety of sources when no physiotherapy is routinely organised. The 
research highlights that what physiotherapy patients receive following joint arthroplasty in the 
UK, and its content, is actually unknown. A patient survey to obtain information regarding the 
extent and nature of post discharge physiotherapy after knee joint arthroplasty would both 
provide information about current practice and provide an estimation of the level of resources 
currently consumed by this area of care. This information could also be used to develop a 
more comparable treatment arm against which to investigate a future functional exercise and 
task specific training physiotherapy trial.  
 The measurement of complications following knee joint arthroplasty has been 
indicated as another area that would benefit from further research. The development of 
measures and procedures to obtain accurate and relevant data regarding complications is 
apparent. The current uncertainty and lack of reporting regarding complications, and 
complication rates, that matter to patients and health care professionals cannot be allowed to 
continue for such a common orthopaedic procedure. Patients should be able to expect to be 
provided with clearer information regarding complications when deciding whether to undergo 
major surgery.  
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4.9 CHAPTER SUMMARY.  
This chapter explained the choice of methodological approach, the development of a trial 
intervention, and presented the trial protocol and results. The trial is an innovative trial to start 
to explore the role of functional exercise and task specific training in patients undergoing 
primary elective total knee arthroplasty for osteoarthritis.  
The alternate hypotheses for this trial, that participants receiving two additional 
physiotherapy home visits after discharge from hospital following knee joint arthroplasty 
would show greater improvement in Oxford Knee Scores and secondary outcomes than 
participants receiving usual physiotherapy care, were rejected.  
The trial null hypotheses, that  no statistically significant difference in Oxford Knee 
and secondary outcome scores at 3,6, and 12 months post operation time points between 
participants receiving two physiotherapy home visits and participants receiving usual 
physiotherapy care would be observed, are accepted.  
The trial proved to be underpowered with the presence of potential confounders 
affecting the home visit physiotherapy group more than the usual physiotherapy group. 
Therefore, although the lack of differences found between groups might still be due to both 
treatment arms providing similar outcomes, this cannot be assumed at this stage. A future, 
adequately powered trial, whose altered methodology allows for a higher dose of the 
intervention and the impact of future surgery, additional physiotherapy and the development 
of co-morbidities, is required before an accurate answer can be obtained.  
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5 CHAPTER FIVE. BLIND OUTCOME ASSESSMENT IN A 
PRAGMATIC PHYSIOTHERAPY REHABILITATION 
TRIAL. 
 
5.1 CHAPTER OVERVIEW. 
This chapter will commence by providing definitions of terms used with blinding in clinical 
trials and outlining the ambiguities within existing definitions. The background to the subject 
is then presented, followed by an overview of the effects on clinical trials of blinding and 
unblinding. The feasibility of achieving successful blind outcome assessment in trials and the 
difficulties this creates are then raised, and existing measurement and analysis approaches 
discussed. Following this, the purpose and methodology of a study exploring the feasibility of 
achieving blind outcome assessment in a pragmatic physiotherapy rehabilitation trial 
involving older people is detailed. Results are presented next, followed by a discussion of the 
study’s findings. 
5.2 INTRODUCTION. 
Whilst it was not possible to blind participants and clinicians providing the trial intervention 
regarding treatment allocation, it was possible to blind the outcome assessor. As will be 
shown later in this chapter, there is uncertainty regarding how best to measure blind outcome 
assessment with few trials providing blind outcome assessment success rates or adequate 
details regarding blind outcome assessment.  This study provided the opportunity to enable 
detailed reporting of blind outcome assessment procedures and rates as recommended by the 
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CONSORT statement and also the opportunity to explore further the feasibility of achieving 
successful blind outcome assessment in pragmatic rehabilitation trials. 
5.3 DEFINITIONS AND TERMINOLOGY. 
 
Blinding refers to the process of concealing group identity after treatment assignment through 
randomisation (Schulz et al., 2002). Sometimes the term masked is used rather than blinding 
(Schulz et al., 2002). Terminology surrounding blinding remains varied and confusing; a 
survey of physicians and textbooks found that for one widely used term, double blind, 17 
interpretations were provided by physicians and 9 by textbooks (Devereaux  et al.,  2001). 
Similar confusion exists for published trials; one review identified 8 varying definitions of a 
double blind trial amongst 83 trials (Montori  et al.,  2002); another found 15 different 
operational meanings for the term amongst 200 trials (Haahr and Hróbjartsson, 2006). 
 Generally, trials are labelled open, single, double or triple blind trials. 
Open trials are where both participant and investigator are aware of treatment 
allocation (Day & Altman, 2000). The term open trial may also be referred to as a non blind 
trial and may also denote a trial where the participant, investigator and outcome assessor are 
all aware of treatment allocation (Schulz et al., 2002). 
Single blind trials are where only either the participant or the investigator is blind to 
treatment allocation (Day & Altman, 2000; Forder et al.,  2005), or where only one of the 
participant, investigator or blind outcome assessor are aware (Schulz et al., 2002).  
Double blind trials are where both participants and investigator are blinded to 
treatment allocation (Day & Altman, 2000; Forder et al.,  2005) or where two of the  
participant, investigator or blind outcome assessor are aware (Schulz et al., 2002) or 
sometimes all three (Fergusson  et al., 2004a). 
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Triple blind trials describe either a double blind trial plus blind data analysis, or a trial 
where participant, investigator and outcome assessor are all blinded (Schulz et al., 2002). The 
latter being the same as Fergusson et al’s., (2004a) definition of a double blind trial. In 
addition, the investigator and the outcome assessor may be the same person so a triple blind 
trial might also be a double blind trial depending on which definition is used!  
It is likely that the definitions by Schulz et al., (2002) supersede those by Day and 
Altman (2000), since Altman co-authored both papers, but later definitions by Fergusson  et 
al.,  (2004a) and  Forder  et al.,  (2005) illustrate continuing confusion. Schulz et al., (2002) 
reflect that the “fuzziness reflects true ambiguity” and urges authors to explicitly state what 
blinding occurred in a trial rather than solely using single/double/triple blind terminology; a 
view concurred with by Devereaux  et al.,  (2001) and Haarh and Hróbjartsson, (2006). 
 
5.4 BACKGROUND. 
Blinding has been used in medical research for over 200 years with the intention of reducing 
bias and false treatment effect estimates, preventing participant attrition, and reducing the 
occurrence of co-interventions/additional therapeutic interventions within trials (Altman  et 
al.,  2001; Schulz et al., 2002). Bias in this chapter is used to describe systematic errors which 
encourage one outcome over any others and, in particular, blinding aims to minimise bias 
associated with researchers and participants expectations (Gluud, 2006). The use of blinding 
is generally well accepted (Davis Eyler et al., 1999).  However, frustratingly it is often 
erroneously assumed that a double blind trial must be of higher quality than a single blind trial 
even when double/triple blinding is impossible to achieve (Schulz et al., 2002).  
 Although clear reporting of blinding evaluations was recommended in the original 
CONSORT statement to improve the reporting of clinical trials (Altman  et al., 2001) the vast 
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majority of published trials do not include evaluations of blinding (Sackett, 2007; Bang  et al.,  
2004) and even when included, details are often missing or poorly reported (Altman  et al.,  
2001; Montori  et al.,  2002; Schulz and Grimes, 2002; Hróbjartsson  et al.,  2007). In a 
review of 200 trials published in 2001, none of the trials claiming to be double blind (n=156) 
were considered to have completely reported the blinding status of key trial personnel and 
only 2% explicitly reported the blinding status of participants, providers and data collectors. 
(Haahr and Hróbjartsson, 2006).  However it must not be assumed that trials which do not 
report blinding have not used blinding measures to reduce bias, even if this is the assumption 
within many systematic reviews and openly advised by some researchers (Schulz and Grimes, 
2002): when contacted directly, many trial authors supply full and adequate details regarding 
blinding processes (Hill  et al.,  2002; Devereaux  et al., 2004). Additionally it does not 
follow that the use of blinding processes includes measuring blinding success. When 
Hróbjartsson  et al.,  (2007) contacted the authors of 200 trials not containing details 
regarding blinding success only 12% (n=15) of 130 respondents replied they had formally 
measured blinding success.  The same authors found that only 31/1599, or 2%, of blinded 
randomised clinical trials indexed in the Cochrane Central Register of Controlled Trials 
published in 2001 reported tests for the success of blinding. The authors discuss the 
possibility of the occurrence of selective reporting, with underreporting of unsuccessful 
blinding because of the impact poor blinding might have upon the perceived validity of the 
trial, in addition to lack of testing. The size of their study, plus its inclusion of trials both 
reporting and not reporting results, make this study one of the most useful ones to date in 
identifying the scale of the issues surrounding blinding in clinical trials. 
The proportion of published trials in leading orthopaedic journals providing 
inadequate details regarding blinding has been reported as 54% (Bhandari  et al.,  2002). 
 209
Poolman et al., (2007) found that sixteen of the 32 orthopaedic trials included in their review 
(which contained one physiotherapy trial) did not report blinding of outcome assessors when 
blind outcome assessment was considered possible. This appears lower than the 72% of 50 
non pharmocological trials reporting the occurrence of outcome assessment blinding when 
this was considered feasible by Boutron  et al., 2004. The difference may be due to the 
different study populations. This trial again found that blind outcome assessment is 
problematic for many rehabilitation and similar trials; for the subgroup of rehabilitation trials 
(n=27) the proportion of trials where blind outcome assessment was considered possible was 
only 22%.  
  A further issue is that it is also unclear what should be done if blinding processes 
prove inadequate since, although there is then potential for bias to occur, it does not follow 
that this is necessarily the case (Prescott et al., 1999). Trials with lapses in blindness should 
not necessarily be dismissed as poor since this may be the case for many, if not most, trials 
because true blinding is so difficult to achieve (Turner et al.,  2002). In a random sample of 
200 trials published in high repute journals, the success of blinding was described as less than 
optimal in nine of fourteen trials reporting information regarding blinding (Fergusson et al., 
2004). Even in the trials reporting blinding success this was considered debatable by the 
reviewers.  Hróbjartsson  et al.,  (2007) also found that in 6 out of 7 trial reports they 
identified containing findings which indicated a loss of blinding, the risk of bias due to 
unblinding was either disregarded or ignored by authors. Clear interpretations regarding 
blinding related bias were evidently not occurring in these trial reports and appear to be 
generally omitted. This may be partly due to the difficulties researchers experience in 
assessing what determines successful blinding since it seems there is little mention of what 
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constitutes poor, acceptable or successful blinding in the literature which makes it hard for 
researchers to adequately measure and report findings. 
 
5.4.1 EFFECTS OF BLINDING. 
 
A discussion by Day and Altman (2000) explains that the relevance and appropriateness of 
blinding varies according to circumstances and the type of intervention under investigation. 
Generally trials using inadequate blinding show larger treatment effects than effectively 
blinded studies. Also, blind outcome assessment can often be more important than blind 
treatment administration, especially when using subjective outcomes, since lack of blind 
outcome assessment can result in systematic differences in outcome measurement known as 
ascertainment bias (Boutron  et al.,  2006).  
Studies vary in their findings regarding the impact of non blinded studies upon 
treatment effect. Some studies reviewing the effects of non blind outcome assessment have 
demonstrated significantly larger estimates of treatments ranging from ratio of odds ratios 
0.31 (95% CI 0.2 to 0.47) (Poolman  et al.,  2007). Research has also reported that general 
non blinding can exaggerate treatment effects by 20-45% relative to the true treatment effect 
which may be important for trials, such as physiotherapy trials, seeking small to moderate 
effects in trials (summarised by Devereaux,  et al., 2004). Other research reports lesser impact 
upon treatment efficacy. A previous meta-analysis, relating key aspects of trial quality to 
effect estimates by Jüni et al.,  (2001a), estimated that open trials exaggerate treatment effect 
by 14%. This lower figure may in part be due to the inclusion of a study showing no effect 
from lack of double blinding. Additionally, an earlier meta-analysis of quality within trial 
reports found a small absolute difference of 3.7% scores higher for masked than unmasked 
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scores, compared to 30-40% exaggerated treatment efficacy for trials with inadequate 
allocation concealment (Moher  et al., 1998). These authors subsequently query whether the 
effort required to achieve successful double blinding in trials is worthwhile. The low quality 
of the trials included in this meta-analysis may have contributed to its findings. Therefore, 
while bias may often exaggerate treatment effect size this cannot be assumed; additionally the 
direction of bias may be difficult to ascertain since this is highly unpredictable (Fergusson  et 
al.,  2004a; Gluud, 2006).  
 
Schulz et al., (2002) summarise the effects of bias produced by non/poor blinding as 
follows: knowledge of the intervention can affect treatment response, participants generally 
assume a new intervention is better than those already existing, adherence to new 
interventions may be greater than for established treatment/control arms, and the beliefs of 
investigators can influence participants and outcome assessment (a view concurred by Davis 
Eyler  et al.,  1999). Many authors consider that subjective outcomes are considered more 
prone to this bias than objective ones (Day and Alman, 2000; Schulz et al., 2002; Schultz and 
Grimes, 2002; Veira and Bangdiwala 2007). Hróbjartsson  et al., (2007) and Boutron  et al.,  
(2006) add the possibilities of creating differing tendencies to drop out of the trial, in seeking 
out non-protocolised additional treatments, and in differing degrees of the attention provided 
to participants to this list of potential biases. 
 
5.4.2 FEASIBILITY OF ACHIEVING BLIND OUTCOME ASSESSMENT 
The feasibility and relevance of blinding varies between pharmaceutical and non 
pharmaceutical trial interventions (Boutron  et al.,  2003; Day & Altman, 2000 ).  Double 
blind trials, difficult to achieve even in pharmaceutical trials (Turner  et al.,  2002), are often 
impossible for orthopaedic trials involving interventions such as surgery and physiotherapy 
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(Poolman  et al.,  2007; Schulz and Grimes, 2002). In these trials it is frequently impossible to 
blind patients and care providers and care providers themselves are usually an integral part of 
the intervention (Boutron  et al.,  2003). Such trials need to be judged on their merit rather 
than an inappropriate and inapplicable standard based upon the use of double blinding (Schulz 
and Grimes, 2002). Sham interventions or withholding treatment may also be unethical as 
well as impossible (Boutron  et al.,  2003).  Although double blinding may not be possible it 
is usually possible and necessary to use blind outcome assessment to prevent/limit biased 
outcome assessment (Poolman  et al.,  2007; Prescott  et al.,  1999; Forder  et al.,  2005). 
 
It is difficult to establish the feasibility of achieving successful blinding when, as 
already identified, so few trials report whether blind outcome assessment occurred let alone 
the blinding rates achieved. Boutron  et al., (2004) examined 50 non pharmacologic trials 
(including 27 rehabilitation and similar trials of which 14 were related to physiotherapy) and 
determined the blinding of participants to be feasible in 22% of the rehabilitation and similar 
non pharmacologic trials, the blinding of care providers to be feasible in 18% and the blinding 
of outcome assessors to be feasible in 22%. For the current trial participants and care 
providers are not blinded regarding treatment assignation. There is mixed feasibility regarding 
outcome assessment. Although the majority of secondary trial outcomes are objective 
measures, for which blind outcome assessment is feasible, the primary outcome is a self 
report measure and the patients are aware of their treatment allocation. Boutron  et al., (2003) 
state blind outcome assessment is impossible to achieve when patients are unblinded to 
treatment assignation and the primary outcome is a self report measure.  Their associated 
belief that blind outcome assessment is achieved when a blind patient completes a self report 
outcome (Boutron  et al., 2004) has been refuted by Poolman  et al.,  (2007) who have 
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demonstrated that, unless the adminstrator of the self report measure is also blind, larger 
treatment effects occur.  
It is difficult to assess blinding accurately. Attempts to measure blinding may be 
measuring treatment hunches; for example there may be an assumption that improving trial 
participants are receiving the active intervention (Sackett, 2004, 2007).  Where two patients in 
different trial arms have equal responses to treatment the patient assumed to be in the active 
treatment group may be rated more highly (Carroll et al 1994). In this way outcome 
influences blinding responses. Studies report variety in their reported blind outcome results. 
Davis Eyler et al., (1999) found that guesses from their blind evaluator team were correct only 
slightly more often than chance (56%). Carroll et al., (1994) report their two outcome 
assessors to have correctly guessed treatment allocation with greater accuracy (76%). As 
Boutron  et al.,  (2005) discuss, some researchers consider blinding to be successful if the 
proportion of guesses is no better than chance. However an unequal proportion of guesses is 
also possible in well blinded trials; for example correct guesses may be higher when an 
intervention is proving successful so the usefulness of guessing is debatable. Measurement is 
therefore not straightforward. 
 
5.4.3 MEASUREMENT AND ANALYSIS OF BLIND OUTCOME ASSESSMENT 
There is no concensus regarding the optimum method to measure blindness in clinical trials 
since no validated measure has yet been developed and agreed. This creates considerable 
uncertainty and variety regarding how best to measure blinding and whom should be tested: 
participants or trial personnel (Hróbjartsson  et al.,  2007; Boutron  et al.,  2005). Although 
indices have been published (Bang et al., 2004) they have not been widely accepted or 
reported in subsequent trial reports. These are not appropriate for use in the current trial since 
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they are designed to measure participant’s beliefs regarding treatment assignation and the 
participants in this trial are aware of their assignation. Similarly, the minimum set of reported 
blinding information required for each trial suggested by Fergusson et al., (2004a) also 
includes the counts of participants correctly guessing treatment assignation. Hróbartsson et 
al., (2007)  also suggest asking key trial persons to guess treatment allocation, enabling the 
comparison of this data to be compared with the actual treatments, to assess blinding success.  
 Fergusson et al., (2004a) suggest that the minimum set of blinding methods and 
information, to be reported by trialists, consists of a reported count of  participants guessing 
rates, inclusion of analytical methods and results used to evaluate the extent to which blinding 
is considered successful, plus an interpretation of the efficacy of blinding and any effects on 
study results. These suggestions have provoked many responses on the publishing journal’s 
comments pages (11 to date) criticising the validity of counting guesses with some even 
advocating no during/after trial measurements of blinding. This lack of consensus regarding 
measurement creates difficulties for researchers who need to be able to report and interpret 
any blinding processes; to enable readers to determine the extent to which blinding related 
bias may have been introduced into studies.  
 Published blinding methods have been summarised by Boutron  et al., (2006, 2007). 
They describe the use of sham procedures, blinding participants to the trial hypothesis and the 
use of blinded centralization of the primary outcome. Sham exercise for the knee does not 
exist and was not considered possible for the current trial. It was considered that blinding 
participants to the trial hypothesis until the end of the trial would have been unethical for the 
current trial since patients needed to be aware of the time commitment required by the 
intervention programme prior to deciding whether to participate. It also would not have been 
possible to prevent contact between the two trial arms since patients may meet on the hospital 
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wards. The resources available for this trial prevented blinded centralization of the primary 
outcome via video, audiotape or photography or by someone not associated with the trial. The 
outcome assessor was employed to also approach potential participants so needed to know the 
purpose of the study.   
 Another approach is to develop a specific trial protocol designed to minimise possible 
causes of unblinding (Davis Eyler et al., 1999). Carroll et al., (1994) follow this approach 
recommending that outcome assessors are limited in the amount of trial information they are 
allowed to handle, participants are thoroughly informed about the importance of blinding and 
repeatedly requested not to reveal their treatment allocation, and safeguards are put in place to 
minimise unblinding. Additionally, procedures should be established at the beginning of the 
trial for dealing with any instances of unblinding (Forder et al., 2005). Turner  et al.,  (2002) 
add to this list of recommendations by suggesting the study expectations and beliefs of 
involved personnel, such as outcome assessors, also needs to be explored. 
An alternative to asking categorical Yes/No/Don’t know responses to questions and 
guesses regarding blinding is to ask participants and/or outcome assessors and/or investigators 
to rate their certainty regarding their treatment assignation guess on a scale from 0-10 (Turner  
et al.,  2002). This option does not allow for “do not know” responses however and excludes 
data from people with this opinion. Since “do not know” rates may be high in a successfully 
blinded trial, (although this may not always be true) it can be argued that these responses, and 
also the rate of non response, do need to be reported and included in data analyses where 
possible (Boutron  et al.,  2005). In addition, Boutron  et al.,  (2005) feel that it should be 
reported whether participants are forced to guess or allowed to express uncertainty regarding 
blinding to assist accurate interpretation of results. Rees  et al.,  (2005) have studied “do not 
know” responses at multiple time points during a trial investigating the efficacy of water 
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treatment units (179 trial participants). They obtained forced guesses from participants 
providing “do not know” responses and found that “do not know” respondents at the 
beginning of their trial held similar beliefs regarding group allocation to those providing 
unprompted responses, whereas forced guesses at the end of their trial were more consistent 
with random guesses.  
 The time points at which blinding should be tested is a further area of debate. Trials 
are inconsistent regarding when, and how often, blinding measurement occurs (Boutron  et 
al., 2005). Sackett  (2004) and Walter et al.,  (2005) advocate testing for blindness prior to 
trials, not during or after them, on the grounds that it is not possible to separate the efficacy of 
blinding from the effects of pre-trial hunches regarding efficacy.  These authors however are 
referring to double blind pharmacological trials where it is possible to blind participants and 
clinicians.  This is not possible for non pharmacologic trials and the majority of published 
reports for these trials involve measuring blinding during or at the end of trials (Bhandari et 
al., 2002; Poolman  et al., 2007;  Boutron  et al., 2004). In addition, measuring blindness prior 
to the trial does not permit the extent to which blinding was maintained through the trial to be 
evaluated (Hróbjartsson  et al.,  2007). The difficulty of measuring blinding at the end of the 
study, however, is that assessment may influenced by observations and assumptions regarding 
efficacy and symptoms which may cause bias (Walter et al., 2005; Sackett, 2007). The 
presence of a true intervention effect would also impact upon measures of blindness at this 
time and, as already mentioned, a lack of blinding does not necessarily mean the bias has been 
introduced into the study (Hróbjartsson  et al.,  2007). Some trials measure blindness only 
once whilst others measure it several times to provide information at multiple timepoints and 
allow for changes in blinding status to be picked up more easily (Boutron  et al.,  2005). 
Measuring blindness solely at the end of a trial in order to identify significant group 
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differences due to unblinding depends upon the assumption that participants beliefs regarding 
treatment allocation are undecided at the start of the trial (Rees  et al.,  2005).  A recent study 
by Rees  et al.,  (2005) studied changes in participant’s beliefs regarding treatment allocation 
at multiple time points during a trial, and found little difference between measuring twice, 
early and late trial, and measuring six times during the trial. They recommend testing at the 
two time points to prevent repeated questioning drawing attention to treatment allocation and 
risking increased unblinding, a risk in their own study. Their study also indicated that 
participants tended to initially believe they were assigned to the intervention group and that 
many participants altered their beliefs during the trial (31% or 41/132). They argue that bias 
may not only occur when participants correctly guess allocation but also when intergroup 
differences regarding treatment group allocation differentially effect outcome. 
 In their review identifying blinding methods used in randomised clinical trials, 
Boutron  et al.,  (2005) found that the most frequently reported method of analysis was counts 
of participant’s guesses (79% or n=43). Statistical analyses were included in 57% (n=31) trial 
reports, usually to compare the proportion of correct guesses among those produced by 
chance in each group or globally or to use a chi-square test to check for a relation between 
participants’ guesses and group allocation. Trials including uncertainty, for example by 
allowing participants to state “do not know” did not usually analyse this data statistically. 
While the authors promoted the use of indices to allow this data to be statistically analysed 
they found the use of such indices were rarely reported and, for this trial, no index for use 
with blind outcome assessors rather than participants could be found. In their review of 
blinding in 94 psychiatric trials Fergusson  et al.,  (2004) identified few reports giving any 
details regarding statistical data analysis;  chi square tests (n=3), kappa values (n=2) and 
Fishers exact test (n=1) results were provided in six studies. 
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 5.4.4 SECTION SUMMARY. 
The use and value of blinding within randomised clinical trials is generally, but not 
universally, accepted. Ambiguities in defining terms used to describe blinding exist and it is 
not clear what constitutes successful blinding in reported trials. Uncertainty regarding the 
effects and feasibility of blinding and regarding how and when to best measure and analyse 
blinding data are evident. 
 
5.5 PURPOSE OF STUDY. 
The purpose of this study was to explore the feasibility of achieving blind outcome 
assessment in a pragmatic physiotherapy rehabilitation trial involving older people and to 
contribute to the limited available knowledge in this area. This was achieved by the following 
two objectives. 
1.   To record and present the number of instances of unblinding occurring during the trial. 
2.   To fully document details surrounding each instance of unblinding and to present a 
content analysis of the results. 
 
 
5.6 METHOD.  
5.6.1 SECTION OVERVIEW. 
 
 This section provides a description of the methods used to minimise instances of unblinding 
and to record all instances of unblinding occurring in the trial.  
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5.6.2 Protocol to minimise instances of unblinding.  
Since the blind outcome assessor was involved in approaching participants she had to be 
aware of the trial question and design. She reported no strong preference for either trial arm 
and no strong beliefs or expectations about the outcome of the trial. She did not see all 
participants prior to randomisation/intervention and blinding was not measured at this time. It 
was possible to measure outcome assessment blinding at the three and twelve month follow 
up time points and therefore this approach was chosen.  
All trial participants were informed about blind outcome assessment and its importance 
during their baseline assessment. All participants were requested not to reveal their group 
allocation on the following occasions: 
1. Baseline assessment; both immediately prior to, and after, randomisation. 
2. During the two home visits provided to the Home Visit treatment group. 
3. On each occasion when participants were telephoned to arrange follow up visits. 
4. At the commencement of each follow up visit. 
In addition the following safeguards were followed. The outcome assessor had no access to 
any study data which could compromise blind outcome assessment. They had no access to the 
password protected study database or to completed assessments, treatment notes or 
questionnaires which were secured in a locked filing cabinet. Although it is recommended 
that blind outcome assessors should not come into contact with those colleagues providing the 
intervention (Boutron  et al.,  2007) this was not possible since staff shared the same office 
and space restrictions prevented further office space from being available. For this reason 
three other safeguards were put in place: 
1. The names and locations of home visits were not mentioned in the office. 
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2. Telephone calls to arrange visits were not made when the outcome assessor was in the 
office. 
3. Incoming telephone calls to the office were screened. Either other staff answered the 
telephone or, if this was not possible, the outcome assessor would determine which of the 
Unit’s trials the caller was telephoning about and arrange for the trial co-ordinator to 
telephone the participant back for callers involved in the present trial.  
         
5.6.3 Recording instances of unblinding. 
Every follow up assessment questionnaire contained the following question. 
 
 
This question asks you whether you are aware/ unaware of which treatment group this patient 
belongs to in the trial. 
(Please tick one box only) 
 
I do not know which group the patient is in……………………………. 
 
 
I have guessed the patient is in the home treatment group …………… 
 
 
I have guessed the patient is in the usual care group ………………… 
 
 
The patient has told me they are in the home treatment group………… 
 
 
The patient has told me they are in the usual care group……………….. 
   
 
 
This question included both guesses and knowledge because the impact of guessing allocation 
is likely to be different than that of actually knowing the intervention (Boutron  et al.,  2004). 
Unless the outcome assessor stated they did not know to which group the participant had 
been allocated they recorded why/how they had guessed/knew group allocation in a field 
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diary kept for the purpose. Each instance was recorded on a separate page and sealed to 
ensure the outcome assessor could not revisit previous instances to lessen the chance of the 
assessor remembering allocation when next seeing the participant. 
 
5.7 DATA ANALYSIS. 
The questionnaire data was analysed descriptively and the results presented using bar charts 
and tables. As previously mentioned there are no existing indices or accepted other 
approaches available for use to evaluate the opinions of blind outcome assessors. The diary 
data was fully transcribed and categories identified using content analysis and constant 
comparison; the data was read and re-read to identify these categories following which each 
item was checked and compared against all others to establish the categories as truly 
reflective of the data (Pope  et al., 2000). The findings from this process were then 
summarised in a table.  
 
5.8 RESULTS. 
The vast majority of all outcome assessments at all time points were performed by the same 
assessor. A few assessments only were performed by another blinded and experienced 
research physiotherapist in the rare event of the lead assessor being unavailable.  
5.8.1 Questionnaire Findings. 
The bar charts below provide a visual representation of blind outcome assessor beliefs 
regarding treatment arm allocation at three and twelve month face-to-face follow up 
assessments. Since randomisation occurred after baseline assessment and six month follow up 
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was a postal questionnaire there are no data for these time points.  The tables following this 
show the frequencies of correct and incorrect answers. These tables show successful blind 
outcome assessment occurring for the majority of assessments: 74/91 (81.32%) of participants 
at 3/12 and 83/91 (91.21%) at 12/12 follow ups therefore fewer instances of unblinding occur 
at the 12/12 time point. At both timepoints a few incorrect guesses/telling occur: 3 instances 
at 3/12 and 2 at 12/12.    
 
 
 
 
Fr
eq
ue
nc
y
0
20
40
60
80
PQF_2
told patient is in 
control group 
told patient is in 
treatment 
group
guessed in 
control group
guessed in
treatment 
don't know 
group 
Figure 27. Bar chart to show the outcome assessor’s beliefs regarding treatment allocation at three month 
follow up assessments.  
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Figure 28.  Bar chart to show the outcome assessor’s beliefs regarding treatment allocation at twelve 
month follow up assessments. 
 
 
Table 25. Table to show the numbers of correct and incorrect guesses of the outcome assessor’s beliefs 
regarding treatment allocation at three month follow up assessments. 
 
  Percent Frequency 
Frequency of 
correct 
guesses 
Frequency of 
incorrect 
guesses 
Valid don't know 74 69.2  
  guessed in treatment 
group 7 6.5 6 1
  guessed in control group 1 .9 1 
  told patient is in treatment 
group 7 6.5 6 1
  told patient is in control 
group 2 1.9 1 1
  Total 91 85.0   
Missing 999 2 1.9    
  Number not assessed 14 13.1    
  Total 16 15.0    
Total 100.0 107    
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Table 25. Table to show the numbers of correct and incorrect guesses of the outcome assessor’s beliefs 
regarding treatment allocation at twelve month follow up assessments. 
 
  Percent Frequency 
Frequency of 
correct 
guesses 
Frequency of 
incorrect 
guesses  
Valid don't know 83 77.6  
  guessed in treatment 
group 3 2.8 2 1
  told in treatment group 3 2.8 2 1
  told in control group 2 1.9 2 
  Total 91 85.0   
Missing 999 3 2.8    
  Number not assessed 13 12.1    
  Total 16 15.0    
Total 100.0 107    
 
5.8.2  Diary Data. 
40 instances (28 participants) of unblinding were recorded in the Unblinding Events Diary 
during the trial by the outcome assessor. The table  below summarises the results of the 
content analysis of the diary data and presents the main reasons/causes of unblinding 
incidents. Not all unblinding instances provided correct information: 12.5% of events lead to 
the outcome assessor reaching the wrong conclusion regarding to which treatment arm an 
individual had been allocated. In addition, it was also mentioned that three participants 
revealed their allocation close to the end of their assessment and one after the assessment has 
finished but before the participant had left.  
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Table 26. Correct and incorrect instances of unblinding documented in assessor’s diary (40 instances in 28 
subjects) 
 
Methods of unblinding Correct instances of unblinding:  
assessor informed/guessed 
correctly 
Incorrect  instances of unblinding: 
assessor informed/guessed 
incorrectly 
 
Revealed by patient: 
 
Patient telling assessor 
 
Patient asking additional queries 
 
Patient mentioning other 
physiotherapy /follow ups 
 
Patient phoning to rearrange 
appointment times 
 
Patient leaving randomisation 
card outside envelope  
 
 
 
 
18 
 
 
 
 
 
 
 
2 
 
 
1 
 
 
 
 
 
1 
 
 
3 
Revealed by relative/friend: 
 
Relative/friend telling assessor 
 
 
 
3 
 
 
1 
Revealed by colleagues: 
 
During conversation with 
physiotherapy colleagues 
 
Overhearing office 
conversations /phone calls 
 
Assessor receiving phone call 
about a specific participant’s 
needs 
 
Assessor answering query from 
another member of staff 
 
 
4 
 
 
3 
 
 
1 
 
 
 
1 
 
 
Seeing trial paperwork: 
 
Home diary from patient 
 
Patient summary with 
randomisation 
 
 
1 
 
1 
 
 
Total 35 5 
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5.9  DISCUSSION.   
5.9.1 SECTION OVERVIEW. 
This section contains the discussion of the methodology and findings of the study evaluating 
and exploring the feasibility and success of achieving blind outcome assessment in a 
pragmatic physiotherapy rehabilitation trial. The section begins with a summary of the key 
findings of the study. It then provides a discussion of the strengths and limitations of the 
study’s procedures followed by a discussion of the implications of the study and directions for 
future research.  
 
5.9.2 SUMMARY OF KEY FINDINGS. 
The study shows that successful blind outcome assessment rates were obtained during this 
pragmatic physiotherapy rehabilitation trial. Successful blinding rates of over 80% of 
assessments at three month follow up, and over 90% at twelve month follow up, were 
achieved. The main cause of unblinding events was participants telling the assessor. The 
findings show that not all unblinding events are remembered at subsequent assessments, even 
in this relatively small trial.  
 
5.9.3 STRENGTHS AND LIMITATIONS OF THE STUDY’S PROCEDURES. 
 
As highlighted in the backgound section in chapter four, the vast majority of published trials 
either do not include evaluations of blinding (Sackett, 2007; Bang  et al.,  2004)  or 
evaluations are poorly reported (Altman  et al.,  2001; Montori  et al.,  2002; Schulz and 
Grimes, 2002; Hróbjartsson  et al.,  2007). This study therefore is one of the few available 
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musculoskeletal rehabilitation studies providing data regarding blind outcome assessment for 
a randomised clinical trial. By providing outcome assessment blinding rates, in addition to 
explaining why the participants and clinicians providing the trial intervention cannot be 
blinded, this study goes beyond the newly extended CONSORT statement detailing standards 
for the reporting of pragmatic trials (Zwarenstein et al., 2008).    
The questionnaires findings contained 81-91% “do not know” responses from the 
outcome assessor. This high value is believed to reflect the success of using a specific trial 
protocol to minimise unblinding events as used successfully by Carroll  et al.,  (1994) and as 
recommended by Davis Eyler  et al.,  (1999).  
As explained in the trial protocol, it was not possible to blind trial participants and 
physiotherapists to treatment assignation. It was noted on the trial database that several usual 
physiotherapy care trial arm participants vocalised disappointment with their group 
assignation at the time of randomisation, stating a preference for the home visit package. The 
presence of any systematic biases resulting from the strength of patient preferences or beliefs 
about the treatment efficacy of the two physiotherapy trial packages is unknown. A patient 
preference trial, where participants with a strong preference to a specific trial arm are assigned 
to that trial arm while people without preferences are randomised as usual, is one option to 
avoid this form of bias (Halpern, 2003). This option was considered during the design stage of 
the trial but not incorporated because since such trials are only partially randomised and 
therefore the trial’s main results could be affected by uncontrolled confounding (Halpern, 
2003).  
In line with Davis Eyler et al., (1999) our study also had instances where comments 
were made that instantly unblinded the outcome assessor. Unlike the previous study however, 
only one blind outcome assessor was available for each follow up session so it was not 
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possible for another blind outcome assessor to take the place of the unblinded one. It was felt 
unreasonable to ask participants to re-attend at another time since, unlike Davis Eyler  et al.,  
(1999) reassessments could not be performed at patients homes. Whilst the majority of 
participants telling their assessor their group allocation did so accurately, one interesting point 
arising from the study was that two participants at 3/12 and one participant at 12/12  directly 
told the assessor their group allocation but provided erroneous information. This may have 
been due to a mishearing / misunderstanding on the part of the assessor, confusion on the part 
of the participant or a direct attempt to confuse/mislead assessor by participants. It does mean 
however that not all statements from patients regarding group allocation are true and assessors 
may believe they have been unblinded when true group allocation has not been revealed.   
Concern has been expressed regarding the use of repeated measures in studies since it 
is feared that repeatedly asking for beliefs regarding blinding may draw attention to the topic 
and make people consider, remember or analyse the issue more often (Rees  et al.,  2005;  
Boutron et al., 2004). This study not only used repeated measures but asked for detailed 
description of all instances of unblinding. We believed it was improbable for repeated 
measures to effect our non blinded participants but there was a concern that the assessor might 
remember instances of unblinding from one time point to another; especially since this trial is 
relatively small. Although this may have occurred to some extent the substantially higher 
twelve month successful blinding rates than those at three months suggest that fully recording 
unblinding events during the trial did not seriously and adversely effect blinding rates at final 
follow up. This adds useful information to the current debate regarding when and how often 
blinding measurements should occur (Boutron  et al., 2005). 
The variation of the timing of the majority of unblinding incidents is interesting.  
There were more instances of unblinding occurring earlier in the trial and at the three month 
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assessment time point than later on and at twelve months. There are several possible 
explanations for this. Whilst some participants repeatedly divulged their group allocation, it is 
possible that some participants did subsequently learn not to mention their group allocation. 
In addition, the diary data does identify instances of unblinding occurring because outcome 
assessment and clinical staff had to share an office. Boutron  et al.,  (2007) recommends that 
blind outcome staff should not come into contact with clinicians to prevent such instances but 
initially this was not possible since additional office space was unavailable. However, the 
main outcome assessor changed jobs partway through the trial. This meant that, after 
completing the vast majority of the 3/12 assessments and only a few 12/12 assessments, she 
moved to a different hospital site only returning to carry out assessments. Since only one 
instance of unblinding was revealed by colleagues after this job move took place this would 
appear to emphasize the importance of keeping the outcome assessor away from the research 
office and clinical environment where possible. 
 The diary data usefully supplemented the questionnaire data in a further way.  
Although the questionnaire question included both guesses and being told group allocation as 
Boutron  et al.,  (2004) recommends, the question used only allowed assessors to state 
whether unblinding occurred. It did not mention when the unblinding incident occurred. The 
diary data recorded several instances when participants revealed their allocation near the end 
of the assessment, with one participant revealing their allocation after all the assessment 
measures had been completed. The question used in the questionnaire therefore would not, in 
its current form, distinguish between participants informing assessors when such information 
is likely to influence results from situations when little impact is likely to have been caused.   
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5.9.4 IMPLICATIONS OF THE STUDY. 
It is difficult to place the results from this study into context with results from other 
physiotherapeutic or orthopaedic trials due to the lack of previously published trial blinding 
rates. However Boutron  et al.,  (2005) helpfully state that a high number of “do not know” 
answers is to be expected in a successfully blinded trial. The 81-91% “do not know” 
responses obtained in this study are considered high and the trial to have successfully 
achieved blind outcome assessment. 
 The combination of using a blind outcome question in follow up questionnaires 
together with a diary to record instances of unblinding has not been found elsewhere. We 
believe it is new to this study. The use of this combination has revealed interesting findings. 
The diary data includes the instances of unblinding not captured via the assessment 
questionnaires (for example, overhearing colleagues discussing the trial or during telephone 
calls with patients). It suggests that instances of unblinding occurring in the office 
environment or revealed by colleagues were less remembered than patients directly informing 
the assessor during assessments. It has also identified a limitation of the questionnaire 
question, the issue of distinguishing between participants informing assessors when such 
information is likely to influence results from times when little impact is likely to have been 
caused. The completion of an unblinding diary adds little to the workload of the outcome 
assessor. The length of entries suggests that all the useful information can be obtained via 2-3 
minutes of writing time. The use of a diary allows any type of event to be recorded 
spontaneously and expressively, whilst avoiding the limitations of closed questions or 
preordained categories (Oppenheim, 1992 p.113-114). 
Since undertaking this study a provocative commentary has been published which 
questions the whole validity and possibility of measuring blindness; arguing that blinding 
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should be relegated to the level of process and the emphasis shifted to testing for bias-
generating consequences for any loss of blinding instead (Sackett, 2007). This identifies 
several bias generating consequences which apply to the current study. Firstly, the level of 
contamination caused by participants in the usual physiotherapy trial arm obtaining the 
intervention elsewhere since they know they will not receive it from the trial. Since 
participants were requested to detail any additional physiotherapy they received external to 
the trial in their patient diaries it has been possible to assess the extent to which this occurred 
and this is discussed in chapter four. Secondly, if physiotherapists who are aware of treatment 
allocation provide effective treatments to the usual physiotherapy trial arm participants this 
again could cause bias. The design of the current trial, which assessed the efficacy of an extra 
intervention in addition to any usual physiotherapy received, made this concern unlikely.  In 
addition the physiotherapists providing the trial intervention did not treat any of the 
participants in any other setting. Thirdly, if participants or physiotherapists know or have 
hunches regarding their trial arm they may downplay or under report symptoms/adverse 
outcomes. Although this can not be ruled out for the current trial, the detailed information 
participants provided regarding symptoms and complications makes this appear unlikely.  
 232
This commentary by Sackett (2007) may reflect an important thought shift in the 
research community. The CONSORT statement has been revised for pragmatic trials 
to remove the sentence regarding the necessity of evaluating and reporting blindness; 
this has been toned down to providing an explanation of the approach used 
(Zwarenstein  et al.,  2008). It is presently unclear whether this change is being driven 
by increasing awareness that researchers are simply unwilling to measure/report 
blindness rates or by an increasing acceptance that it is pointless to do so. The recent 
publication of further papers calling for detailed reporting regarding blindness, such 
as Poolman  et al., (2007) mean this issue may become a contentious topic of trial 
design in the next few years. Schulz (2002) opines that “investigators must not only 
minimise bias but must also communicate those efforts to the reader”.  Hróbjartsson  
et al.,  (2007) state that the critical appraisal of blinding in most trials is meaningless 
because of grossly incomplete reporting. The long awaited revised CONSORT 
statement for pragmatic trials (Zwarenstein  et al.,  2008) seems disappointingly 
vague, missing the opportunity to facilitate true development in the measurement and 
reporting of blinding in pragmatic trials.  In the meantime, reporting full information 
regarding blinding methods and results as suggested by Fergusson et al., (2004a) 
seems a sensible approach. Particularly if, as also suggested, trialists provide readers 
with an interpretation of the results. Such interpretations might prevent possible errors 
in understanding, such as those recounted by Sackett (2007), from occurring. As 
Fergusson  et al., (2004 b) argue, although the methods by which blinding is currently 
measured could do with improvement, to subsequently decide to ignore blinding  and 
not even attempt to assess it is a poor decision. Clinicians seeking evidence based 
information upon which to make treatment decisions are still often forced to base their 
decisions on trials with unclear control of bias (Gluud, 2006). This study allows us to 
 233
provide researchers and clinicians with results regarding the effectiveness of blinding 
procedures used in the physiotherapy trial earlier in this thesis. These results, plus 
their interpretation, should enable readers to assess for themselves the extent to which 
blinding has been successful and bias minimised. 
 
5.9.5 FUTURE DIRECTIONS. 
From a physiotherapy perspective the paradigm shift raised by Sackett (2007) 
would appear potentially positive. If trial evaluations and systematic review scoring 
systems were subsequently revised to allow the extent to which bias generating 
concerns from loss of blinding to be assessed in trials, instead of immediately 
downgrading the quality of a trial because it is not possible for double blinding to 
occur, then this could promote improved quality assessments in future physiotherapy 
trials. Blind outcome assessment, plus additional forms of blinding when possible and 
appropriate, could remain integral to trial design plus increased explicit consideration 
would then occur regarding possible consequences of loss of blinding. 
Patient preferences regarding treatment allocation may have influenced this trial. 
Halpern (2006) suggests that one approach to include patients’ preferences for 
treatment arms, whilst avoiding the pitfalls of a patient preference trial design, is to 
assess participants’ preference prior to subsequently randomising them in the 
normally accepted way. Preference can then at least be included and quantified in the 
trial’s statistical analyses. Although not yet common within physiotherapy/therapeutic 
trials this is not unknown (for example Klaber-Moffett  et al.,  1999, Kalauokalani  et 
al., 2001) and results have appeared mixed. Preference affected outcome in one of 
these trials (Kalauokalani  et al., 2001) but not the other (Klaber-Moffett  et al.,  
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1999). Further research is required to determine whether the benefits of quantifying 
preference bias in this way are worth the additional data collection and analysis.  
 As already mentioned resource restrictions prevented the use of centralised 
outcome assessment advocated by Boutron  et al.,  (2005). However this is a 
possibility to consider in future trials. If this approach was included it would also then 
permit the exploration of the impact of blinding in the way that Noseworthy  et al.,  
(1994) performed. By asking both blinded and non blinded outcome assessors to 
assess efficacy Noseworthy  et al.,  (2004) were able to demonstrate the impact of 
blinding in their trial; physician blinding prevented an erroneous conclusion regarding 
treatment efficacy in their trial and it would be very interesting to investigate the 
impact of outcome assessor blinding within future physiotherapy trials in this way. 
Hróbjartsson  et al.,  (2007) stress the need for both improved methodologies and 
improved reporting of blinding by clinical trialists. It is hoped that this study may 
assist the development of an improved methodology. It is likely that, after future 
research, that the categories developed from this, and future studies, diary data could 
be used to develop a coding system for responses which would then enable responses 
to be quantified (Oppenheim, 1992 p.113-114). This, together with the questionnaire 
question used in this study,  plus a further question to identify whether unblinding 
occurred before, during or following assessment might form the basis of a quick and 
easy to complete tool by which to measure blind outcome assessment in pragmatic 
trials.  Since the majority of existing blinding measures relate to the blinding of 
participants such a tool would appear to be a valuable addition to available 
methodologies.  
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 5.10 Chapter Summary. 
After presenting definitions and background research, this chapter presented the 
protocol, results and discussion of a study exploring the feasibility of achieving 
successful blind outcome assessment in a rehabilitation trial involving older people. 
The study found that blind outcome assessment was feasible and that a high rate of 
blinding was achieved. 
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6 CHAPTER SIX. A SUMMARY OF THE MAIN 
FINDINGS, IMPLICATIONS AND FUTURE 
RESEARCH SUGGESTIONS IN THIS THESIS.  
 
6.1 CHAPTER OVERVIEW. 
This chapter will summarise the main findings for the systematic review, the 
randomised clinical trial and the study evaluating blind outcome assessment. For each 
of these three component pieces of research the main implications for clinicians and 
researchers, and the priorities for future research will also be summarised. Finally, the 
conclusions of this thesis will be presented.    
 
6.2 SYSTEMATIC REVIEW. 
6.2.1 Summary of main findings.  
The main purpose of this review, to evaluate the effectiveness of post discharge 
physiotherapy exercise on function, walking, range of motion, quality of life and 
muscle strength, for osteoarthritic patients following elective primary total knee 
arthroplasty, was successfully achieved.  
 Six trials were identified, five of which were suitable for inclusion in meta-
analyses. A 0.33 (95% CI 0.07 to 0.58) small to moderate standardised effect size, in 
favour of functional exercise, was seen for function at 3-4 months post operatively. 
Small to moderate weighted mean differences of 2.9 (95% CI 0.61 to 5.2) for range of 
joint motion and 1.66 (95% CI  -1 to 4.3) for  quality of life were seen, in favour of 
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functional exercise, at 3-4 months post operatively. Post-treatment benefits were not 
carried through to one year.  
6.2.2 Implications of the Research.  
It would appear reasonable to refer patients for a short course of physiotherapy 
following discharge to provide short term patient benefit. The small to moderate 
standardised effect size obtained for function, favouring the intervention, is 
considered clinically important. This reflects actual improvements in one or more 
important aspects of function reported by patients after receiving the treatment 
intervention. The type of physiotherapy provided to patients following discharge after 
knee replacement surgery needs consideration. Traditional exercise programmes may 
be less effective in the short term following total knee arthroplasty than functional 
physiotherapy exercise interventions.  
 
6.2.3 Future Research Suggestions.  
Where an effect is shown it is not huge indicating that although there are not many 
studies and they are not large they are still likely to have detected most worthwhile 
effects. These tentative findings suggest that further research would be worthwhile to 
reduce the level of uncertainty currently present and thus contribute to the 
acknowledged knowledge gap in post knee replacement rehabilitation.  The content, 
dosage and timing of physiotherapy rehabilitation interventions following knee joint 
arthroplasty for osteoarthritis all warrant futher investigation. 
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6.3 RANDOMISED CLINICAL TRIAL.  
6.3.1 Summary of main findings.  
The alternate hypotheses for this trial, that participants receiving two 
additional physiotherapy home visits after discharge from hospital following knee 
joint arthroplasty would show greater improvement in Oxford Knee Scores and 
secondary outcomes than participants receiving usual physiotherapy care, were 
rejected.  
The trial null hypotheses, that  no statistically significant difference in Oxford 
Knee and secondary outcome scores at 3,6, and 12 months post operation time points 
between participants receiving two physiotherapy home visits and participants 
receiving usual physiotherapy care would be observed, are accepted.  
The trial proved to be underpowered with the presence of potential confounders 
affecting the home visit physiotherapy group more than the usual physiotherapy 
group.  
 
6.3.2 Implications of the Research.  
This trial is an innovative, early, trial to start to explore the role of functional exercise 
and task specific training in patients undergoing primary elective total knee 
arthroplasty for osteoarthritis. The intervention itself is still believed to be a 
potentially promising approach which needs further research before its value can be 
accepted or refuted. The approach was based upon a systematic review (Minns Lowe  
et al., 2007) and was as evidence based as it was possible to make at the time. Whilst 
there were no differences observed between the two trial arms, the trial was impacted 
 239
upon by some important factors which could potentially have masked any treatment 
trends occurring in the home visit group. 
In addition, the current trial showed that a significant proportion of patients 
receive additional physiotherapy from a variety of sources when no physiotherapy is 
routinely organised. The research highlights that what physiotherapy patients receive 
following joint arthroplasty in the UK, and its content, is actually unknown.  
 
6.3.3 Future Research Suggestions.  
There were three main areas for future research. Firstly it is believed that the current 
trial has demonstrated the need for a future adequately powered trial investigating the 
role of physiotherapy upon functional outcome following discharge from hospital 
following physiotherapy. This trial has also informed the development of such a 
future trial.   
Secondly, a patient survey to obtain information regarding the extent and nature of 
post discharge physiotherapy after knee joint arthroplasty would both provide 
information about current practice and provide an estimation of the level of resources 
currently consumed by this area of care.  
 Thirdly, the development of measures and procedures to obtain accurate and 
relevant data regarding complications following knee joint arthroplasty has been 
indicated as another area that would benefit from further research. The current 
uncertainty and lack of reporting regarding complications, and complication rates, that 
matter to patients and health care professionals requires to be addressed.  
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6.4 BLIND OUTCOME ASSESSMENT IN A PRAGMATIC 
PHYSIOTHERAPY REHABILITATION TRIAL. 
6.4.1 Summary of main findings.  
This study successfully explored the feasibility of achieving blind outcome 
assessment in a pragmatic physiotherapy rehabilitation trial involving older people. 
Successful blinding rates of over 80% of assessments at three month follow up, and 
over 90% at twelve month follow up, were achieved. The main cause of unblinding 
events was participants telling the assessor. The findings show that not all unblinding 
events are remembered at subsequent assessments, even in this relatively small trial 
 
6.4.2 Implications of the Research.  
This study is one of the few available musculoskeletal rehabilitation studies providing 
data regarding blind outcome assessment for a randomised clinical trial and, by so 
doing, has to contribute to the limited available knowledge in this area. 
The study also contributes useful information to the current debate regarding 
when and how often blinding measurements should occur. The substantially higher 
twelve month successful blinding rates than those at three months suggest that the use 
of repeated measures, plus fully recording unblinding events during the trial, did not 
seriously and adversely effect blinding rates at final follow up. 
This study used the combination of using a blind outcome question in follow 
up questionnaires together with a diary to record instances of unblinding. This dual 
approach has not been found elsewhere but, with each methodology providing both 
different and complementary information has proved a valuable methodology to 
achieve successful measurement. The questionnaire allowed blinding rates to be 
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established: the diary data captured incidents of unblinding the questionnaire was 
unable to record and identified that the questionnaire question was limited in its 
ability to distinguish between participants informing assessors when such information 
is likely to influence results from times when little impact is likely to have been 
caused.  
 
6.4.3 Future Research Suggestions.  
Existing research demonstrates the need for new and improved methodologies to 
measure blinding in trials. The majority of available measures are for use when 
measuring the extent to which trial participants remain blind during trials with scant 
attention paid to the measurement of blind outcome assessment.  It is hoped that 
similar diary data from future studies could be used to develop a coding system for 
responses which would then enable responses to be quantified (Oppenheim, 1992 
p.113-114). This, together with the questionnaire question used in this study,  plus a 
further question to identify whether unblinding occurred before, during or following 
assessment might form the basis of a quick and easy to complete tool by which to 
measure blind outcome assessment in pragmatic trials.  It is believed this would be of 
value to other researchers undertaking pragmatic trials in addition to facilitating the 
reporting of blind outcome assessment rates for the benefit of those reading and 
applying future trials to their clinical practice.  
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6.5 CONCLUSIONS OF THIS THESIS. 
6.5.1 SYSTEMATIC REVIEW. 
The results of the systematic review to evaluate the effectiveness of physiotherapy 
exercise following knee arthroplasty for osteoarthritis are not conclusive; they 
indicate however that functional exercise interventions following discharge show 
promise for this patient group. Effect sizes were small to moderate.  No long term 
benefit was found. Further research in this area therefore would appear justifiable and 
worthwhile.  
From the evidence to date, it is proposed that functional exercises should be 
considered for inclusion in post discharge physiotherapy programmes following knee 
arthroplasty.  
 
6.5.2 THE RANDOMISED CLINICAL TRIAL.  
No significant statistical differences were observed between the home visit 
physiotherapy and usual physiotherapy groups for the primary outcome, the Oxford 
Knee Score, and all secondary outcomes at three, six and twelve months post 
discharge from hospital following knee joint arthroplasty.   
This early trial was underpowered. Whilst there were no differences observed 
between the two trial arms, the trial was impacted upon by some important factors 
which could potentially have masked any treatment trends occurring in the home visit 
group. 
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 A future, adequately powered trial, using the findings from this current trial, 
is indicated to be worthwhile for this large patient group undergoing this common 
orthopaedic condition. 
 
6.5.3 BLIND OUTCOME ASSESSMENT. 
Successful blind outcome assessment is both achievable and measurable in pragmatic 
rehabilitation trials. The use of repeated measures did not prove to be of concern in 
this instance. The use of specific trial protocols designed to minimise incidents of 
unblinding, together with a dual measurement approach of questionnaire questions 
plus a diary to fully detail every events of unblinding was used to achieve successful 
measurement of blind outcome assessment in this trial  successfully in the trial in this 
thesis.  
 
6.6 OVERALL THESIS. 
This thesis produced the first systematic review to evaluate the effective of 
physiotherapy exercise following joint replacement. It included the development of a 
new trial physiotherapy intervention, plus an early trial exploring this new 
rehabilitation approach. It also provided a new approach to the measurement of blind 
outcome assessment which has the potential for future development into a new 
research tool. Overall, this thesis has successfully contributed new knowledge to the 
area of physiotherapy rehabilitation following knee joint arthroplasty for patients with 
osteoarthritis.  
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APPENDIX II.   LANGUAGE BIAS: ITS IMPLICATIONS 
FOR A PROPOSED SYSTEMATIC REVIEW. 
 
This assignment was written by Catherine Minns Lowe and submitted as part of the Systematic 
Reviews Module, Department of Continuing Education, University of Oxford 01/07/2005. It was 
awarded Grade A. 
 
Introduction. 
This assignment addresses the question: should our planned review (Sub Appendix I), 
evaluating the effectiveness of post-operative physiotherapy exercise following 
hospital discharge for patients undergoing elective total hip/knee arthroplasty, be 
restricted to the inclusion of English language trial reports, or should all appropriate 
reports be considered regardless of their language? 
 
Background.  
The inclusion of an unbiased selection of relevant studies in a systematic review is 
central to its validity1. Many systematic reviews exclude non English Language trial 
(NELT) reports1-7. Excluding NELTs may introduce bias, termed language bias1, 
however, including them may be problematic1, 3. It was therefore decided to ascertain 
how language bias might effect our review and whether NELTs should be included. 
 
Options. 
Information was obtained (Sub Appendix II) and considered. Four possible options 
were identified. Firstly, exclude NELTs from our review. Secondly, include all papers 
identified by the search strategy, regardless of language of publication. Thirdly, 
screen all abstracts identified by the search strategy and only obtain papers meeting 
pre-specified criteria. The final option was to ignore the issue. These options will now 
be explored.  
 
1. Effects of Exclusion.  
Exclusion of NELTs can affect the results of meta-analyses2, excluding around 20%1, 
3 of trials from Medline searches and more for databases relevant to our search such as 
Embase 3 and CINAHL.   Although exclusion generally has little effect on treatment 
effect estimates, the size and direction of any differences are unpredictable and 
precision may be reduced1,5. This is relevant for our review since treatment effects 
sizes in trials are usually small and even small changes in meta-analysis results may 
have clinical import. Evidence exists that authors are likely to report trials with 
statistically significant results in English, although this trend may be decreasing6. 
Again this could effect our review since we may include exercises in our intervention 
believing they are effective when they are actually less / not effective.  Additionally 
the number of papers included in a review is relevant2. If a review includes a large 
number of papers then excluding one or two NELTs may not make any significant 
difference to the results. However for our review, since physiotherapy research is 
often limited or inadequate8, any exclusions might alter the results in a significant 
way; as demonstrated in small reviews, which may even reach a different conclusion 
if NELTS are excluded1,3, with consequential  influence upon clinical practice. Or, 
where reviews fail to reach a conclusion when a conclusion may have been possible7. 
For our review, even though huge heterogeneity prevents meta-analysis, NELTs 
remain important since all available evidence is required to assist the development of 
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a trial intervention (Appendix I). Furthermore, excluding such papers casts doubt 
upon the thoroughness of our review1-2 and our decision making7. Greater confidence 
may be inspired by their inclusion1 since language inclusiveness indicates a higher 
quality review9. 
 
2. Effects of Inclusion.  
The inclusion of NELTs may also adversely effect our review. The methodological 
quality of NELTs tends to be poorer1,5, although these differences in quality may be 
small4,6,  and it might be expected that these differences may also be unpredictable. 
For our review this is a concern. Physiotherapy trials have traditionally been of low 
quality8 even in English. Plus, we believe physiotherapy practice varies widely across 
countries so practice in some countries may be inappropriate to inform practice in 
England. Including NELTs can also create difficulties when findings have been 
reported in both English and non English6, 8 since the duplication of findings can 
effect results. We have identified one duplicate trial in English and German. 
If NELTs are reported less fully than those published in English then it also 
might be appropriate not to include them4. We plan to screen trials for quality prior to 
inclusion. Additionally, work on language bias has been limited to several languages 
and languages / countries do not seem to respond similarly to language bias1,4-5. The 
NELTs languages involved in our review (Swedish and Russian) have not been 
researched and so if / how they are likely to be effected by language bias is unknown.  
  The importance of including / excluding NELTS depends on the review’s 
topic area6.9. It has been recommended that for orthopaedic reviews like ours it is 
important to include NELTs1,6, and to search widely since Medline is not able to 
identify all relevant trials3,6 which we have done (Appendix I).  
Furthermore, including NELTs can add considerably to the costs and time 
required to undertake the review and delay the review’s conclusion1,3,9. Although, 
with the development of the Cochrane Central Register of Controlled Trials 
(CENTRAL), locating NELTs should get easier10, locating physiotherapy trials is 
currently time-consuming. CENTRAL identified none of our three identified NELTs. 
Our costs and time are constrained with the trial starting 01/10/2005.  
If we include NELTs we need to address who/how should translations be 
performed? Reviewers have used translations by themselves, colleagues or 
professional translators 2,4.  Sandford (1996)11 opines that specialist subject 
knowledge, plus fluency, is required to obtain an accurate translation which 
incorporates how medical practice, language, abbreviations and cultural differences 
vary across countries with only professional medical translators being used. This 
approach would add significantly to our costs. 
 
3. Screening. 
A further approach is to have an abstract or article translated “ to the degree 
necessary”3 to determine whether it meets the review inclusion criteria and then take 
further action as appropriate. This approach averts the decision to include / exclude all 
NELTS and makes an individual decision for each trial report. This would appear to 
be a pragmatic and cost effective practical approach to relate to our review.  
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4. Ignore. 
Given the evidence that language bias exists we decided to reject this option. We 
concur that it “surprising” how often reviews are limited, without discussion, to 
English language publications2. 
 
Decision.  
Although our review is constrained, we believe it is necessary to include all identified 
trials meeting our criteria, regardless of language. Although meta-analysis will be 
inappropriate for our review, we feel that the introduction of language restrictions 
might affect the quality of our future trial intervention; an avoidable risk.  We accept 
Sandford’s (1996)11 concern regarding the use of non-professional medical 
translators, however we have budgetary restrictions and need to be pragmatic. We will 
therefore screen our NELTs with colleagues who come from Russia and Sweden. Any 
reports appearing pertinent to our review will subsequently be sent for full 
professional translation. This approach meets our constraints, since the number of 
NELTS is few, and has been approved by the review team and external experienced 
allied health professional systematic reviewers. 
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SUB APPENDIX I. 
 
A SUMMARY OF OUR PROPOSED REVIEW. 
 
Title: A systematic review evaluating the effectiveness of post operative 
physiotherapy exercise following discharge from hospital (in terms of improving 
function, mobility and strength) for patients undergoing elective total hip or knee 
arthroplasty (joint replacement). 
 
Background: Generally there is a marked and rapidly decreasing length of stay 
following arthroplasty. Previous work suggests that early discharge after arthroplasty 
frequently results in persistent muscle weakness and poor functional mobility and that 
further rehabilitation within primary care may be required to optimise recovery for 
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these patients. It is not yet known whether such physiotherapy interventions are 
effective in improving function, mobility, strength or range of movement.  
 
Purpose: This review is primarily being undertaken to inform the development of a 
new complex intervention for use in a randomized controlled trial “Is post discharge 
physiotherapy effective in improving function and mobility following elective joint 
arthroplasty in a Diagnostic and Treatment Centre?” The trial is due to start in 
October 2005. The purpose of the trial is to discover whether patients discharged 
early following elective joint arthroplasty significantly benefit from additional 
physiotherapy post discharge, compared to usual care.   
 
Participants: The participants for inclusion in this review are patients undergoing 
elective total hip or knee arthroplasty who have received physiotherapy following 
discharge from hospital post-operatively. 
 
Intervention: The intervention “physiotherapy” is referred to by different names in 
the literature; namely, physiotherapy, physical therapy, home programme, exercise 
and rehabilitation. For the purposes of this review the term physiotherapy refers to 
any exercises or exercise programme provided by physiotherapists/physical therapists 
during the rehabilitative period after discharge from hospital after joint replacement 
surgery occurring in the out patient, community or home setting. 
 
Comparison: The review will include randomized clinical trials relevant to the 
review question, regardless of language of publication. Trials will be included if they 
compare a post discharge physiotherapy exercise intervention compared with either 
control group, usual care or another form of physiotherapy exercise intervention. 
 
Outcomes: The relevant outcomes by which effectiveness is to be measured include 
the following: Function, Mobility, Muscle strength, Range of motion.  
 
Location of Studies: Early searches were conducted prior to this systematic review 
to begin to identify appropriate search terms. Since these searches indicated that a 
large number of terms seemed relevant, a broad area search was initially undertaken 
which was followed by a number of more specific searches to check that as many 
relevant records as possible were identified. It was accepted that this inclusive 
approach would identify many papers irrelevant to the review but this approach 
seemed to offer the most comprehensive method of locating the maximum possible 
number of trials present. The databases searched were: AMED 1985-; 
CINAHL 1982-;EMBASE 1974-;KingsFund 1979-;MEDLINE 1966-;The Cochrane 
library (including Cochrane reviews, Cochrane Central Register of Controlled Trials, 
DARE); 
PEDro physiotherapy evidence database; The Department of Health National 
Research Register 
Terms searched included: 
Hip, knee, replacement, arthroplasty, trial, exercise, physiotherapy and physical 
therapy, home programme. 
 
Selection of Studies: Two reviewers will independently assess the eligibility of 
identified studies for inclusion into the review against specified criteria. A consensus 
meeting will be held to discuss discrepancies. 
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Data Extraction: Data regarding the quality of the studies and their results will be 
independently extracted by two reviewers. A consensus meeting will be held to 
discuss discrepancies and a third reviewer is available for further discussion.  
Quality: A form, based upon the CONSORT statement1 and the CASP guidelines2 
has been developed to extract information for the review. This form includes rating 
the following aspects: adequate randomisation procedures; adequate concealment; 
blinding of outcome assessment; attrition; power and size of study; effect size.  
Analysis:  This stage of the protocol is still being developed. A statistician is being 
consulted regarding the design of this section. It is anticipated that, since the studies 
included in this view are not likely to be heterogenous, a meta-analysis will be 
inappropriate and potentially misleading  for this review. 
 
1. Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., 
Gøtzsche, P. C., Lang, T. (2001) The revised CONSORT statement for  reporting 
randomized trials: explanation and elaboration. Annals of Internal Medicine, 134: 
663-694. 
2. Critical Appraisal Skills Programme (accessed 14/05/05) 10 questions to help you 
make sense of randomised clinical trials. http://www.phru.nhs.uk/casp/rct.pdf  
 
SUB APPENDIX II. 
To identify information for this assignment on line databases, including Medline, 
Embase and Cinahl, were searched using the title term “language bias” AND 
document term “systematic review”. The Cochrane Library Methodology Reviews, 
Cochrane Reviewer’s Handbook 4.4.2, and the National Coordinating Centre for 
Health Technology Assessment Monograph Series on CD-ROM were also searched. 
Relevant papers identified from these searches were obtained and their reference lists 
and citations were searched for further publications, as were references lists from 
course notes and the Systematic Reviews Course’s recommended text (see 
bibliography). This search strategy was not intended to be 100% exhaustive but was 
designed to provide sufficient relevant and appropriate information for this 1000 
word assignment.  
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APPENDIX III. 22 Item Checklist. (based on the 
CONSORT1 statement and CASP2 guidelines.) 
 
Authors and Year of Publication:  
         
Item  
Number 
Paper Section  
and Topic 
Descriptor: Does the study include/ 
mention this? 
1 Title & abstract 
how participants were allocated to  
interventions? (eg: “random allocation” “randomized”) 
2 
the scientific background and explanation of  
rationale included? Introduction: Background 
 
Eligibility criteria 3 Methods: Participants 
 
Method of recruitment  
 
 
Setting and locations where data was collected 
4 Methods: Interventions 
Precise details of the interventions intended for each  
group and how and when they were actually  
administered 
Methods: Objectives 
Specified objectives and hypotheses 
5 
Clearly defined primary and secondary outcome  
Measures.  
 
6 Methods: Outcomes 
Please state outcome measures used 
 
When applicable, any methods used to enhance the  
quality of measurement (e.g. multiple observation, 
training of assessors) 
7 Methods: Sample size 
How sample size was determined and, when applicable, 
explanation of any interim analyses 
 
PLEASE STATE SAMPLE SIZE 
 Methods: randomisation 
Does it state that randomisation has occurred? 
8 Methods: Randomisation 
Sequence generation 
Method used to generate the random allocation 
sequence, including details of any restriction (Eg: 
blocking or stratification) 
9 Methods: Randomisation 
Allocation concealment 
Method used to implement the random allocation  
Sequence, cf: whether the sequence was concealed  
until interventions were assigned 
10 Methods: Randomisation 
Who generated the allocation sequence, who enrolled  
Patients, and who assigned patients to their groups 
Implementation 
Were participants blinded to allocation? 
(Consider that this may not be possible2) 
 
Were those administering the intervention blinded? 
(Consider that this may not be possible2) 
 
11 Methods: Blinding 
Was outcome assessment blinded? 
 
12 Methods: Statistical methods
Methods used to compare groups for primary outcomes 
and methods for additional analyses (such as subgroup 
and adjusted). Please state. 
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13 Results: Participant flow 
Flow of participants through each stage (i.e. number  
Randomized, receiving intended treatment, completing 
protocol, analysed. Also, protocol deviations (&  
reasons) as planned. 
14 Results: Recruitment 
Dates defining the periods of recruitment and follow-up 
15 Results: Baseline data 
Baseline demographics and clinical characteristics  
presented for each group 
No of participants in each group included in each  
Analysis 
 
PLEASE PROVIDE NUMBERS (in absolute numbers 
rather than percentages) 
16 Results: Numbers analysed 
Was the analysis by intention to treat? 
For each primary and secondary outcome are the  
following included? 
 
Results: Outcomes and  
estimation 
 
Summary of results 
 
 
Estimated effect size 
 
 
Precision (eg. 95% confidence interval) 
17 
Please state the results for  
each outcome measure 
 
 
18 Results: Ancillary analyses 
Address multiplicity by reporting any other 
analyses performed, including sub group and  
adjusted analyses, indicating whether those  
preplanned, and those exploratory 
19 Results: Adverse events 
All important adverse events or side effects in each  
Group 
20 Discussion: Interpretation 
Interpretation of the results, taking into account study 
hypotheses, sources of potential bias or imprecision,  
and the dangers associated with multiplicity of analyses 
outcomes 
21 Discussion: Generalizability 
Extent of generalisability 
 
22 
General interpretation  of results in the context of  
Discussion: Overall evidence current evidence 
 
1Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T. (2001) 
The revised CONSORT statement for  reporting randomized trials: explanation and elaboration. Annals of Internal 
Medicine, 134, 663-694. 
2Critical Appraisal Skills Programme (accessed 14/05/05) 10 questions to help you make sense of 
randomised clinical trials. http://www.phru.nhs.uk/casp/rct.pdf  
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APPENDIX IV. ASSESSING THE QUALITY OF 
RANDOMISED CLINICAL TRIAL REPORTS FOR A 
PROPOSED REVIEW: IS BLINDING NECESSARY? 
 
This assignment was written by Catherine Minns Lowe and submitted as part of the 
Systematic Reviews Module, Department of Continuing Education, University of 
Oxford 01/07/2005. It was awarded Grade A. 
 
Introduction. 
This assignment addresses the question: is it necessary for systematic reviewers 
assessing the quality of trial reports in a proposed systematic review, evaluating the 
effectiveness of post-operative physiotherapy exercise following hospital discharge 
for patients undergoing elective total hip/knee arthroplasty, (Sub Appendix I), to be 
blinded to certain details of the report?  And, if so, to what aspects of the trials should 
blinding be applied? 
 
Background. 
The issue of blinding is not new. Nearly 20 years ago it was suggested that the quality 
of reports should be assessed under blind conditions to prevent/minimise the 
introduction of selection and data-extraction bias into the review process1. However, 
until recently, little research has been undertaken to assess whether blinding 
increases/reduces such bias2-4. Contradictory evidence supports4-6 or refutes2,7-9 
whether blinding reviewers affects the quality or outcome of the review process and 
introduces bias. An ongoing systematic review may provide more definitive answers 
but has yet to be completed10. 
 
How blinding might effect our review. 
Information was obtained (Sub Appendix II) and considered with regard to our review 
and its constraints and practical limitations.  
Blinding reviewers would be problematic for our review. The review team 
consists of three physiotherapy researchers; with no funding for extra assistance. 
Reviewer 1 has identified studies and, through peer review with Reviewer 3, has 
selected studies for inclusion into the review; both cannot be blinded for the quality 
reviewing stage. In addition, Reviewer 1 has in-depth knowledge of the review topic 
and, even if blinding could have taken place, would be highly likely to recognise 
studies (a recognised difficulty/limitation of the blinding process2) and may be less 
critical of their quality because of her interest and enthusiasm for the topic11. Such 
prior knowledge of study results may be a problem since studies may be 
selected/rejected according to the reviewer’s preconceived ideas about the topic10. 
Reviewer 1 believes she has no preference regarding the outcome of the review but 
may be unconsciously biased12.  Reviewer 2 was not involved in study selection and is 
able to be blinded for the data extraction stage to rate study quality. Reviewer 2 has a 
background in physiotherapy research but no specific knowledge of joint replacement 
physiotherapy research and is unlikely to have previously read the studies.  She may 
therefore be more critical of the quality of studies because of lower professional 
interest in the topic11 and, although as an experienced researcher blinding may be less 
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successful7, she may review more strictly5. For these reasons it would be 
inappropriate to randomise blinding / non-blinding status for the reviewers10 but we 
could allocate a blind and non blind reviewer.  Other research indicates that reviewer 
characteristics have little effect on reviewing quality13 so a variety of views exists.   
Surprisingly little is known about the cognitive aspects of reviewing12 and other 
factors may influence how our reviewers rate study quality that are not yet 
predictable. 
If we include blinding we need to decide what study aspects to blind and, 
again, considerable variety occurs. Blinding for author1-2,4,7-10, because either well-
known authors may be rated less critically2 or more harshly due to professional 
jealousies5, is unlikely to be relevant to review since there are no renowned experts in 
our review topic area. The identified research is by different authors with no 
programmes of research in the area. However, there is the risk of reviewers personally 
knowing authors. Blinding for affiliation 2,4,7 8,10, acknowledgements4, funding source4 
or location14 appears relevant since recognised centres of excellence for physiotherapy 
research exist and may influence reviewer’s perception of quality.  Blinding for 
journal1,4,10,14, and the look of the journal10, may also be important since our reviewers 
may give greater import to high repute journals.  Blinding for study results10 and 
identity of control and treatment groups3 might also influence our review if, as 
mentioned previously, preconceptions about treatment effect are held by reviewers: 
however, this is not thought to be true. 
Blinding methods10 are another issue for our review. Concealment ranges from 
electronically scanning and editing reviews3 to using a black marker/opaque tape to 
score out relevant aspects6,14.   We have no scanner so the latter would be a practical 
and less time consuming3,6 choice.   The extent of blinding also varies10; some 
researchers remove relevant aspects throughout the study3, others only from the title 
page, headers/footers and acknowledgements and not from the main text where 
identifiers may still be included2,7,8-9. Elsewhere this is unclear4,14. 
Advocates of blinding reviewers believe this may produce less biased reviews5 
of higher quality6 and with lower and more consistent scores than non blinded ones4 
whilst other research suggests that blinding is not achievable or worth the time and 
effort required2,4-5,7,9 
For example, Berlin (19973) concluded blinding was not worthwhile. Berlin’s 
research was then criticised for the small number of meta-analyses, plus the 
considerable heterogeneity, involved15.  The low rates of blinding achieved, ranging 
from 54-73%2,5-6,9 are another reason why some advocate blinding to be 
inappropriate/unnecessary. Additionally, some reviewers find blind reviewing more 
difficult5; as our reviewers are experienced this is unlikely to be a problem.  
 
Decision. 
Using the literature alone, no definitive answer was discovered although there seems 
to be more support for the view that blinding is not successful or worthwhile.  
However, since debate exists and conclusive evidence is absent, decisions regarding 
blinding rest with the authors and the available resources16. For our review Reviewer 
1 will not be blinded to the review whilst Reviewer 2 will be blinded. Success/failure 
rates of blinding will be assessed and interobserver agreement will be measured as 
advised1. This approach of using blinded and non blinded reviewers and comparing 
the results has previously been used successfully9. Reviewer 1 will conceal 
affiliations, acknowledgements, funding, location and journal throughout the 
documents for Reviewer 2, trying to avoid creating incomprehensible text10. 
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Following independent review by Reviewers 1 and 2, discrepancies will be discussed 
in an attempt to reach consensus17.  Discrepancies will also be discussed with 
Reviewer 3 to assist achieving consensus. We will clearly state the processes we have 
used in our review write up16 and believe that having a blinded reviewer will assist 
acceptance for publication in addition to contributing to the quality of our review. 
Additionally, we accept that blinding is only one aspect of a review’s quality and that 
all aspects of the review effecting quality, such as the quality review instrument used9 
need to be adequately addressed. 
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ADDITIONAL. 
 
The following paper was identified and ordered but did not arrive in time for inclusion 
into this assignment.  
 
Berlin, J. A., Miles, C. G., Crigliano, M. D. et al., (1997) Does blinding of readers 
affect the results of meta-analyses? Results of a randomized trial.  Online J Curr Clin 
Trials. Document no 205. 
 
SUB APPENDIX I. 
 
A SUMMARY OF OUR PROPOSED REVIEW. 
 
Title: A systematic review evaluating the effectiveness of post operative 
physiotherapy exercise following discharge from hospital (in terms of improving 
function, mobility and strength) for patients undergoing elective total hip or knee 
arthroplasty (joint replacement). 
 
Background: Generally there is a marked and rapidly decreasing length of stay 
following arthroplasty. Previous work suggests that early discharge after arthroplasty 
frequently results in persistent muscle weakness and poor functional mobility and that 
further rehabilitation within primary care may be required to optimise recovery for 
these patients. It is not yet known whether such physiotherapy interventions are 
effective in improving function, mobility, strength or range of movement.  
 
Purpose: This review is primarily being undertaken to inform the development of a 
new complex intervention for use in a randomized controlled trial “Is post discharge 
physiotherapy effective in improving function and mobility following elective joint 
arthroplasty in a Diagnostic and Treatment Centre?” The trial is due to start in 
October 2005. The purpose of the trial is to discover whether patients discharged early 
following elective joint arthroplasty significantly benefit from additional 
physiotherapy post discharge, compared to usual care.   
 
Participants: The participants for inclusion in this review are patients undergoing 
elective total hip or knee arthroplasty who have received physiotherapy following 
discharge from hospital post-operatively. 
 
Intervention: The intervention “physiotherapy” is referred to by different names in 
the literature; namely, physiotherapy, physical therapy, home programme, exercise 
and rehabilitation. For the purposes of this review the term physiotherapy refers to 
any exercises or exercise programme provided by physiotherapists/physical therapists 
during the rehabilitative period after discharge from hospital after joint replacement 
surgery occurring in the out patient, community or home setting. 
 
Comparison: The review will include randomized clinical trials relevant to the 
review question, regardless of language of publication. Trials will be included if they 
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compare a post discharge physiotherapy exercise intervention compared with either 
control group, usual care or another form of physiotherapy exercise intervention. 
 
Outcomes: The relevant outcomes by which effectiveness is to be measured include 
the following: Function, Mobility, Muscle strength, Range of motion. 
 
Location of Studies: Early searches were conducted prior to this systematic review to 
begin to identify appropriate search terms. Since these searches indicated that a large 
number of terms seemed relevant, a broad area search was initially undertaken which 
was followed by a number of more specific searches to check that as many relevant 
records as possible were identified. It was accepted that this inclusive approach would 
identify many papers irrelevant to the review but this approach seemed to offer the 
most comprehensive method of locating the maximum possible number of trials 
present. The databases searched were: AMED 1985-; 
CINAHL 1982-;EMBASE 1974-;KingsFund 1979-;MEDLINE 1966-;The Cochrane 
library (including Cochrane reviews, Cochrane Central Register of Controlled Trials, 
DARE); 
PEDro physiotherapy evidence database; The Department of Health National 
Research Register 
Terms searched included: 
Hip, knee, replacement, arthroplasty, trial, exercise, physiotherapy and physical 
therapy, home programme. 
 
Selection of Studies: Two reviewers will independently assess the eligibility of 
identified studies for inclusion into the review against specified criteria. A consensus 
meeting will be held to discuss discrepancies. 
 
Data Extraction: Data regarding the quality of the studies and their results will be 
independently extracted by two reviewers. A consensus meeting will be held to 
discuss discrepancies and a third reviewer is available for further discussion.  
 
Quality: A form, based upon the CONSORT statement1 and the CASP guidelines2 has 
been developed to extract information for the review. This form includes rating the 
following aspects: adequate randomisation procedures; adequate concealment; 
blinding of outcome assessment; attrition; power and size of study; effect size.  
Analysis:  This stage of the protocol is still being developed. A statistician is being 
consulted regarding the design of this section. It is anticipated that, since the studies 
included in this view are not likely to be heterogenous, a meta-analysis will be 
inappropriate and potentially misleading  for this review. 
 
1. Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., 
Gøtzsche, P. C., Lang, T. (2001) The revised CONSORT statement for  reporting 
randomized trials: explanation and elaboration. Annals of Internal Medicine, 134: 
663-694. 
2. Critical Appraisal Skills Programme (accessed 14/05/05) 10 questions to help you 
make sense of randomised clinical trials. http://www.phru.nhs.uk/casp/rct.pdf  
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7  
 
 
SUB APPENDIX II. 
 
To identify information for this assignment on line databases, including Medline, 
Embase and Cinahl, were searched using the title term “blinding” AND document 
term “systematic review”. The Cochrane Library Methodology Reviews, Cochrane 
Reviewer’s Handbook 4.4.2 and the National Coordinating Centre for Health 
Technology Assessment Monograph Series on CD-ROM were also searched. 
Relevant papers identified from these searches were obtained and their reference lists 
and citations were searched for further publications, as were references lists from 
course notes and the Systematic Reviews Course’s recommended text (see 
bibliography). This search strategy was not intended to be 100% exhaustive but was 
designed to provide sufficient relevant and appropriate information for this 1000 word 
assignment.  
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APPENDIX V. Blinding Monitoring Form. 
 
1. Can you identify the authors of this research report? (Please tick one response) 
 
 
 
      Yes         No                              Think I can guess 
 
If you have answered ‘YES’ or ‘Think I can guess’, then please write the author/s below 
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
2. Can you identify any author affiliations of this research report? (Please tick one 
response) 
 
 
 
      Yes         No                              Think I can guess 
 
If you have answered ‘YES’ or ‘Think I can guess’ , then please write the affiliations  below 
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
3. Can you identify the funding source for this research? (Please tick one response) 
 
 
 
      Yes         No                              Think I can guess 
 
If you have answered ‘YES’ or ‘Think I can guess’, then please write the funding source 
below 
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
4. Can you identify the location/s at which this research took place? (Please tick one 
response) 
 
 
 
      Yes         No                              Think I can guess 
 
If you have answered ‘YES’ or ‘Think I can guess’, then please write the location/s below 
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
5.  Can you identify the journal this research report is published in? (Please tick one 
response) 
 
 
 
      Yes         No                              Think I can guess 
 
If you have answered YES, then please write the Journal name below 
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…………………………………………………………………………………………………
………………………………………………………………………………………………… 
APPENDIX VI. DATA EXTRACTION FORM FOR SYSTEMATIC REVIEW (based on the CONSORT1 statement and CASP2 guidelines.) 
Authors and Year of Publication:  
         
Item  
Number 
Paper Section  
and Topic 
Descriptor: Does the study include/ 
mention this? 
YES or NO or  
Partial or Unclear 
       
Appropriate / 
Inappropriate 
Comments /  
Details 
1 Title & abstract 
how participants were allocated to  
interventions? (eg: “random allocation” “randomized”)    
2 Introduction: Background 
the scientific background and explanation of  
rationale included?    
 
Eligibility criteria 
 
 
 
 
 
 
 
 
Method of recruitment  
 
     
  
 
3 Methods: Participants 
 
 
 
 
 
Setting and locations where data was collected 
 
  
 
4 
 
 
Methods: Interventions 
Precise details of the interventions intended for each  
group and how and when they were actually  
administered 
 
 
 
 
 
 
 
 
 
 
   
5 Methods: Objectives 
Specified objectives and hypotheses 
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Clearly defined primary and secondary outcome  
Measures.  
 
  
 
Please state outcome measures used 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 Methods: Outcomes 
When applicable, any methods used to enhance the  
quality of measurement (e.g. multiple observation, 
training of assessors) 
  
 
7 Methods: Sample size 
How sample size was determined and, when applicable,
explanation of any interim analyses 
 
PLEASE STATE SAMPLE SIZE 
  
 
 Methods: randomisation 
Does it state that randomisation has occurred? 
   
8 Methods: Randomisation 
Sequence generation 
Method used to generate the random allocation 
sequence, including details of any restriction (Eg: 
blocking or stratification) 
   
9 Methods: Randomisation 
Allocation concealment 
Method used to implement the random allocation  
Sequence, cf: whether the sequence was concealed  
until interventions were assigned 
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10 Methods: Randomisation 
Implementation 
Who generated the allocation sequence, who enrolled  
Patients, and who assigned patients to their groups    
Were participants blinded to allocation? 
(Consider that this may not be possible2) 
 
   
Were those administering the intervention blinded? 
(Consider that this may not be possible2) 
 
 
  
11 Methods: Blinding 
Was outcome assessment blinded? 
 
   
12 
 
Methods: Statistical methods 
Methods used to compare groups for primary outcomes
and methods for additional analyses (such as subgroup 
and adjusted). Please state. 
 
   
13 Results: Participant flow 
Flow of participants through each stage (i.e. number  
Randomized, receiving intended treatment, completing
protocol, analysed. Also, protocol deviations (&  
reasons) as planned. 
   
14 Results: Recruitment 
Dates defining the periods of recruitment and follow-up
   
15 Results: Baseline data 
Baseline demographics and clinical characteristics  
presented for each group    
No of participants in each group included in each  
Analysis 
 
PLEASE PROVIDE NUMBERS (in absolute numbers
rather than percentages) 
 
  16 Results: Numbers analysed 
Was the analysis by intention to treat?    
For each primary and secondary outcome are the  
following included? 
 
   17 Results: Outcomes and  
estimation 
 
Summary of results 
 
   
 290
 
Estimated effect size 
 
   
 
Precision (eg. 95% confidence interval)    
Please state the results for  
each outcome measure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
18 Results: Ancillary analyses 
Address multiplicity by reporting any other 
analyses performed, including sub group and  
adjusted analyses, indicating whether those  
preplanned, and those exploratory 
 
 
   
19 Results: Adverse events 
All important adverse events or side effects in each  
Group 
 
 
   
20 Discussion: Interpretation 
Interpretation of the results, taking into account study 
hypotheses, sources of potential bias or imprecision,  
and the dangers associated with multiplicity of analyses 
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outcomes 
 
 
21 Discussion: Generalizability 
Extent of generalisability 
 
   
22 Discussion: Overall evidence 
General interpretation  of results in the context of  
current evidence 
 
 
 
 
   
 
1Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T. (2001) The revised CONSORT statement for  reporting randomized trials: 
explanation and elaboration. Annals of Internal Medicine, 134, 663-694. 
2Critical Appraisal Skills Programme (accessed 14/05/05) 10 questions to help you make sense of randomised clinical trials. http://www.phru.nhs.uk/casp/rct.pdf  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX VII. LITERATURE  SEARCH STRATEGIES. 
 
Initially a broad area search was undertaken which was followed by a number of more specific searches to check 
that as many relevant records as possible were identified.  
 
Terms searched included: 
Hip, knee, replacement, arthroplasty, trial, exercise, physiotherapy and physical therapy. The full search 
strategies are listed below. 
 
SEARCH 1. 
Date: 10-11th March 2005 
Databases: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” 
AND “replacement” OR “arthroplast$” 
AND “rehabilitation” AND “trial$”  
 
The whole documents were searched. 
 
Hits: Total number of hits = 747 
After removal of duplicates command the number of hits = 595 
After hand searching the records more duplicates were found and 8 further records were removed. The final 
numbers of hits = 587 
 
Results: The records were searched and the table below shows the subject areas found.   
 
Subject Number  
Records relating to rehabilitation 
and / or exercise 
56 
 
Of these 25 abstracts related to post operative exercise / 
rehabilitation 
11 related to pre operative exercise 
therapeutic modalities (e.g. TNS, electrical stimulation) = 6 
gait = 5 
muscle training = 4 
weight bearing = 1 
manipulation = 1 
overview = 1 
In patient exercise=1 
Home programme = 1 
Records relating to other conditions 
(for example, fractured neck of 
femurs, cruciate ligaments) 
317 
Records relating to operative and 
postoperative procedures, 
complications and drugs. 
50 
Records relating to the condition 
Osteoarthritis 
42 
Records relating to predictors of 
outcome or outcome measures 
25 
Records relating to patient 
information &/or education 
20 
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Records relating to the use of 
continuous passive motion  
22 
Records providing reviews or 
opinions 
17 
Records relating to prostheses 15 
Records relating to pain 7 
‘other’ records (relating to aspects 
like nutrition, fatigue, practice 
guidelines, patient / carer 
experience, cost effectiveness of 
hospital at home schemes, length of 
stay) 
33 
 
These numbers total 604 because some records belonged in more than one category. 
 
Updated 24/04/2007:  180 hits 
Nil new records. 
 
SEARCH 2 
Following the above search, several more specific searches were undertaken to enhance likelihood of all 
possible relevant records being identified. 
 
Date: 16th March 2005 
Databases: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “exercise” AND “trial$” (title) 
 
Hits: Total number of hits = 198 
After removal of duplicates command the number of hits = 118 
 
3 new relevant records, on post operative exercise were identified for consideration for inclusion into the review. 
A further 8 records, relevant to the proposed trial, were located. Of these, 3 were review articles, one record 
related to recreational exercise after joint arthroplasty, 3 to pre operative exercise, and one to inpatient pre and 
post operative exercise. 
 
Updated 24/04/2007:  1 hits 
Nil new records. 
 
 
SEARCH 3 
Date: 16th March 2005 
Databases: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “physiotherapy” AND “trial$” (title) 
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Hits: Total number of hits = 6 
After removal of duplicates command the number of hits = 2 
 
Results: No new relevant records found. 
 
Updated 24/04/2007:  4 hits 
Nil new records. 
 
 
SEARCH 4 
Date: 16th March 2005 
Databases: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND  physiotherapy  (title) 
 
Hits: Total number of hits = 63 
After removal of duplicates command the number of hits = 39 
 
Results: No new records for consideration for inclusion into the review were identified. New related records 
identified = 5.  One record related to a post operative complication, one to a conference paper about preoperative 
physiotherapy, one to post operative physiotherapy and 2 were reviews. 
 
Updated 24/04/2007:  14 hits 
Nil new records. 
 
 
SEARCH 5 
Date: 16th March 2005 
Databases: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND physical therapy (title) 
 
Hits: Total number of hits = 66 
After removal of duplicates command the number of hits = 43 
 
Results: 8 new records were identified for consideration for inclusion in to the review.  A further 13 new 
relevant related records identified were identified for the proposed trial: 7 reviews or opinions, 3 comparing 
continuous passive motion and physical therapy, 1 relating to prosthetic type, 1 ‘other’ relating to service 
utilisation and 1 relating to osteoarthritis. 
 
Updated 24/04/2007:  15 hits 
Nil new records. 
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SEARCH 6. 
Date: 16th March 2005 
Database: The Cochrane library (including Cochrane reviews, Cochrane Central Register of Controlled Trials, 
DARE) 
 
Search: 
Browsed by topic musculoskeletal 
Search narrowed osteoarthritis 37 hits 
Search narrowed rehabilitation 9 hits 
Search narrowed exercise 3 hits  
 
Results: 1. Intensity of exercise for the treatment of osteoarthritis. 2. Home versus centre based activity 
programmes for older adults. 3. Exercise for osteoarthritis of the knee 
Patient education 1 hit 
Continuous passive motion 1 hit 
Modalities 1 (electromagnetic fields) 
Splints / orthoses 1 hit 
Multidisciplinary rehabilitation 1 hit   
Result: protocol for Multidisciplinary rehabilitation interventions for joint replacement at the knee and hip for 
arthropathies. 
To check the search, a further search of the term “joint replacement” was done. Of the 80 hits identified, there 
were no other relevant records. 
 
Updated 24/04/2007: Nil new relevant records. 
 
 
 SEARCH 7. 
Date: 16th March 2005 
Database: PEDro physiotherapy evidence database 
 
Search terms: 
joint replacement AND rehabilitation 
Result: 1 hit (record already identified in search 1) 
 
Search terms: The search terms were then broadened to, 
joint replacement 
 
Results: 5 hits. 1 relevant record (already identified in search 1) therefore no new records were identified via 
this search. 
 
Updated 24/04/2007: Nil new relevant records. 
 
 
SEARCH 8. 
In addition to searching for published research, efforts were made to identify ongoing relevant research projects. 
 
Date: 16th March 2005  
Database: the Department of Health National Research Register. 
 
Search terms:  joint replacement AND rehabilitation .  
Result:  0 hits 
   
Search terms:  joint replacement AND physiotherapy   
Results: 7 hits - 2 ongoing, 5 completed. Ongoing projects included a pilot project of class versus outpatient 
physiotherapy after knee replacement, plus a project determining prognostic factors for joint replacement 
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outcomes. Completed projects included 1 on osteoarthritis, 1 on rheumatoid arthritis, 1 on acupuncture pre 
operatively, 1 on health beliefs and 1 on patient satisfaction. 
 
Search terms: Joint replacement AND exercise 
Results: 2 hits, both already identified in the previous search 
 
Search terms: Joint replacement AND Physical Therapy 
Results: 3 hits, no new records 
 
Search terms: joint arthroplasty AND physiotherapy 
Results: 0 hits 
 
Search terms: joint arthroplasty AND rehabilitation 
Results: 2 hits, one relevant new record relating to pre operative advice. 
 
Updated 24/04/2007:  1 new trial protocol record. Lead investigator contacted. Recruitment failed therefore trial 
halted and not completed. 
 
 
SEARCH 9. 
Following reading of abstracts and initial reading of papers, a further search including “home programme” was 
performed since this one a further way by which exercise / rehabilitative approaches were termed. 
 
Date: 24thth March 2005  
 
Database: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “home programme”(title) 
 
Hits: Total number of hits = 7 
After removal of duplicates command the number of hits =2 
 
Result:  Both trials had already been found in search 1. 
 
Updated 24/04/2007:  1 hits  
Nil new records. 
 
 
SEARCH 10. 
Since so few articles were found in search 9, the search was then broadened 
Date: 24thth March 2005  
Database: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” (whole document) 
AND “replacement” OR “arthroplast$” (whole document) 
AND “home programme”(whole document) 
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Hits: Total number of hits = 31 
After removal of duplicates command the number of hits =22 
 
Result:  No further trials were identified. One new relevant review, one article on patient’s perspective of joint 
replacement provision and one descriptive study were found; these were considered relevant to the proposed 
trial but not for the systematic review.   
 
Updated 24/04/2007:  27 hits  
Nil new records. 
 
SEARCH 11. 
Hand searches of key journal and conference proceedings occurred between June 27th and July 6th 2005.  The 
supervisors and applicant discussed and decided which sources would be most appropriate to search. The 
following were searched: 
 
Physiotherapy  Journal 1985-2004 inclusive. Contents page of each issue searched. No new relevant articles 
identified. 
 
Physical Therapy 1985-2004 inclusive. Contents pages of each issue searched. 12 issues were missing from 
the library: 
Vol 65 July 1985 
Vol 65 October 1985  
Vol 65 November 1985 
Vol 66 September 1986 
Vol 69 July 1989 
Vol 69 October 1989 
Vol 70 May 1990 
Vol 71 August 1991 
Vol 73 February 1993 
Vol 73 June 1993 
Vol 74 June 1994 
Vol 74 September 1994 
 
For years with missing journals, the annual index to the journal was fully searched. 
 
No new relevant articles were identified for the systematic review. 
 
Journal of Bone and Joint Surgery (Britain) Conference Proceedings 
1985-2004 inclusive. The Proceedings and Reports of Universities, Colleges, Associations and Societies were 
searched until 1991. From 1992 onwards this section was replaced by the Orthopaedic Proceedings 
Supplements, which were searched. 
 
Results. 2 relevant new abstracts were identified for consideration for inclusion into the systematic review. One, 
from 2004 does not appear to be published yet (author written to requesting further information). The second 
abstract was then looked up via KA24 (on a Medline, CINAHL and EMBASE search) and details of a full paper 
located and obtained.  
 
Updated 21/04/2007:  1 new record in JBJS, duplicate of trial already included. 
 
 
SEARCH 12. 
One supervisor also suggested searching for relevant articles from the Occupational Therapy evidence base 
since rehabilitation following joint replacement is also a part of occupational therapy treatment..   
Date: 6th July 2005 
Databases: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
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    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” 
AND “replacement” OR “arthroplast$” 
AND “occupational therapy ” AND “trial$”  
 
The whole documents were searched. 
 
Hits: Total number of hits = 0 
 
Updated 24/04/2007:  0 hits  
Nil new records. 
 
 
SEARCH 13.  
Date: 6th July 2005 
Databases: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” (whole document) 
AND “occupational therapy” (title)  
 
Hits: Total number of hits = 55 
After removal of duplicates command the number of hits = 35 
Results: No new records identified. 
 
Updated 24/04/2007:  3 hits  
Nil new records. 
 
 
SEARCH 14. 
Date: 6th July 2005 
Databases: Searched the following clinical databases via KA 24  
    AMED 1985- 
    CINAHL 1982- 
    EMBASE 1974- 
    KingsFund 1979- 
    MEDLINE 1966- 
Search terms: 
“hip” OR “knee” (whole document) 
AND “occupational therapist$” (title)  
 
Hits: Total number of hits = 7 
Results: No new records identified. 
 
Updated 24/04/2007:  3 hits  
Nil new records. 
 
 
SEARCH 15. 
Date: 6th July 2005 
Database: Database: the Department of Health National Research Register. 
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Search terms:  joint replacement AND occupational therapy.  
Result:  5 hits.  No new relevant records identified fro consideration for the review. 
 
Updated 24/04/2007: Nil new records. 
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APPENDIX VIII. REASONS FOR THE SELECTION OF 
PAPERS INCLUDED IN /EXCLUDED FROM THE REVIEW. 
 
A. Full papers/details obtained and considered for inclusion/exclusion. 
 
Codine  et al., 2004; trial to evaluate the use of low velocity submaximal eccentric hamstring contractions on 
recovery of extension (day 10-30 post op). INCLUDED in the review. 
 
Frost et al., 2002; pilot trial after TKR functional versus traditional exercise. INCLUDED in the review. 
 
Grange et al., 2004; restricted rct (n=14) of arm crank intervention post operatively following THR. Unclear 
from abstract when the intervention occurred. (?when post op). Subsequently EXCLUDED from the review (19th 
May 2005) after the full paper was read since the intervention took place whilst the participants were inpatients 
at a rehabilitation centre. 
 
Gursen and Ahrens, 2004; the full paper was obtained since there was no available abstract. Upon reading the 
full paper, it was EXCLUDED from the review (14th July 2005) since the trial intervention was a pre operative 
home visit.   
 
Hauer  et al.,  2002; trial to evaluate a training after falls rehabilitation intervention. The intervention was 
provided 6-8 weeks post hip surgery (following fracture or elective hip TJR). The population was a  sub 
population of  a larger study of patients with a history of injurious falls. The paper was subsequently 
EXCLUDED  (19th May 2005) since 25 / 28 patients were hip fractures and only 3 were elective joint 
replacements and the surgery was mixed (TJR = 14; hemiarthroplasty = 4; osteosynthesis = 7). 
 
Hesse et al., 2003; trial of treadmill training versus control following total knee joint replacement. It was not 
clear from abstract when the intervention occurred. The paper was subsequently EXCLUDED from the review 
(14th July, 2005) since on reading the full it seemed that the intervention occurred whilst the participants were 
inpatients. 
 
Jan  et al., 2004; rct home programme following joint replacement. INCLUDED in the review.  
 
Johnsson et al., 1988; trial of Physiotherapy intervention 2/12 after THR. INCLUDED in the review.  
 
Kramer  et al.,  2003; trial of clinic and home based rehabilitation following TKR. INCLUDED in the review.  
 
Maire  et al.,  2004. trial of arm-interval training versus control following THR. From the abstract it was unclear 
when the intervention occurred. The full paper was subsequently EXCLUDED (19th May 2005) from the review 
since the intervention took place whilst participants were in a rehabilitation centre.   
 
Mockland and Beverland, 2004; Abstract only for a trial evaluating whether outpatient physiotherapy improves 
range of motion after knee replacement, versus control. From the abstract we would INCLUDE this trial in the 
review therefore the authors were written too and further information requested and later full details were 
obtained. This enabled the study to be included. 
 
Moffet et al., 2004; intensive rehabilitation 2 months after discharge. INCLUDED in the review. 
 
Patterson  et al.,  1995; methodology unclear from abstract. Comparison of exercise program after THR with 
control. INCLUDED in the review. 
 
Rajan  et al., 2004; rct comparing outpatient PT. INCLUDED in the review. 
 
Suetta, et al., 2004; rct comparing standard, muscle strengthening and EMS post THR. INCLUDED in the 
review.  
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Sashika  et al 1996; Clinical trial THR – home program. INCLUDED in the review. 
 
Trudelle Jackson  et al., 2004. rct of late ex programme after THR. INCLUDED in the review.  
 
Worland  et al., 1998;  trial comparing home Continuous Passive Motion machine versus a physiotherapy 
programme following total knee replacement. EXCLUDED from the review (19th May 2005) since CPM is not 
considered active exercise.  
 
B.           Non English Language Papers. Papers reviewed. 
 
Nyberg and Kreuter, 2002. trial comparing group physical therapy and individual training at home in patients 
following THR (n=33). This Swedish paper was translated by a professional translation service for INCLUSION 
in the review (10th June 2006). 
 
Lapshin  et al., 2002. Russian paper re: therapeutic ex in rehabilitation of elderly and aged patients after hip joint 
replacement. No English abstract available therefore the paper was obtained for translation. The paper was read 
by a colleague fluent in Russian who confirmed that the research was not a randomised clinical trial and the 
paper was therefore EXCLUDED (10th June 2006). 
 
 
C.       Non English Language Papers. Abstracts reviewed.  
 
      Chen  et al., 2004. Chinese paper. Abstract in English is difficult to fully understand.  Rct (n=45) of routine and 
recovery rehabilitation groups following hip replacement. EXCLUDED from the review (19th May 2005) 
because the intervention appeared to be an inpatient intervention aimed at reducing post operative complications.  
 
      Kolarz et al., 1999. German paper comparing young (n=58 , aged <70) and older  n=40> age 70) patients 
receiving inpatient rehabilitation following knee replacement. EXCLUDED (19th May 2005) because the trial 
was for an inpatient intervention.  
 
      Nyberg and Kreuter, 2002. Swedish rct comparing group physical therapy and individual training at home in 
patients following THR (n=33). From the English abstract this paper was INCLUDED in the review and was 
translated by a professional translation service. 
       
Tum-Sugden, 1976; The English abstract for this German paper does not describe a trial and includes ice in the 
treatment given to patients. The paper did not meet the inclusion criteria and was therefore EXCLUDED ((19th 
May 2005).   
 
      Ulreich et al., 1997; German paper evaluating the effectiveness of a multidisciplinary rehabilitation programme 
after total knee replacement (n=65). EXCLUDED (19th May 2005) because this was a pilot study rather than a 
clinical trial and the intervention was an  inpatient treatment.  
 
      Werner et al., 2004; German paper comparing treadmill training with partial body   weight support and traditional 
physiotherapy following THR. N = 80. From the abstract this appeared to be a duplicate of the study by Hesse  et 
al, 2003 (same authors, same results numbers) and was EXCLUDED from the review (19th May 2005).  
 
D.    Excluded 19th May 2005 (Abstracts reviewed only).  
 
Beaupre et al., 2001; intervention was post op inpatient regimes  
 
Benedetti et al., 2003; Longitudinal study to evaluate residual muscle function abnormalities after TKA. 
 
Cullen  et al., 1973; Not a trial. Study is describing post THR rehabilitation n = 53. 
 
Drabsch  et al., 1998; Descriptive study of task specific training on walking and sit-to-stand after total hip 
replacement.  
 
Freburger, 2000; Not a trial. Study examining PT utilisation and outcomes (cost, discharge destination) 
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Gilbey et al., 2003; intervention was both pre op (for 8 weeks) and post op (for 12 weeks) 
 
Gilbey  et al., 2003 b. seems the same trial as above but in different journal. 
 
Hewitt & Shakespeare, 2001; intervention was post op inpatient mobilisation regimes rather than post discharge. 
 
Hughes  et al., 1993; Evaluated the effect of inpatient physiotherapy on hospital length of stay. 
 
Jeudason and Stiller, 2002; intervention was post op inpatient regimes  
 
Karst  et al., 1995; study evaluating in patient PT post op. 
 
Kim and Moon, 1995; intervention was post op inpatient regimes  
 
Kumar et al., 1996; intervention was post op inpatient regimes  
 
Lang, 1998; comparison of 6 & 7 day PT on length of hospital stay.  
 
Licciardone  et al., 2004; trial for osteopathic manipulation following TJR rather than PT. 
 
Montgomery & Eliasson, 1996; in patient trial only (CPM v Ex)  
 
Munin et al., 1998; rct of inpatient rehab only.  
 
Richardson, 1975. Not a trial. Paper describes management of THR. 
 
Ritter  et al., 1989; inpatient study re: CPM 
 
Shih et al., 1994; not a trial. A prospective study which aimed to quantitatively measure relative muscle torque 
strengths around the hip. 
 
Stevens, J. E. 2002, rct evaluating neuromuscular stimulation after TKR.  
 
Waters, 1974. Review of two different prosthetic TKRs.  
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APPENDIX IX. STATISTICAL TESTS FOR REVIEWER 
AGREEMENT IN THE SYSTEMATIC REVIEW. 
 
 
KAPPA  
Crosstabs 
  
Output Created 25-OCT-2006 13:37:55 
Comments   
Data 
E:\PhD\Systematic review\cmlsr2.sav 
Filter <none> 
Weight <none> 
Split File <none> 
Input 
N of Rows in Working 
Data File 160 
Definition of Missing User-defined missing values are 
treated as missing. 
Missing Value 
Handling 
Cases Used Statistics for each table are based on 
all the cases with valid data in the 
specified range(s) for all variables in 
each table. 
Syntax CROSSTABS 
  /TABLES=VAR00001  BY 
VAR00002 
  /FORMAT= AVALUE TABLES 
  /STATISTIC=KAPPA 
  /CELLS= COUNT 
  /COUNT ROUND CELL . 
 
Elapsed Time 0:00:00.05 
Dimensions Requested 2 
Resources 
Cells Available 116508 
 
 Case Processing Summary 
 
Cases 
Missing Valid Total 
  N Percent N Percent N Percent 
CML * KB 160 100.0% 0 .0% 160 100.0% 
 
 
 CML * KB Crosstabulation 
Count  
KB 
1.00 2.00   3.00 4.00 Total 
1.00 70 6 27 85 
2.00 4 36 52 47 
3.00 13 4 18 26 
CML 
4.00 1 1 0 0 2 
Total 88 47 17 8 160 
 304
 
 
 Symmetric Measures 
 
  Value 
Asymp. 
Std. 
Error(a) 
Approx. 
T(b) Approx. Sig. 
Measure of Agreement Kappa .524 .054 9.369 .000
N of Valid Cases 160     
a  Not assuming the null hypothesis. 
b  Using the asymptotic standard error assuming the null hypothesis. 
 
 
Reliability  ICC (2,1) Absolute Agreement 
 
Output Created 25-OCT-2006 14:19:02 
Comments   
Data 
E:\PhD\Systematic review\cmlsr1.sav 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working 
Data File 165 
Input 
Matrix Input 
E:\PhD\Systematic review\cmlsr1.sav 
Definition of Missing User-defined missing values are 
treated as missing. 
Missing Value 
Handling 
Cases Used Statistics are based on all cases with 
valid data for all variables in the 
procedure. 
Syntax RELIABILITY 
  /VARIABLES=VAR00001 VAR00002 
  /FORMAT=NOLABELS 
  
/SCALE(ALPHA)=ALL/MODEL=ALPH
A 
  /ICC=MODEL(RANDOM) 
TYPE(ABSOLUTE) CIN=95 
TESTVAL=0 . 
 
Elapsed Time 0:00:00.03 
Memory Available 524288 bytes 
Largest Contiguous Area 524288 bytes 
Resources 
Workspace Required 128 bytes 
 
 
 Case Processing Summary 
 
N %   
Valid 165 100.0
Excluded(
a) 0 .0
Cases 
Total 165 100.0
a  Listwise deletion based on all variables in the procedure. 
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 Reliability Statistics 
Cronbach's 
Alpha N of Items 
.475 2 
 
 
 Intraclass Correlation Coefficient 
  
Intraclass 
Correlation(a) 95% Confidence Interval F Test with True Value 0 
    
Lower 
Bound 
Upper 
Bound Value df1 df2 Sig 
Single Measures .312(b) .167 .444 1.903 164 164 .000
Average Measures .476 .287 .615 1.903 164 164 .000
Two-way random effects model where both people effects and measures effects are random. 
a  Type A intraclass correlation coefficients using an absolute agreement definition. 
b  The estimator is the same, whether the interaction effect is present or not. 
 
 
 
Reliability   ICC (2,1) Consistency Definition 
 
Output Created 25-OCT-2006 14:23:06 
Comments   
Data 
E:\PhD\Systematic review\cmlsr2.sav 
Filter <none> 
Weight <none> 
Split File <none> 
Input 
N of Rows in Working 
Data File 160 
Definition of Missing User-defined missing values are 
treated as missing. 
Missing Value 
Handling 
Cases Used Statistics are based on all cases with 
valid data for all variables in the 
procedure. 
Syntax RELIABILITY 
  /VARIABLES=VAR00001 VAR00002 
  /FORMAT=NOLABELS 
  
/SCALE(ALPHA)=ALL/MODEL=ALPH
A 
  /ICC=MODEL(RANDOM) 
TYPE(CONSISTENCY) CIN=95 
TESTVAL=0 . 
 
Elapsed Time 
0:00:00.03 
Memory Available 524288 bytes 
Largest Contiguous Area 524288 bytes 
Resources 
Workspace Required 128 bytes 
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 Case Processing Summary 
 
N %   
Valid 160 100.0
Excluded(
a) 0 .0
Cases 
Total 160 100.0
a  Listwise deletion based on all variables in the procedure. 
 
 
 Reliability Statistics 
 
Cronbach's 
Alpha N of Items 
.487 2 
 
 
 Intraclass Correlation Coefficient 
 
  
Intraclass 
Correlation(a) 
95% Confidence 
Interval F Test with True Value 0 
    
Lower 
Bound 
Upper 
Bound Value df1 df2 Sig 
Single Measures .322(b) .176 .454 1.948 159 159 .000
Average Measures .487 .299 .624 1.948 159 159 .000
Two-way random effects model where both people effects and measures effects are random. 
a  Type C intraclass correlation coefficients using a consistency definition-the between-measure variance is 
excluded from the denominator variance. 
b  The estimator is the same, whether the interaction effect is present or not. 
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APPENDIX X. TRIAL EXERCISE BOOKLET. 
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APPENDIX XI. COPIES OF ETHICS AND TRUST 
MANAGEMENT APPROVAL AND INDEMNITY LETTERS. 
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APPENDIX XII. DISC OF QUESTIONNAIRES USED IN THE 
TRIAL. 
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APPENDIX XIII. STANDARISED TRIAL PROCEDURES. 
 
 
This manual describes the assessment procedures for the knee trial. It is intended to supplement the 
assessment questionnaires and to be used as a reference manual during trial assessments.  The manual 
is designed to enable all measurements to be taken as consistently as possible throughout the trial.  
 
Because this is a clinical trial all the explanations to patients, instructions to patients and procedures 
followed need to be standardised and followed as closely as possible. Any deviations from these 
protocols need to be noted and explained on the patient’s assessment form. Please do not give any 
extra verbal encouragement or give any feedback to patients regarding their performance. 
 
Procedures are included for the following: 
 
1. Measuring Joint Range of Motion. 
 
2. Timed Walk Test. 
 
3. Leg Extensor Press. 
 
4. Timed Sit-to-Stand.  
 
 
JOINT RANGE OF MOTION. 
 
Knee joint range of motion is being measured using the approach of Norkin and White (2003).   
Explanation to Participants:  The standardised explanation provided to participants is as follows:  
“I am going to measure the amount of movement you have at your knee joint. The instrument 
I will be using to obtain the measurements is called a goniometer. It is similar to a protractor but it has 
two extensions called arms (shows it to patient).  In order to obtain accurate measurements I will need 
to identify some anatomical landmarks (obtain permission to remove trousers/lift skirt if necessary). 
Also I’ll need to press my fingers against your skin to locate some of the landmarks if that is alright? 
(obtain permission). There is a recommended testing position to help make joint measurements easier 
and more accurate so, if possible, I’d like you to lie down on this plinth on your back with your leg out 
straight. If you need any help please let me know. Also, please let me know if you are in any 
discomfort or wish me to stop at any time. Do you have any questions?” 
 
Instructions to Patient: Each movement needs to be demonstrated as a passive movement on the 
participant prior to them performing the movement actively. Before each passive movement the 
examiner instructs the participant that “I will ask you to move your knee in exactly the same way that I 
move your knee”.  After the passive movement then ask the patient whether they have any questions 
before they do the movement actively.  
 
Procedure: Please measure the patient’s knee joint range of motion (in degrees) using the Goniometer 
marked “DoH KNEE TRIAL”.  
 
Knee Flexion. 
 
Starting position: Participant is supine with the knee extended. The hip should be in neutral at the start 
of the movement. A rolled up towel is placed under the ankle to allow the knee to fully extend. 
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Movement demonstration: The examiner holds the ankle with one hand and the posterior thigh with 
the other. The hip is flexed to 90 degrees and stabilised prior to fully flexing the knee until end feel. 
The hand on the femur is also used to stabilise against hip flexion, extension or rotation.  
Goniometric alignment: The fulcrum of the goniometer is centred over the lateral femoral epicondyle. 
The proximal arm is aligned with the lateral midline of the femur, using the greater trochanter as a 
reference point. The distal arm is aligned with the lateral midline of the fibula, using the lateral 
malleolus as a reference point.  
Movement:  The participant actively flexes the knee. 
Recording: The examiner reads the goniometer and records the measurement on the data collection 
form in the patient assessment questionnaire.  
Please remember to write in the whole range (e.g. 0- 90, or 20-120 etc) of active movement. 
 
 
Knee Extension. 
 
Starting position: Norkin and White (2003) state that extension is not usually measured since it is the 
starting position for flexion. However, it is customary clinical and research practice to record knee 
extension, to allow clinical conditions such as a fixed flexion deformity to be estimated, and therefore 
this measurement will be included in this trial. Again the starting position of supine lying will be used 
for the trial. The hip should aim to be in neutral position at the start of the movement. A rolled up 
towel is placed under the ankle to allow the knee to fully extend. 
Movement demonstration: The examiner uses one hand to extend the knee until end feel and the other 
hand to stabilise the femur to prevent hip flexion, extension or rotation.  
Goniometric alignment: The fulcrum of the goniometer is centred over the lateral femoral epicondyle. 
The proximal arm is aligned with the lateral midline of the femur, using the greater trochanter as a 
reference point. The distal arm is aligned with the lateral midline of the fibula, using the lateral 
malleolus as a reference point.  
Movement:  The participant actively extends the knee.  
Recording: The examiner reads the goniometer and records the measurement on the data collection 
form in the patient assessment questionnaire. Please indicate whether a fixed flexion deformity is 
present and, if so, the amount (in degrees) Although hyperextension is uncommon in this clinical 
group, please indicate if this is present and, if so, the amount (in degrees).  
 
 
 
TIMED WALK TEST. 
 
Explanation to Patients: The standardised explanation provided to participants is as follows:  
“In a moment I’m going to ask you to walk between these two markers (show them) and time how 
long it takes you”. 
Instructions to Patients: Patients are instructed to “Please walk at a normal comfortable speed”. I’m 
going to count down three two one Go! And I’d like you to start walking as soon as I say go!  Is that 
alright? (gain permission)Do you have any questions? Are you ready?” Please do not speak to – or 
encourage – the patient during the test itself. 
Procedure: 
Please take the patient to the marked 10m walkway. The walkway has the start and end of the 10 m 
length clearly marked. Please ensure the patient has their shoes on for the duration of this test. Please 
do not assist the patient during the test (unless a safety issue arises – in which case the test will be 
voided and repeated if possible).  
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Please check whether or not the patient usually uses a walking aid. If so, please ensure they use it for 
the test and please ensure that you have completed which type of walking aid they use in the patient 
assessment questionnaire.  
 
Please make sure you are behind the patient during the test (to avoid pacing).  
Please use a count down of “three, two, one, go!” and start timing on “go!” Stop timing when the 
patient crosses the 10m mark. 
Please record the time taken in the patient assessment questionnaire.            
 
 
 
LEG EXTENSOR PRESS. 
 
Explanation to Patients: The standardised explanation provided to participants is as follows:  
“Next I’m going to measure the power you have in your legs. I’m going to ask you to sit down, put 
one leg onto the foot plate, fold your arms and push the foot pedal down as hard and as fast as you can 
(demonstrate). There is a lot of previous research on this machine and we know that it is safe to use 
after knee joint replacements. We’ll practice the movement first so you can get the feel of it. And we’ll 
measure the power of both legs. Is that alright? (gain permission) Have you any questions?”  
 
Procedure: 
Sit patient on LEP seat, making sure their back is positioned against the back rest. Please ensure they 
are wearing shoes.  
 
Baseline measurement. Adjust the seating position by placing one foot on the fully depressed 
footplate and pushing the seat back slowly until the leg is extended as fully as comfortable possible. 
Make sure the seat position is clamped in place after adjustment.  
 
Please record the seat position in centimetres (up to 2 decimal places; eg 45.12cms) on the 
questionnaire. Measure the distance from the front base of the seat (labelled yellow marker 1) to the 
back end of the runner (labelled yellow marker 2).  
 
Follow Up measurements. Each follow up measurement MUST have the same seat position. Please 
set the seat position to be exactly the same as the baseline measurement. Please refer to the LEP 
Master List for this measure if it is not marked on questionnaire (housed in the file marked LEP 
Master list in the front of the top drawer of Catherine Minns Lowe’s filing cabinet). 
 
Please obtain measurements for both legs, starting with the leg NOT undergoing knee replacement 
first. Reset the recording device prior to each test. 
 
Instruct the patient to place the foot of the leg about to measured upon the footplate with their free foot 
resting on the floor.   
 
Instruct them to “fold their arms” and ensure patients keep their arms folded throughout the tests.  
 
Allow 2 warm up attempts for each leg. Please instruct the patient to “push the foot pedal as hard and 
as fast as possible after the count down of three, two, one, push!”  
 
Allow a relaxation period of 15 seconds between each test.  
 
Please record all the results (in Watts) in the table in the patient assessment questionnaire. 
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Please ensure that at least five further tests (not including the warm ups) are carried out on each leg 
and recorded. If the patient is still showing signs of improvement please allow them to continue up to 
a maximum of 10 tests per leg.  
 
Please also make sure you have weighed the patient on the calibrated SECA bathroom scales, and 
recorded this measure in the patient assessment questionnaire since this is needed to perform data 
analysis.  
 
 
TIMED SIT-TO-STAND. 
 
Explanation to Patients: The standardised explanation provided to participants is as follows:  
“This is the last test. I’m going to ask you to sit down on this chair like this (demonstrate) and ask if 
you can stand up and sit down like this (demonstrate). Do you have any questions? Is that alright? 
(obtain permission)” 
Instructions to Patients: The starting position is in sitting. Patients are instructed to “please fold your 
arms across your chest. In a moment I’m going to ask you to stand up and sit down as many times as 
you can within thirty seconds. I’m going to count down three two one Go! And I’d like you to start as 
soon as I say go. Do you have any questions? Are you ready?” Please do not speak to the patient – or 
encourage them – during the test itself. 
Procedure:   
Please use the chair labelled “DoH KNEE TRIAL CHAIR” for use in this part of the study. Place the 
chair next to a wall, with the back legs braced against the wall.  Please ensure the patient has their 
shoes on for the duration of this test. The patient starts the test in the sitting position. 
Use a count down of “three, two, one, go!” Please start timing on “go!”  Please count the number of 
times the patient completes a sit to stand and say “stop!” after thirty seconds and stop timing. Please 
do not assist the patient during the test (unless a safety issue arises in which case the test will be 
voided and repeated if appropriate). 
Please record the number of completed sit-to-stands in the patient assessment form. If the patient is 
unable to do any sit-to-stands then please put 0 in the patient assessment questionnaire.      
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APPENDIX IV. HOME VISIT CASE REPORT FORMS. 
 
Date of visit: 
 
Time of visit: 
 
Duration of visit (in minutes): 
 
Mileage (round trip): 
 
Treatment visit no:   one / two (delete as appropriate) 
 
CONTENT OF VISIT 
Please fill in the approximate time spent on each of the following activities during the visit: 
 
Component Time (in minutes) 
Subjective patient assessment  
Objective patient assessment  
Gait re-education  
Teaching new exercises  
Checking exercises  
Progressing exercises  
Giving Advice  
Task training – getting in /out of car  
Task training – getting up from chair at table  
Task training – walking outside  
Task training - stairs  
Addressing individual patient concerns  
Other: please list  
  
  
Please turn over 
Please list any individual concerns/queries raised by the patient in the space below: 
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APPENDIX XV. DISC OF STATISTICAL TESTS USED IN 
THE TRIAL. 
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 APPENDIX XVI. COPIES OF KNEE AND HIP SYTEMATIC 
REVIEW PUBLICATIONS.   
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